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Adult stem cells are the basis of our reproductive potential, of tissue growth and 
maintenance, and of wound healing and regeneration. Ageing phenotypes such as hair 
loss or brittle bones in fact reflect the gradual decline of the proliferative capacities of 
adult stem cells with time. On the other hand, stem cells that proliferate too fast 
provoque diseases such as cancer. Understanding the molecular players regulating the 
decision of stem cells to divide or differentiate is therefore of prime importance to 
treat conditions caused by stem cell dysfunction. Many pathways that regulate the 
maintenance and differentiation of stem cells, as well as features distinguishing stem 
cells from their more committed progeny, are known today, among them the 
conserved Notch signaling pathway. How these molecules instruct stem cell identity is 
however largely unknown.  
C.elegans germline stem cells, which are maintained by Notch signaling, 
constitute an excellent model to study the regulation of stem cell identity. C.elegans is 
amenable to genetic manipulation, to gene knockdown by RNAi, and to transgenesis. 
Additionally, the C.elegans germline can be readily monitored in live animals through 
the transparent cuticle as well as dissected for gene expression studies or 
immunofluorescence.  
Here, we use these tools to identify genes that respond to Notch signaling in 
germline stem cells. We find that many Notch responsive genes reside on the X-
chromosome. In the following, we uncover a crosstalk between Notch signaling and the 
C.elegans Polycomb proteins MES-2,-3,-4, and -6, which are known to repress X-
linked genes in the germline. 
Additionally, we identify a role of the CIP/KIP cell cycle inhibitor CKI-2 in the 
self-renewal versus differentiation decision of C.elegans germline stem cells. We find 
that CKI-2 is a key target of two conserved stem cell regulators, the RNA binding 
proteins FBF/Pumilio and MEX-3. Particularly FBF/Pumilio proteins have been implied 
in stem cell regulation in many organisms, and in C.elegans are required to maintain 
stem cells during adulthood. Key targets among the mRNAs targeted by FBF/Pumilio 
proteins have however remained elusive. We demonstrate that both MEX-3 and 
FBF/Pumilio proteins associate with the cki-2 3’UTR, that FBF/Pumilio binding elements 
are required for 3’UTR mediated regulation in vivo, and that regulation of CKI-2 by 
FBF/Pumilio contributes to the maintenance of germline stem cells. 
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1.  Why are stem cells fascinating? 
 
1.1 Hunting the origins 
 
Humans have always been curious about origins. What was the origin of the universe? 
How was our planet formed? And how come there is life, how come we are here? Every 
time and culture found their own answers and passed them on in their myths and 
religious beliefs. Modern mankind, despite an increasing unwillingness to believe in 
tranditional explanations, still faces the same questions. This is why scientific news 
that deal with our history such as the birth of a solar system millions of lightyears 
away are as fascinating to the general reader as the discovery of a human ancestor or 
the extraction of mammoth genetic material. On the personal level, we similarly set 
high value in knowing our roots. This seems essential even more in today’s mobile and 
globally connected society. We define ourselves (and others) by looking at ethnic and 
social background. Knowing our personal origins is an existential need, demonstrated 
by the desire of adopted kids to face their genetic parents to whom they have no 
personal connection at all. On an even smaller scale, we chase our personal genesis. We 
try to understand who we are by looking back at childhood experiences, nourishing 
armadas of therapists on the way. We trace times we cannot remember with the help of 
stories and pictures, and ultimately end up at the earliest of events, our personal stem: 
Really, “me” all began with two cells? 
The desire to trace ourselves as individuals, as communities, to trace the 
existence of life and everything around us may reflect our desire to understand 
existence. If we know where we come from, how we were made, we know why we are 
here... don’t we? 
 
1.2  Chasing immortality 
 
Another obsession of humanity that plays into stem cell research, equally strong and 
existential as our drive to unearth our roots, is concerned with death/finiteness and its 
pretty sister eternity. The concept of an absolute and irreversible end exceeds human 
imagination. Just like for origins, virtually every human culture has developed myths 
about continuity after death. To bury or conserve the dead and supply them with grave 
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goods, a habit that implies belief in some kind of afterlife, is generally considered a 
transition to a higher cultural level in the history of mankind. Virtually all religions are 
based on the concept of infiniteness, be it resurrection, passage of the dead into 
another world, or reincarnation. 
The pursuit of eternal life, however, is not exclusively religious. In fact, science 
as we know it today is a side product of the efforts of medieval alchemists to 
synthesize the Philosopher’s Stone, which would not only turn worthless materials into 
noble metal, but also liquids into potions of strong healing powers and rejuvenating 
power. The desire for an elixir of life that confers immortality recurs in myths as greek 
Ambrosia and Hindu Amrit, the drinks of the immortal gods. Obviously, the Elixier of 
Life, although feverishly sought after, remained elusive. However, it did not escape 
human cognition that some organisms possess regenerative capabilities that 
approximate immortality. Being chopped in half, a deadly assault for the pride of 
creation, primitive earthworms would not only survive but double. Again, mythology 
reflects mankind’s fascination with regeneration. Hydra regrows not only one, but two 
heads for every one scythed by Herakles’ sword, and Prometheus’ liver feeds the eagle 
day after day.  
Today’s research on regeneration and stem cells is just another version of the 
hunt for the Elixir of life. Why can’t we, like Axolotl, regrow entire body parts upon 
amputation, when we are comparatively similar in body morphology and genetic 
makeup? And if we knew - could we eventually defeat death? The molecular and 
mechanistic basis of stem cell capacities are intensely investigated today. However, the 
picture is far from complete, and common themes are only starting to emerge. Stem 
cells retain their mystical, mythical and magical image, an image reflected in the 
naming of the stem cell factor Nanog after Tir Na Nog, the land of eternal youth in 
celtic mythology (MacKillop 2004). 
 
These two metaphorical implications of stem cell research - our desire to understand 
origins on one hand and our desire to defeat mortality on the other hand - fuel stem 
cell research to this hour. They contribute to researchers’ motivation, they stimulate 
funding sources to invest in stem cell research, and they fascinate the broader public. 
Stem cell research promises benefits that exceed the mere satisfaction of knowledge 
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acquisition, since stem cell based applications promise relief from our existential fears 
of losing beauty, youth, friends, and ourselves. 
 
2. What are stem cells? 
 
2.1 Defining “Stem Cell” 
 
What do we mean when we call something a stem cell? Semantically, the term 
“stem cell” has a hierarchical connotation and implies linear succession. Today’s 
functional definitions are however much more narrow. “Stemcellness” entails, in the 
classical view, proliferative capacity, selfrenewal, clonality, and potency. Stem cell 
systems conform to these criteria to varying extents. Sensu strictu, although the most 
potent cells imaginable, the earliest cells of an embryo are NOT self renewing, since 
they cannot balance the decision to self renew or differentiate. Yet, in vitro, the very 
same cells (embryonic stem cells, ESCs) have the potential to self-renew indefinitely. 
What is called “stem cell” thus depends on the context, and a definition based on 
functionality seems most appropriate. According to this criterion, a stem cell – no 
matter whether embryonic stem cell, progenitor cell, founder cell, precursor cell or 
transit amplifying cell – has the ability to reconstitute, in dependence of its potency, all 
or parts of a given tissue. Early blastomeres, the in vivo equivalent to ESCs, are the 
most potent cells in an organism. These cells will not only contribute to all tissues of 
the next generation, but will also produce extraembryonic tissues. Embryonic Cancer 
Cells (ECCs), which are derived from germ cell cancers (teratomas), compare to ESCs in 
potency. ECCs differentiate into all three germlayers and were used heavily in the early 
days of in vitro stem cell research because they are easy to handle and meet no ethical 
objections,. Since the advent of ESCs and induced pluripotent cell lines (iPSCs), ECCs 
have however mostly disappeared from the labs. Truly totipotent in vivo, though less 
well amenable to research, are germ cells (GCs). They will give rise to all tissues of the 
next generation, and thus are the only totipotent cell population in adult organisms. 
Otherwise, stem cell identity in the adult is restricted to adult stem cells (ASCs). 
Whether ASCs never completely lost potential during development, or regained 
potency at a later stage, is not known. ASCs maintain and repair tissues, and therefore 
ASC failure results in impaired wound healing and aging, while uncontrolled ASC 
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proliferation has been proposed as a cause of cancer. Finally, cancer stem cells (CSCs), 
the mere existence of which is still debated, have achieved dubious fame. CSCs may 
not only seed tumors, but may also display particular resistance to therapy. Relapse 
after treatment is therefore blamed on this poorly defined cell population (Visvader 
2011). Today, we know how to artificially induce stem cell behaviour in terminally 
differentiated cells to produce induced pluripotent cells (iPSCs) (reviewed by Stadtfeld 
and Hochedlinger 2010). Such reprogramming experiments will be crucial for 
understanding how cell fate decisions are regulated. However, iPSCs do acquire new 
traits such as mutations during reprogramming and also do not entirely eradicate their 
previous identity (Pera 2011), challenging their applicability in the clinic. 
 
2.2 Evolutionary origins of stem cells 
 
Stem cell research on a variety of models underlined their diversity rather than 
unifying principles in the regulation of stemcellness. One possible approach towards 
identifying core stem cell regulators and properties is therefore to look at the 
evolution of stem cells and at the requirements of stem cells in evolutionarily ancient 
organisms.  
Tissue specification implies the existence of a progenitor cell during 
development. In an evolutionary sense, stem cells therefore emerged concomitantly 
with the appearance of specialized tissues (in the most simple scenario, soma and 
germline). The most prominent example for early multicellularity involving progenitor 
cells is found in subspecies of the green algae Volvox. Volvox are considered the most 
ancient truly multicellular organism by the criteria of synergism / division of labor, 
dispensability of individual cells, and reproductive altruism.1 In Volvox, a gene also 
found in unicellular algae (regA) was adapted for a multicellular lifestyle. regA, which 
                                                 
1 Although prokaryotic Myxobacteria and eukaryotic slime molds (such as Dictyostelium) 
are capable of impressive and complex multicellular behaviour, including functional 
specialisation of cells and reproductive altruism (reviewed in Gross, J. D. (1994). "Developmental 
decisions in Dictyostelium discoideum." Microbiol Rev 58(3): 330-51. and in Shimkets, L. J. 
(1990). "Social and developmental biology of the myxobacteria." Microbiol Rev 54(4): 473-501), 
their take on multicellularity neither involves kinship of cells (clonality) nor progressive 
restriction of developmental potential along a cell lineage, and therefore represents a 
sophisticated form of colonialism. 
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in a unicellular context directs temporal alternation of reproductive and vegetative 
lifestyle, directs reproductive and vegetative lifestyle in a spatial context in Volvox 
(reviewed in Michod 2007). RegA promotes a non-dividing, flagellated cell fate 
(terminal differentiation). Cells which do not express regA grow in size beyond the 
threshold required for cell divisions and thus assume reproductive fate. Reproductive 
cells of Volvox give rise to both types of cells in the next generation and can therefore 
be considered developmental stem cells.  
Animal multicellularity supposedly arose through a similar colonialisation-
driven process. The development of cell-cell-communication and nutrient exchange 
among unicellular flagellated choanocytes likely enabled the development of cells 
specialized in reproduction and / or proliferation versus feeding (Nielsen 2008). This 
idea is supported by the build of sponges, which by several criteria (sponges dispose 
of very few cell types, do not obviously gastrulate (although this is a matter of debate: 
(Muller 2006) and (Nielsen 2008)), and lack true epithelia connected by tight cell 
junctions as well as true and clustered HOX genes) reside at the root of the metazoan 
tree (Halanych 2004; Muller 2006) and resemble a permanent choanoflagellate colony. 
How sponges maintain stem cells may therefore tell about universal and ancient stem 
cell requirements. Sponge blast cells and adult stem cells, so called archaeocytes, can 
be identified based on the expression of genes identified as stem cell markers in 
higher organisms, such as the Polycomb group gene EED (Muller 2006), MsCP1, Noggin, 
and glia maturation factor (Muller, Korzhev et al. 2003), indicating that the molecular 
machinery promoting stemness is both evolutionarily ancient and highly conserved. 
Also, sponge stem cells depend on interactions with surrounding tissue for their 
proliferative capacity and immortality; as single cells, they arrest proliferation and lose 
telomerase expression (Koziol, Borojevic et al. 1998). Organismal control of the 
proliferative capacities of the stem cell pool through niche-like interactions is 
therefore an ancient concept. 
Interestingly, in the organism Trichoplax, an organism that competes with 
sponges for the most basal position in the metazoan phylum, the ParaHox gene Trox-2 
has been ascribed a function in tissue maintenance (Jakob, Sagasser et al. 2004). In 
Cnidarians and Bilateria, Hox genes control the patterning of the body axis; 
duplications and differential regulation of Hox genes are considered a major driving 
force of macroevolutionary innovation. Trichoplax is, however, a non-axial organism 
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composed of an upper, ciliated epithelium and a lower, digestive epithelium. Trox-2 is 
expressed in a ring of cells around the junction of the two epithelia and is required for 
continuous growth and fission of the organism (Jakob, Sagasser et al. 2004). Hox genes 
might therefore represent another class of ancient genes originally involved not only in 
patterning, but also stem cell biology. 
Next to sponges and Placozoa, Ctenophores are considered closest to a 
common ancestor of all metazoa, and might therefore be useful to determine the 
origin of metazoan stem cells and universal stem cell properties (Halanych 2004; 
Dunn, Hejnol et al. 2008). Ctenophores are, although still diploblastic, much more 
complex in body morphology than sponges and dispose of several highly specialized 
cell types. Expression analyses of the stem cell marker genes of the SOX family have 
identified several cell populations in Ctenophores, among them a group of cells at the 
base of the tentacle which is continuously supplying cells to that organ (Jager, 
Queinnec et al. 2008). These cells therefore represent the most ancient adult stem cell 
population identified to date which is dedicated to maintain homeostasis in a 
specialized tissue.  
A fascinating hypothesis on the evolutionary origin of adult stem cells is based 
on the observation that many primitive organisms, including sponges and ctenophores, 
reproduce through a larval stage (Arenas-Mena 2010). Evidently, organisms with 
biphasic development set aside plastic cells during larval stages to support 
metamorphosis into the adult animal. Although this practice is obsolete in 
uniphasically developing organisms such as vertebrates, the allocation of plastic cells 
according to the metamorphosis model has been retained during evolution. Our adult 
stem cell pools may thus originate from the metamorphic lifestyle of our sponge-like 
ancestors. 
Molecules expressed in embryonic and adult stem cells in diverse organisms 
are often highly conserved, such as Sox2 or the Puf protein family (Spassov and Jurecic 
2003; Jager, Queinnec et al. 2008), supporting the idea that stemcellness may have 
universal traits, and that stem cells across organisms and tissues may have very 
similar requirements. It is therefore noteworthy that the prominent mammalian stem 
cell factor Oct4 is an evolutionarily novel acquisition. Invertebrate genomes do not 
contain related sequences, and the related pou2 gene of egg-laying vertebrates such as 
fish, xenopus or axolotl cannot substitute for Oct4 function in mouse ES cells. The first 
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gene resembling Oct4, Pou5f1, appears in the order of monotremes along with the first 
appearance of rudimentary placental structures. Oct4, although known to us as 
paradigm pluripotency factor, is therefore a byproduct of placenta evolution (Niwa, 
Sekita et al. 2008).  
 
2.3 The origins of stem cell research 
 
A 21st century stem cell researcher ought to give credit to the giants whose shoulders 
she is standing on. The idea of dividing cells as smallest unit of growth and 
regeneration seems natural to a contemporary biologist, but in fact, this idea was novel 
and exciting only two hundred years ago. Lizard tail regeneration, which we today 
recognize as prime example of adult stem cell capacitiy readout, was already 
documented by Aristotle in his Historia Animalium (Aristotle, Balme et al. 2002). 
However, these observations got unearthed only during Renaissance. A seminal 
publication by the french natural scientist René-Antoine Ferchault de Réaumur 
(Reaumur 1712) re-initiated the field and was followed by multiple observations on 
the regenerative capabilities of diverse organisms. Around the same time, microscopes 
initially devised by Galileo and Janssen were improved by Huygens and Leeuwenhook, 
and scientists became more and more aware that tissues consisted of smaller units of 
some sort. However, it took more than a hundred years from the first observation of 
cellularity of cork by Hooke in 1665 until Dutrochet, Milne-Edwards and Raspail 
between 1824 and 1833 came to the conclusion that all animals and plants have a 
similar cellular structure. In 1839, Schwann finally stated once and for good that all 
organisms were constructed from cells. Only then could any debate on the origin of 
those cells initiate. Schwann himself, though today considered the father of the cell 
theory, was an adept of the exony concept which stated that cells would arise from 
matter outside of cells. Another idea at the time put forward by Mohl in 1837 was that 
organisms may be born with the full complement of cells which would over time 
enlarge and rearrange. Today we know that this is indeed the case for organisms such 
as C.elegans. Although at Mohr’s lifetime, cell divisions had actually already been 
observed in algae and embryos, the issue was only resolved in 1858 to a point where 
Virchow could make is famous statement “omnis cellula e cellula” (Virchow 1859) – 
every cell stems from another one, a seminal realisation for stem cell research. 
Introduction – History of stem cell research 
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Research on adult stem cells as we know it today was fueled by the collision of 
the discovery of radioactivity late in the 19th century and global conflicts in the first 
half of the 20th century. During and after World War II, the protective effects of spleen 
or marrow cells against lethal doses of irradiation, based on their ability to 
reconstitute the damaged hematopoietic system, became apparent. Long term 
successful bone marrow transplants were however achieved only in the late 50ies 
(Humble and Newton 1958). Based on these transplantation experiments, hierarchies of 
blood precursor cells could be established (Till and Mc 1961), followed by lineage 
analysis of other accessible regenerating tissues, such as gut and epidermis (Withers 
and Elkind 1969). Finally, the discovery of totipotent cells in embryocarcinomas that 
could be propagated in vitro, ECCs (embryonic carcinoma cells), opened up 
experimental avenues that laid the foundation for today’s definition of stemcellness in 
terms of potency: the ability to reconstitute all or parts of an organism. ESCs replaced 
ECCs in 1981 (Martin 1981). Over the years, culture conditions and factors required to 
keep nontransformed cells in culture and maintain their potency have been identified 
and applied inversely to induce stem cell identity in terminally differentiated cells. In 
parallel, genetically amenable model organisms such as C.elegans and Drosophila have 
facilitated the identification of molecular players maintaining stem cells in vivo, so that 
by today, approximately 26.000 Pub-Med indexed publications carry “stem cell” in the 
title. And yet, after a century of research efforts, we still lack universal laws concerning 
the requirements of stem cells. 
 
3. How is stem cell identity maintained? 
 
Certainly, we do know a lot more about stem cells today then when first bone marrow 
transplantation experiments were performed. The model organisms Drosophila and 
C.elegans, later joined by zebrafish, mouse and novel models such as sponges and 
planaria, allowed the characterisation of pathways required to maintain stem cell 
populations. In parallel, it has become clear that stem cells share particular features, 
such as open or bivalent chromatin conformation, a preference for low oxygen 
conditions, and a G1-S heavy cell cycle profile (Lako, Neganova et al. 2009; Edel and 
Belmonte 2010; Lange and Calegari 2010; Rehman 2010; Gaspar-Maia, Alajem et al. 
2011). However, it is largely unknown how stem cell factors induce such stem cell 
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features. Forward approaches using the germlines of C.elegans and Drosophila have 
contributed tremendously to the identification of stem cell factors. As shortlived 
organisms – a few weeks at maximum – worms and flies are largely independent from 
somatic adult stem cells, with the exception of the Drosophila intestine (Ohlstein and 
Spradling 2006); both however contain powerful stem cell populations in their 
germlines. Compromised fertility is therefore a straightforward readout of germline 
stem cell defects in these organisms and facilitated large scale screening efforts.  
Conserved signaling pathways are among the stem cell regulators identified in 
worms and flies. The first germ line proliferation defective mutants in C.elegans were 
identified by Austin and Kimble in 1987 (Austin and Kimble 1987). The affected 
transmembrane protein was later found to be orthologous to Drosophila Notch 
(Yochem and Greenwald 1989). In Drosophila, female GSCs depend on BMP signaling, 
and male GSCs on Jak-Stat signaling (Fuller and Spradling 2007). Other signaling 
pathways have been implied in vertebrate stem cell maintenance, such as Wnt 
signaling in the intestine (reviewed by Lowry and Richter 2007). Conserved RNA 
regulatory proteins (again originally identified in worms and flies) have also been 
implied in stem cell maintenance. Prominent members of this group include Nanos, 
Pumilio, and small RNA pathway components (Spassov and Jurecic 2003; Samji 2009; 
Saga 2010). Finally, cell culture experiments paint a picture of transcriptional 
regulation of pluripotency that involves the transcriptional regulators Oct4, Sox2, Myc, 
and Klf4 (Chambers and Tomlinson 2009; Pei 2009). It is intuitive that cells cultured ex 
vivo in a petri dish do not rely on cell-cell signaling to maintain stem cell properties. 
However, whether signaling pathways identified in vivo converge on the same genes or 
at least regulate the same properties as transcription factors identified in vitro remains 
to be determined.  
 
For the sake of this work, the C.elegans germline and three stem cell factors 
that contribute to stem cell maintenance in the C.elegans germline will be introduced 
in more detail: Notch as an example of a signaling pathway, and MEX-3 and FBF-1 / 
FBF-2 as translational regulators involved in stem cell regulation.  
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3.1 Stem cell maintenance in the C.elegans germline 
 
In stem cell research just like in other areas of research, model organisms have 
tremendously helped to outline basic concepts. Both C.elegans and Drosophila are 
limited in their somatic regeneration capacities. Only recently, somatic stem cells were 
identified in Drosophila (Ohlstein and Spradling 2006); C.elegans is entirely 
predetermined and cannot replace cells during adulthood at all. Other model 
organisms with remarkable somatic regenerative capabilities such as planaria or 
axolotl are much less amenable genetically and experimentally. Both worms and flies 
however dispose of extremely powerful germline stem cell pools. Stem cell 
compartments in both organisms display similarities to vertebrate adult stem cell 
compartments such as gut crypts, and rely on highly conserved molecules to maintain 
stem cell proliferation. For these reasons, C.elegans and Drosophila germlines have a 
longstanding tradition in adult stem cell research. 
In C.elegans, stem cells are located in the distal ends of two gonad arms. Along 
the distal-to-proximal axis of each arm, germ cells develop in a linear, assembly-line 
fashion from germline stem cells to sperm (during juvenile stages) and oocytes (during 
adulthood; Fig. 1A). Oocytes then arrest in meiotic prophase I until fertilisation. Stem 
cell proliferation in the distal gonad is induced by the niche cell (Distal Tip Cell, DTC; 
Kimble and White 1981). The DTC caps the distal end of the gonad and is part of the 
somatic gonad tissue. Germ cells that move away from the DTC lose stem cell identity 
and initiate meiotic differentiation. The DTC extends filamentous processes along the 
mitotic zone and expresses the Notch ligand LAG-2 (Henderson, Gao et al. 1994; Hall, 
Winfrey et al. 1999). LAG-2 activates the Notch receptor GLP-1 expressed on distal 
germ cells (Crittenden, Troemel et al. 1994; Henderson, Gao et al. 1994). The signal is 
then transmitted through the nuclear cofactors LAG-1 and LAG-3 to promote a 
transcriptional profile that supports stem cell proliferation (Christensen, Kodoyianni et 
al. 1996; Petcherski and Kimble 2000). Stem cell proliferation and stem cell identity 
cannot be uncoupled at the level of Notch signaling. Loss-of-function mutations in the 
LAG-2 ligand, the GLP-1 receptor or the LAG-1 and LAG-3 nuclear cofactors cause cell 
cycle exit and terminal differentiation of all stem cells (Austin and Kimble 1987). Gain-
of-function mutations in the GLP-1 receptor on the other hand induce stem cell tumors 
(Gustafsson, Zheng et al. 2005). 
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Figure 1. C.elegans germline and development.
(A) Live C.elegans hermaphrodite, approximate length: 1mm. One gonad arm is magnified and outlined below 
(top panel) as well as depicted schematically (bottom panel). Stem cells proliferate in the distal germline under 
the influence of Notch signaling from the distal tip cell (DTC). When germ cells lose contact with the DTC, they 
enter meiosis in the transition zone, characterized by crescent-shaped morphology in DAPI stainings. More 
proximmally, they differentiate as sperm (juvenile stages) or oocytes (during adulthood). The distal end of the 
gonad is marked by an asterisk. (B) Under favorable conditions, C.elegans development proceeds from embryo 
to adult through four larval stages. When larvae hatch in unfavorable conditions, for example in the absence 
of food, they enter the Dauer stage and survive without food for prolonged periods. When conditions improve, 
development resumes. Reproduced from Fielenbach and Antebi, C. elegans dauer formation and the molecular 
basis of plasticity, 2008.
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It is unclear to date how Notch signaling promotes stem cell identity. Partly, it 
may excert its function through conserved RNA regulators of the Pumilio family, FBF-1 
and FBF-2 (collectively referred to as FBF). These are expressed in the distal germline 
and reported to act downstream of Notch signaling (Lamont, Crittenden et al. 2004; 
Thompson, Bernstein et al. 2005). However, fbf mRNA expression does not strictly 
require Notch signaling – it is expressed in gld-1 gld-2; glp-1 mutant germline tumors 
in which Notch is lacking (own observation; see Figure 22). Since FBF mutants lose 
stem cells only as adults, additional unidentified pathways are clearly operating in 
parallel to FBFs downstream of Notch signaling (Crittenden, Bernstein et al. 2002), 
during juvenile stages. MEX-3 and PUF-8, two other conserved RNA regulators, have 
also been implicated in germline stem cell proliferation and are redundantly required 
for juvenile germ cell proliferation. However, in their absence, stem cells do not 
terminally differentiate into mature gametes, but rather arrest in an undifferentiated 
state.  
FBFs, MEX-3, and PUF-8 are RNA binding proteins and translationally repress 
mRNAs by attaching to the 3’UTR of their targets. The best characterized target of FBF 
is GLD-1, itself an RNA binding protein. FBF-mediated repression prevents GLD-1 
expression in the stem cell compartment (Crittenden, Bernstein et al. 2002). More 
proximally, GLD-1 is upregulated and together with the poly(A)polymerase GLD-2 and 
its adaptors, GLD-3, GLD-4, and RNP-8 (Kadyk and Kimble 1998; Kim, Nykamp et al. 
2009; Schmid, Kuchler et al. 2009; Kim, Wilson et al. 2010) promotes meiotic 
progression of germ cells (Francis, Barton et al. 1995). Recent years have seen large 
scale mRNA-coprecipitation attempts to identify bulk targets for several proteins 
governing the mitosis – meiosis decision, for FBF, GLD-1, GLD-2, RNP-8, and GLD-3 
(Kershner and Kimble 2010; Kim, Wilson et al. 2010; Wright, Gaidatzis et al. 2010). 
Among hundreds of putative targets identified for each, the very factors mediating the 
stem cell maintenance versus meiotic entry decision have however remained elusive, 
with one exception: a combined large scale association – candidate approach in our lab 
has recently identified the first GLD-1 target involved directly in the self-renewal 
versus differentiation transition, CYE-1/Cyclin E (Biedermann, Wright et al. 2009). 
Among 948 putative GLD-1 targets (Wright, Gaidatzis et al. 2010), cye-1 repression is 
crucial to maintain mitotic quiescence in the meiotic germline. For the first time, a 
master regulator of the mitosis – meiosis decision of C.elegans germline stem cells has 
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thus been directly and functionally linked to the executive machinery governing an 
individual cell’s decision to self-renew or to maintain quiescent.  
Germline stem cell proliferation also depends on somatic cues. Certainly, it is a 
good idea to adapt the number of progeny and the energy invested in germ cell 
production to nutrient availability. C.elegans during early development has the option 
to arrest development after hatching (“L1 diapause”) or during the L2 larval stage 
(“Dauer”; Fig. 1B; Riddle and Albert 1997; Fukuyama, Rougvie et al. 2006; Fielenbach 
and Antebi 2008). These arrests are induced by starvation and, in the case of Dauer, 
also by heat stress or crowding. Dauer larvae survive for weeks without food and will 
resume normal development as soon as environmental conditions improve. During 
both L1 diapause and Dauer stage, germ cell proliferation ceases. Stem cell identity is 
however maintained, since germline development will resume after exit from the dauer 
stage just normally. During later stages, starvation elicits a similar program. Adult 
worms deprived of food will not only arrest germline stem cell proliferation, but use 
material from the germline as energy source until only a few distal germ cells remain. 
These are however capable of setting up a germline again when food is provided, and 
worms that have gone through “adult reproductive diapause” (ADR) produce an almost 
wild type complement of progeny (Angelo and Van Gilst 2009). During developmental 
arrests, germline stem cell proliferation and identity can thus be uncoupled. The 
communication of nutritional status from soma to germline requires the Insulin 
signaling pathway, but it is not clear to date whether Insulin signaling regulates germ 
line stem cell proliferation through the known complement of stem cell factors 
(Fukuyama, Rougvie et al. 2006; Narbonne and Roy 2006; Michaelson, Korta et al. 
2010). 
 
3.2 Notch signaling 
 
Notch signaling is a highly conserved pathway mediating communication between 
neighbouring cells (Maine, Lissemore et al. 1995; Lissemore and Starmer 1999; 
reviewed by Bray 2006). It is required for proper development of most tissues (for a 
review of mouse models, see Hansson, Lendahl et al. 2004) and is particularly famous 
for regulating cell fate choices. During development, Notch signaling mediates both 
binary fate decisions, where one cell out of two or more with equivalent developmental 
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potential is singled out to adopt one of two alternative identities (examples: Drosophila 
melanogaster bristle development (Guo, Jan et al. 1996), cell fate specification in the 
C.elegans vulva (Greenwald, Sternberg et al. 1983)), as well as inductive events, where 
cell populations receive a fate-instructing cue from an unaffected signal source 
(examples: developmental boundary formation events (reviewed by Irvine 1999) or, of 
relevance to this work, C.elegans germline stem cell proliferation (Austin and Kimble 
1987)).  
As a universal regulator of cell fate choice, Notch signaling has naturally been 
implied in the maintenance and regulation of stem cells (reviewed by Chiba 2006). The 
most straightforward and historically prime example of Notch-dependent stem cell 
maintenance is Notch requirement and sufficiency in C.elegans germline stem cell 
identity (Austin and Kimble 1987; Berry, Westlund et al. 1997). Notch signaling has in 
the following received attention also in vertebrate stem cell contexts and was found to 
contribute to the maintenance of  
• CNS stem cells (Nakamura, Sakakibara et al. 2000; Solecki, Liu et al. 2001; 
Gaiano and Fishell 2002; Hitoshi, Alexson et al. 2002; Hitoshi, Seaberg et al. 
2004);  
• Intestinal stem cells of the transit amplifying compartment, which require Notch 
signaling to prevent differentiation along the goblet cell lineage (van Es, van 
Gijn et al. 2005), an effect supported by gamma-secretase inhibitor trials 
(Milano, McKay et al. 2004; Wong, Manfra et al. 2004) and Notch overexpression 
experiments (Fre, Huyghe et al. 2005);  
• Melanocyte stem cells (Moriyama, Osawa et al. 2006);  
• Pancreatic precursor cells (Apelqvist, Li et al. 1999; Jensen, Heller et al. 2000; 
Murtaugh, Stanger et al. 2003);  
• and Skin/hair stem cells (Yamamoto, Tanigaki et al. 2003);  
 
Given its widespread requirement in cell fate regulation, it is not surprising that 
defects in Notch signaling contribute to diseases. Notch-related inherited conditions, 
such as Alagille syndrome (Artavanis-Tsakonas 1997; Li, Krantz et al. 1997; Oda, 
Elkahloun et al. 1997), tetralogy of fallot, syndactyly, spondylocostal dysostosis 
(reviewed by Gridley 2003), CADASIL (Joutel, Corpechot et al. 1996; Joutel, Andreux et 
al. 2000; Karlstrom, Beatus et al. 2002; Louvi, Arboleda-Velasquez et al. 2006) and 
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familial aortic valve disease (Garg, Muth et al. 2005) reflect the role of Notch signaling 
during development. In addition, Notch signaling has been implied in various cancers. 
Affected tissues reflect the panel of organs where Notch signaling has been implied in 
development and maintenance and include:  
• the hematopoietic system, particularly T-cells; historically, human Notch was 
actually identified as the gene residing at the breakpoint in a subset of 
chromosomal translocations causing T-cell leukemias (Ellisen, Bird et al. 1991). 
Oncogenic activity of the resulting fusion proteins was confirmed using mouse 
models (O'Neil, Calvo et al. 2006), but in humans, rearrangements turned out to 
be rare. Notch overexpression or mutation however appears to be common in 
leukemia (Jundt, Anagnostopoulos et al. 2002; Bellavia, Campese et al. 2003; 
Chiaramonte, Calzavara et al. 2003; Weng, Ferrando et al. 2004). 
• the intestine, where inhibition of Notch signaling promotes the terminal 
differentiation of adenoma cells along the secretory lineage (van Es, van Gijn et 
al. 2005); 
• the mammary gland; mouse mammary tumor virus provoques cancer due to 
insertions in Notch receptor genes that cause the expression of truncated 
versions (Gallahan, Kozak et al. 1987; Uyttendaele, Marazzi et al. 1996; Dievart, 
Beaulieu et al. 1999). Evidence implying hyperactive Notch signaling in human 
breast cancer is however only correlative (Jhappan, Gallahan et al. 1992; Pece, 
Serresi et al. 2004; Stylianou, Clarke et al. 2006; Dickson, Mulligan et al. 2007; 
Reedijk, Pinnaduwage et al. 2008; Rizzo, Miao et al. 2008). 
• pancreas; in pancreatic cancer, aberrant Notch signaling may be involved in the 
initiation stages and cooperate with TGF-beta signaling (Hingorani, Petricoin et 
al. 2003; Miyamoto, Maitra et al. 2003; Wang, Banerjee et al. 2006; Kimura, 
Satoh et al. 2007). 
• prostate (Santagata, Demichelis et al. 2004) 
• skin/melanocytes (Balint, Xiao et al. 2005; Nickoloff, Hendrix et al. 2005; Liu, 
Xiao et al. 2006); 
• lung (Dang, Gazdar et al. 2000); 
• cervix (Zagouras, Stifani et al. 1995); 
• brain; Notch signaling promotes proliferatoin and invasiveness of glioma cells 
(Pierfelice, Schreck et al.; Shih and Holland 2006; Zhang, Zheng et al. 2008). In 
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the childhood tumor medulloblastoma, expression of the Notch target gene 
Hes1 equals poor prognosis, and Notch signaling is required for unlimited 
growth of medulloblastoma cells and tumor engraftment (Fan, Mikolaenko et al. 
2004; Hallahan, Pritchard et al. 2004; Fan, Matsui et al. 2006). 
 
How Notch signaling contributes to tumor development is not quite clear. In a more 
general manner, Notch signaling acts anti-apoptotic (Rangarajan, Syal et al. 2001; Nair, 
Somasundaram et al. 2003), pro-transformative (Wang, Banerjee et al. 2006), pro-
invasion (Sarmento, Huang et al. 2005), pro-proliferative (Zeng, Li et al. 2005; 
Hellstrom, Phng et al. 2007; Siekmann and Lawson 2007), and pro-angiogenetic 
(Klinakis, Szabolcs et al. 2006; Palomero, Lim et al. 2006; Sharma, Calvo et al. 2006; 
Weng, Millholland et al. 2006; Efstratiadis, Szabolcs et al. 2007) and may thus 
contribute to tumor formation. Proposed tumor promoting-mechanisms also include 
crosstalk to known oncogenes such as myc (Mungamuri, Yang et al. 2006), mTOR/p53 
(Miyamoto, Maitra et al. 2003), and TGF-beta (Nickoloff, Osborne et al. 2003). 
Naturally, cancer therapies targeting Notch signaling have been proposed (Noguera-
Troise, Daly et al. 2006; Ridgway, Zhang et al. 2006; Wang, Zhang et al. 2006; Wang, 
Zhang et al. 2006). While various inhibition strategies aiming at diverse pathway 
components, such as ligand depletion, have been explored (Curry, Reed et al. 2005; 
Paris, Quadros et al. 2005; van Es, van Gijn et al. 2005; Rizzo, Miao et al. 2008), gamma 
secretase inhibitors (gamma secretase mediates cleavage of the Notch receptor upon 
ligand binding, see below) appear most relevant for clinical application (Nicolas, Wolfer 
et al. 2003). Since Notch signaling is required for proper tissue homeostasis, systemic 
administration of Notch inhibitors necessarily provokes adverse effects.  
Given the very general requirement of Notch signaling in cell fate decisions and 
disease, it is of prime importance to understand how Notch signaling affects target 
genes, and how these genes in turn affect cellular identity. However, despite the 
seemingly simple pathway architecture distinguishing Notch signaling from other “ivy 
league” signaling pathways such as MAP kinase, BMP or Sonic hedgehog - the Notch 
signal is directly relayed from the plasma membrane to the nucleus without second 
messengers, since a fragment of the receptor itself acts as transcription factor – few 
Notch target genes have so far been identified. This is even more surprising in light of 
the fact that the name-giving phenotype – notched Drosophila wings (Fig. 2A) - was 
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first observed almost a hundred years ago (Wharton, Johansen et al. 1985). In 
C.elegans, the Notch receptor was independently identified and cloned as vulval 
determinant, embryonic determinant, and germline stem cell factor (Fehon, Kooh et al. 
1990; Rebay, Fleming et al. 1991; Henderson, Gao et al. 1994; Mello, Draper et al. 1994). 
Subsequent studies in Drosophila and C.elegans identified conserved core components 
such as ligands (Pan and Rubin 1997; Sotillos, Roch et al. 1997; Wen, Metzstein et al. 
1997), receptor processing enzymes (Fortini and Artavanis-Tsakonas 1994; 
Christensen, Kodoyianni et al. 1996), the corepressor/coactivator CSL (Doyle, Wen et al. 
2000; Petcherski and Kimble 2000) and the coactivator Mastermind (Fehon, Kooh et al. 
1990; Rebay, Fleming et al. 1991; Henderson, Gao et al. 1994), and linked them 
mechanistically into a pathway (Figs. 2B and C).  
The Notch signaling pathway is heavily regulated by endocytic processes and 
posttranslational modifications (Haines and Irvine 2003; Le Borgne, Bardin et al. 2005). 
However, following sections will focus on the relay of the signal from plasma 
membrane to target genes and the regulation of target gene expression, since these 
aspects are most relevant for this work.  
Both the Notch receptor and its ligands, the DSL (Delta-Serrate-LAG-2) 
proteins (Yochem and Greenwald 1989), are transmembrane proteins (Chen and 
Greenwald 2004; Komatsu, Chao et al. 2008), although secreted DSL variants (D'Souza, 
Miyamoto et al. 2008) as well as non-DSL ligands have been described (reviewed by 
Schroeter, Kisslinger et al. 1998; De Strooper, Annaert et al. 1999). Upon ligand 
binding, the intracellular portion of the receptor (NICD, Notch Intracellular Domain) is 
proteolytically cleaved off by gamma-secretases (Kidd, Lieber et al. 1998; Struhl and 
Adachi 1998) and translocates to the nucleus to affect transcription of target genes 
(Lai 2002).     
In the absence of signal, Notch target genes are considered to be constitutively 
repressed by the DNA-binding protein CSL (named after CBF1/RBP-J, Su(H), and LAG-
1; reviewed by Morel, Lecourtois et al. 2001). CSL recruits chromatin modifiers and 
establishes a repressive environment. In Drosophila, the adaptor Hairless tethers the 
repressors Groucho and dCtBP, which in turn recruit histone deacetylases (Kao, 
Ordentlich et al. 1998), to CSL (Barolo, Stone et al. 2002; Nagel, Krejci et al. 2005). 
Hairless appears to be unique to flies; in mammals, CSL recruits CtBP (Oswald, Winkler 
et al. 2005), HDAC1 (Kao, Ordentlich et al. 1998) and other corepressors such as 
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Figure 2. Notch signaling.
(A) Dorsal view of a Drosophila Notch receptor mutant female. The characteristic notched appearence of the 
wing margin gave receptor and pathway its name. Image reproduced from: T.H.Morgan, The theory of the gene, 
1917. (B) Illustration of the core Notch signaling pathway. Upon ligand binding, the Notch receptor is proteo-
lytically cleaved at the plasma membrane. The intracellular fragment translocates to the nucleus, associates 
with CSL bound at target genes and converts a repressive complex into a transcription-activating complex.  
DSL, Delta-Serrate-LAG-2; CSL, CBF1-Su(H)-LAG-1; HDAC, Histone deacetylase; HAT, Histone acetyltransfer-
ase; MAM, Mastermind. (C) Table illustrating the conservation of Notch pathway components between 
Drosophila, vertebrates, and C.elegans. Table reproduced from S.J.Bray, Notch signalling: a simple pathway 
becomes complex, 2006 
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MeCP2 (Stancheva, Collins et al. 2003) and KyoT2 (Taniguchi, Furukawa et al. 1998) via 
the transcriptional co-repressor SMRT (Oswald, Kostezka et al. 2002) and the SMRT-
associated protein SHARP (Oswald, Kostezka et al. 2002; Oswald, Winkler et al. 2005). 
CSL also interacts with the transcriptional regulator SKIP and the co-repressor CIR 
(Hsieh, Zhou et al. 1999; Zhou, Fujimuro et al. 2000; Kasturi, Zanetti et al. 2010); CIR in 
turns recruits HDAC2 (Goodfellow, Krejci et al. 2007). The histone chaperone Asf1 is 
also recruited by CSL and has been implied in repression (Olave, Reinberg et al. 1998). 
In addition, silencing of Notch target genes may involve direct contact of CSL with 
TFIID and TFIIA, components of the basal transcription machinery (Jarriault, Brou et al. 
1995; Tamura, Taniguchi et al. 1995), and the recruitment of POU homeodomain 
proteins (Neumann and Cohen 1998). 
 Upon ligand binding, the intracellular part of the receptor is released by gamma 
secretases and translocates to the nucleus, where it joins CSL (Petcherski and Kimble 
2000; Lubman, Ilagan et al. 2007; Del Bianco, Aster et al. 2008; Friedmann, Wilson et al. 
2008), and recruits Mastermind (Nam, Sliz et al. 2006; Wilson and Kovall 2006). 
Nipped-A, a component of SAGA and Tip60 coactivator complexes, may impact the 
ability of CSL to recruit Mastermind, since Mastermind binding patterns are disrupted 
on polytene chromosomes of Nipped-A mutant flies (Gause, Eissenberg et al. 2006). 
Tip60 is indeed reported to attenuate Notch signaling through acetylation of NICD 
(Kim, Ann et al. 2007). Upon formation of the ternary complex of CSL, NICD and 
Mastermind, which involves conformational changes and masking of CSL DNA binding 
sites by NICD (Kurooka and Honjo 2000), the remodeled CSL-containing complex now 
recruits general transcription factors and chromatin remodelers. 
Histone acetylation appears essential for Notch target gene activation. HDAC 
antagonizes Notch signaling in the vertebrate retina (Yamaguchi, Tonou-Fujimori et al. 
2005), and the histone deacetylase Sin3a is important for Notch target gene repression 
(Moshkin, Kan et al. 2009). NICD and CSL together recruit the histone acetylases GCN5 
and PCAF (Oswald, Tauber et al. 2001). The histone acetyltransferase p300 contributes 
to target gene activation (Zhou, Fujimuro et al. 2000; Fryer, Lamar et al. 2002; Hansson, 
Popko-Scibor et al. 2009; Saint Just Ribeiro and Wallberg 2009) by recruiting the 
histone acetyltransferase PCAF (Wallberg, Pedersen et al. 2002). The corepressor SMRT 
is displaced by NICD-recruited SKIP (Wallberg, Pedersen et al. 2002). In addition, 
chromatin remodeling complexes SWI/SNF (Kadam and Emerson 2003; Armstrong, 
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Sperling et al. 2005; Gause, Eissenberg et al. 2006) and ISWI/NURF (Kugler and Nagel 
2010) are also involved in transcriptional activation of Notch target genes.  
While histone acetylation status clearly affects Notch target gene regulation, far 
fewer reports imply histone methylation to Notch target gene repression or activation, 
respectively. H3K4 methylation, a mark of transcription competent chromatin, plays a 
role in Notch target gene activation, since target activation depends on the ubiquitin 
ligase Bre1, which is indirectly required for H3K4 methylation (Bray, Musisi et al. 2005). 
The histone demethylase LID/KDM, which removes H3K4me marks, has by genetic 
interaction proposed to be involved in the repression of Notch targets (Moshkin, Kan et 
al. 2009). KDM5A interacts with CSL and may be involved in removal of H3K4me3 from 
target genes after Notch signaling (Liefke, Oswald et al. 2010). Curiously, Delta 
overexpression, which should activate transcription, depletes H3K4me3 globally from 
imaginal discs (Ferres-Marco, Gutierrez-Garcia et al. 2006). Notch signaling has also 
been linked to the repressive H3K27 methylation mark deposited by the Polycomb 
Repressive Complex 2 (PRC2). Mutations in Drosophila Tantalus, an interaction partner 
of the Polycomb protein ASX (additional sex combs), elicits phenotypes reminiscent of 
Notch mutations and interacts with Notch genetically (Dietrich, Yang et al. 2005). 
Deregulation of the Polycomb proteins Pipsqueak and Lola cooperate with Delta 
overexpression in the formation of tumors in Drosophila (Ferres-Marco, Gutierrez-
Garcia et al. 2006). However, Polycomb in these cases acts upstream of Notch signaling 
by deregulating core pathway components, rather than by coregulating target genes 
(Martinez, Schuettengruber et al. 2009; Herz, Madden et al. 2010).  
Most Notch signaling events, particularly during development, are transient and 
require tight temporal and spatial regulation. Formation of the ternary CSL-NICD-
Mastermind complex triggers NICD turnover by ubiquitin-mediated proteasomal 
degradation of NICD after phosphorylation by Cdk8 (Fryer, White et al. 2004), leaving 
the CSL corepressor behind at the target gene (Deftos and Bevan 2000; Gajewski, Sieger 
et al. 2003; Pourquie 2003; Giudicelli and Lewis 2004; Fior and Henrique 2005). 
Ubiquitin-mediated protein degradation has been more generally implied in the 
shutdown of Notch signaling, and mutations affecting NICD degradation have been 
implied in Notch-dependent cancerogenesis (Qiu, Joazeiro et al. 2000; Fryer, White et 
al. 2004; Tsunematsu, Nakayama et al. 2004; Weng, Ferrando et al. 2004; Chiang, Xu et 
al. 2006; O'Neil, Grim et al. 2007; Thompson, Buonamici et al. 2007). Notch targets 
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have also been reported to negatively feed back on their own transcription (Stark, 
Brennecke et al. 2003; Hirata, Bessho et al. 2004; Lai, Tam et al. 2005), or to be 
shortlived and/or targeted by miRNAs (Dou, Zeng et al. 1994; Christensen, Kodoyianni 
et al. 1996). 
Given the apparently simple architecture of the core pathway and its 
significance in development and disease, it is surprising that the identification of 
Notch target genes lags behind. Partly, this is due to the fact that NICD efficiently 
activates target genes at concentrations below detection limit and additionally is 
turned over rapidly, hampering chromatin-immunoprecipitations to identify binding 
sites on DNA. Sequences that promote the association of CSL with individual 
promotors have been identified (Bailey and Posakony 1995; Lecourtois and 
Schweisguth 1995; Christensen, Kodoyianni et al. 1996) but are not sufficiently specific 
to be useful in target predictions. 
 Nonetheless, Notch responsive genes have been identified in several contexts, 
for example in hematopoietic development (IL6 (Kannabiran, Zeng et al. 1997; 
Plaisance, Vanden Berghe et al. 1997), pre-T-Cell receptor alpha (Reizis and Leder 
2002), IL4 (Amsen, Blander et al. 2004)), in the nervous system (GFAP (Ge, Martinowich 
et al. 2002), Brain lipid-binding protein (Anthony, Mason et al. 2005), in cell cycle 
regulation (p21 (Rangarajan, Talora et al. 2001), CycD1 (Ronchini and Capobianco 
2001), SKP2 (Sarmento, Huang et al. 2005), c-myc (Klinakis, Szabolcs et al. 2006; 
Palomero, Lim et al. 2006; Sharma, Calvo et al. 2006; Weng, Millholland et al. 2006) and 
development (Nodal (Krebs, Iwai et al. 2003), Nrarp (Krebs, Deftos et al. 2001). The best 
characterized and conserved targets belong to two families of bHLH genes, Hes (also 
E(sp)) and Herp (also Jey, Hesr, HRT, CHF, gridlock; Oellers, Dehio et al. 1994; Iso, 
Chung et al. 2002; Iso, Kedes et al. 2003). Hes/Herp bHLH proteins repress their target 
genes (Davis and Turner 2001) by recruiting Groucho/TLE proteins (Heitzler, Bourouis 
et al. 1996) or by sequestering transcriptional co-factors (Kuroda, Tani et al. 1999). 
Hes/Herp proteins mediate Notch signaling in mammalian neurogenesis (Kageyama 
and Ohtsuka 1999; Ohtsuka, Ishibashi et al. 1999), endocrine development (Jensen, 
Pedersen et al. 2000; Kita, Imayoshi et al. 2007; Raetzman, Cai et al. 2007), heart 
development (Donovan, Kordylewska et al. 2002; Gessler, Knobeloch et al. 2002; 
Sakata, Kamei et al. 2002; Fischer, Schumacher et al. 2004), pancreas development 
(Murtaugh, Stanger et al. 2003; Sumazaki, Shiojiri et al. 2004), and adipocyte 
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differentiation (Ross, Rao et al. 2004). In C.elegans, the diverged HES-family member 
REF-1 mediates Notch signaling events during embryonic patterning (Neves and Priess 
2005). 
Accessibility of target genes appears to play a major role in target activation by 
Notch signaling, providing an explanation for the wide and versatile use of the 
pathway as cell- and tissue specific activator of transcription (Iso, Chung et al. 2002; 
Cave, Loh et al. 2005; Ong, Cheng et al. 2006). Also, some Notch-responsive enhancers 
are combinatorial and require cooperation with other transcription factors (Cooper, 
Tyler et al. 2000; Furriols and Bray 2001; Neves, English et al. 2007). Thus, Notch 
signaling receptivity can be finetuned to give a very specific output depending on the 
signaling context. Identifying targets that play a role in stem cell maintenance in 
C.elegans therefore may or may not be telling about Notch signaling in general. 
Features of Notch signaling that are conserved between organisms, such as the 
secondary transcription factors Hes/Herp, or the similarity of both the CSL/NICD 
binding site (Tun, Hamaguchi et al. 1994; Christensen, Kodoyianni et al. 1996) and of 
CSL itself across species (CSL is 84% identical between Drosophila and human) suggest 
that extrapolations may be possible. 
 
3.3 The FBF/Pumilio protein family 
 
The conserved family of Pumilio/FBF (Puf) proteins (Fig. 3A) is characterized by the 
Pumilio homology domain / Puf domain, which consists of eight to nine consecutive 
sequence repeats and a flanking region (Zhang, Gallegos et al. 1997), and typically 
recognizes RNAs containing a UGUR (R = purine) trinucleotide followed by AU-rich 
sequences (Wickens, Bernstein et al. 2002; Table 1). 
The structural features of the interaction of Puf proteins with their cognate 
RNAs has been well characterized. Alpha-helical repeats are stacked against each 
other and create a curved surface of alpha helices (Wang, McLachlan et al. 2002), which 
interacts with a 8-10 nt stretch of RNA on a one repeat - one nucleotide basis 
(Opperman, Hook et al. 2005; Gupta, Nair et al. 2008; Wang, Opperman et al. 2009; Fig. 
3B). The ability to flip bases 4-6 away from the protein surface has been demonstrated 
for FBF-2 and provides flexibility in length and base composition of the target motif 
(Wang, Opperman et al. 2009). The amino acid residues providing nucleotide specificity 
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Figure 3. Conservation and RNA recognition of the Pumilio/FBF protein family.
(A) Phylogenetic dendrogram of the Pumilio/FBF (Puf) family of proteins. The Puf family consists of Puf6p, 
Puf1p, FBF, PUM and plant PUM subfamilies. Reproduced from Spassov et al, The PUF family of RNA-binding 
proteins: does evolutionarily conserved structure equal conserved function?, 2003. (B) Schematic representation 
of the Puf domain complexed with cognate RNA. Eight RNA-recognition helices (R1–R8) specifically recognize 
one nucleotide each (U1–A8). Illustration after Opperman et al, A single spacer nucleotide determines the 
specificities of two mRNA regulatory proteins, 2005. 
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to each repeat have been mapped (Sonoda and Wharton 1999; Opperman, Hook et al. 
2005; Miller, Higgin et al. 2008; Wang, Opperman et al. 2009). Modifications that 
introduce key residues of other family members induce the predicted specificity 
changes (Cheong and Hall 2006; Koh, Opperman et al. 2009). The Pumilio domain is 
therefore being promoted as attractive candidate for an RNA recognition adaptor that 
could be engineered to the researchers needs (Satou 1999; Schoppmeier, Fischer et al. 
2009; Takada, Kawana et al. 2009).  
 
Table 1. Recognition motifs of Puf proteins 
protein recognition sequence determined by publication 
Pumilio HHUGUAHAUAHDHWDD RIP-chip, MEME (Gerber, Luschnig et al. 2006) 
Puf1p 
Puf2p 
Puf3p 
Puf4p 
Puf5p 
none identifyable 
none identifyable 
YHUGUAHAUA  
HNUGUAHAHUA  
WUGUAWYWDUA  
RIP-chip, MEME (Gerber, Herschlag et al. 2004)  
Pum1 
Pum2 
NNUGUAHAUANN 
NNUGUAHAUANW 
RIP-chip, MEME (Galgano, Forrer et al. 2008)  
Pum2 UGUANAUARNNNNBBBBSCCS SELEX (White, Moore-Jarrett et al. 2001)  
Pum1 NNNNNUDUAHAWANN RIP-chip, MEME (Morris, Mukherjee et al. 2008)  
PUF-8 
FBF 
UGURHRDW 
UGUAHHAU 
Y3H (Opperman, Hook et al. 2005)  
PUF-5 NNHUGUHNBBDNN Y3H (Stumpf, Kimble et al. 2008)  
PUF-11 
HHUGURAAUR 
HDYUGURYHHKRW 
HHHUGUHRDRWND 
Y3H (Koh, Opperman et al. 2009)  
FBF-1 NVNDNNHNUKHDHNDDN Y3H (Bernstein, Hook et al. 2005)  
R = A,G; K = G,U; Y = C,U; W = A,U; V = A,C,G; D = A,G,U ; H = A,C,U ; N = any base 
 
Puf proteins owe their name to two prominent family members, Drosophila 
Pumilio and C.elegans FBF (Nusslein-Volhard, Frohnhofer et al. 1987; Zhang, Gallegos 
et al. 1997). Drosophila Pumilio was originally identified in screens for maternal effect 
lethal mutations affecting embryonic patterning conducted by Ruth Lehmann and 
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Christiane Nüsslein-Volhard. Pumilio mutant Drosophila embryos essentially lack 
posterior structures and are therefore smaller than average (hence the name from latin 
pumilius pumilio, dwarf). The isolation of zygotic lethal alleles in the same screen 
pointed towards an additional function of pumilio in adult flies. Indeed, other 
independently isolated alleles (“bemused”, “pumuckl”, and “ovarette”) have 
behavioural, locomotory, or adult germline defects (Stern, Blake et al. 1995; Lin and 
Spradling 1997; Schmucker, Jackle et al. 1997), uncovering the requirement of Pumilio 
in the nervous system and in germline stem cells. 
The identity of Pumilio as RNA binding protein targeting the hunchback mRNA 
was confirmed in 1995 by Murata (Murata and Wharton 1995). The first C.elegans Puf 
family member, FBF, was isolated based on its RNA binding property by a reverse 
approach starting from the fem-3 mRNA – hence the name fem-3 mRNA binding factor 
(Zhang, Gallegos et al. 1997). The, retrospectively, main and conserved role of FBF – 
C.elegans germline stem cell maintenance - was described only after simultaneous 
disruption of both FBF proteins, FBF-1 and FBF-2, which are almost identical in 
sequence and are redundantly required for continued stem cell proliferation in the 
germline (Crittenden, Bernstein et al. 2002).  
Since then, the Pumilio family as well as their RNA target list have kept 
expanding. With the availability of genome sequences, Puf proteins have been 
identified in all eukaryotic organisms, including plants (Fig. 3A). While Drosophila and 
Vertebrates dispose of one and two Puf proteins, respectively, five members have been 
described in yeast, twelve in C.elegans and more than twenty in Arabidopsis thaliana 
(Spassov and Jurecic 2003; Abbasi, Park et al. 2011). These expansion of the gene 
family confers robustness to the system and at the same time allows the evolution of 
distinct RNA binding properties and functions. In C.elegans, Puf proteins often come in 
duplicated, redundant gene pairs, and even mouse PUM1 and PUM2 target largely 
overlapping populations of mRNAs (Galgano, Forrer et al. 2008). Puf proteins therefore 
exemplify the importance to choose the least complex model possible – discovery in 
Drosophila was possible because there is just one Puf protein in flies. Puf proteins are 
at the same time an example that sometimes, “horizontal” extrapolation between 
model organisms makes sense. The role of Puf proteins as conserved stem cell 
regulators was eventually disclosed in C.elegans (Crittenden, Bernstein et al. 2002), and 
taking a step down the evolutionary ladder to Planaria has prompted a revised look at 
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the Puf family as ancient stem cell regulators that only later evolved additional tasks in 
higher organisms (Salvetti, Rossi et al. 2005). 
While Puf function in stem cells and the nervous system appears conserved, 
this is not the case for Puf targets (Morris, Mukherjee et al. 2008). For yeast Puf1-5p, 
Drosophila Pumilio, human Pum1 and Pum2, and C.elegans FBF, targets have been 
determined large scale by RNA-co-IP (White, Moore-Jarrett et al. 2001; Gerber, 
Herschlag et al. 2004; Fox, Urano et al. 2005; Gerber, Luschnig et al. 2006; Galgano, 
Forrer et al. 2008; Morris, Mukherjee et al. 2008; Kershner and Kimble 2010). Each 
protein associates with hundreds of mRNAs, which frequently belong to functional 
units. For example, yeast Puf3p preferentially associates with mRNAs involved in 
mitochondrial metabolism, while C.elegans FBF targets entire signaling pathways and 
functional units, such as the MAP Kinase pathway or the apoptotic machinery 
(Kershner and Kimble 2010). This strategy of coregulation of a substantial fraction of 
the transcriptome has been termed RNA regulon or RNA operon concept (Keene 2007). 
Possibly, Puf proteins may have preceeded chromatin as global regulatory mechanism 
of mRNA expression. This ancient function may be preserved in stem cells. Stem cell 
chromatin has been described as comparably transcription-competent (Gaspar-Maia, 
Alajem et al. 2011), and Puf proteins together with other translational regulators may 
globally govern gene expression of stem cells until chromatin-based mechanisms of 
regulation take over during differentiation.  
 Large scale target identification efforts have permitted the computation of 
motifs correlating with Puf binding. In most cases, the 3’UTRs of Puf targets are 
enriched for a UGU trinucleotide motif, which is followed by a more flexible two- to 
four nucleotide long spacer and an AU-rich region. Bases outside the core motif also 
contribute to affinity (Zhu, Stumpf et al. 2009). Interestingly, human Pum1 and 
Drosophila Pumilio, although they have identical binding preferences, associate with 
very different mRNA pools, indicating that Puf proteins may be rapidly adapted for 
new purposes by target site evolution (Morris, Mukherjee et al. 2008).  
 Pumilio proteins have been reported to destablize their associated mRNAs by 
recruiting the deadenylation machinery and the exosome (Wreden, Verrotti et al. 1997; 
Olivas and Parker 2000; Goldstrohm, Hook et al. 2006; Goldstrohm, Seay et al. 2007; 
Ulbricht and Olivas 2008; Chritton and Wickens 2010). However, Puf targets in 
Xenopus oocytes and in neurons are not degraded, but rather stored and/or 
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transported in a deadenylated state to be available for translation upon oocyte 
maturation and synaptic remodeling, respectively (Chen, Li et al. 2008; Pique, Lopez et 
al. 2008; Ota, Kotani et al. 2011). Also, since mRNAs associated with Puf proteins can 
be coimmunoprecipitated (Gerber, Herschlag et al. 2004; Fox, Urano et al. 2005; Gerber, 
Luschnig et al. 2006; Galgano, Forrer et al. 2008; Morris, Mukherjee et al. 2008; 
Kershner and Kimble 2010), Puf proteins clearly do not induce immediate degradation 
of all associated targets, and under certain circumstances may even promote 
translation, as reported for FBF-1 and its target egl-4 (Kaye, Rose et al. 2009). 
Differential effects of Puf proteins on their targets – degradation versus storage 
- may reflect the habit of Puf proteins to cooperate with other proteins on the same 
mRNA. For example, hunchback regulation in the Drosophila embryo requires the 
recruitment of the conserved meiotic regulator Nanos by Pumilio (Sonoda and Wharton 
1999). The interaction and cooperation of Pumilio and Nanos in the germline is 
conserved in worms and vertebrates (Kraemer, Crittenden et al. 1999; Moore, 
Jaruzelska et al. 2003). Regulation of the bicoid mRNA on the other hand does not 
require Nanos (Gamberi, Peterson et al. 2002). Another conserved meiotic regulator, 
the DAZL/Boule protein family, also co-occupies mRNAs with Pumilio (human Pum2) 
(Xu, Moore et al. 2001). Interestingly, Boule-Pum2 targets do not overlap with Pum2-
only targets (Urano, Fox et al. 2005), suggesting that cooperating proteins may not 
serve as combinatorial code to subset the total target pool, but may actually affect the 
mRNA recognition properties of Puf proteins. Considering the spring-like architecture 
of the Pumilio RNA binding domain, it is easily conceivable how a protein interacting 
with the backbone could distort the RNA-interface to accomodate slightly different 
recognition elements. Inversely, RNA binding may expose or occlude protein 
interaction sites on the protein surface such that the target mRNA may determine its 
own fate in dependence of the precise binding motif – deadenylation, storage, 
degradation, or transport, depending on the protein sets Pumilio could or could not 
accomodate when bound to a certain motif.  
Finally, several pieces of evidence link Puf proteins to the miRNA machinery. 
Drosophila Pumilio recruits the TRIM protein Brat, a component of the miRNA 
machinery, to the hunchback mRNA (Sonoda and Wharton 2001). Interestingly, human 
TRIM proteins do interact with Puf proteins (Inga Loedige, FMI, personal 
communication), and many human Pum1 and Pum2 targets are also predicted miRNA 
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targets (Galgano, Forrer et al. 2008; Kedde, van Kouwenhove et al. 2010; Leibovich, 
Mandel-Gutfreund et al. 2010). At least in the case of human p27 mRNA, recognition 
of a miRNA target site by its cognate miRNA depends on Puf, which upon binding 
unfolds a secondary structure in the 3’UTR which otherwise masks the site (Kedde, van 
Kouwenhove et al. 2010). Whether this is a general feature of the Puf-miRNA axis 
remains to be determined. 
 
3.4 MEX-3  
 
Like Puf proteins, MEX-3 proteins are conserved among metazoans (Buchet-Poyau, 
Courchet et al. 2007). They belong to the KH family of RNA binding proteins and 
additionally contain a C-terminal RING finger domain, the function of which is not 
clear to date. Curiously, the prototypical and name-giving C.elegans MEX-3 (for Muscle 
EXcess – C.elegans MEX-3 prevents muscle fate in non-muscle lineages in the embryo) 
lacks the RING finger, and no interaction partner reported to date contains such a 
domain (Huang, Mootz et al. 2002). According to the prediction programs TargetScan 
and NetPhos, C.elegans MEX-3 is likely posttranslationally modified and may interact 
with 14-3-3 proteins and several protein kinases (Figs. 4 and 5; Blom, Gammeltoft et 
al. 1999; Obenauer, Cantley et al. 2003). Indeed, vertebrate MEX-3 is reported to be a 
phosphoprotein and to bind to 14-3-3 proteins and Argonautes in dependence of its 
phosphorylation status (Courchet, Buchet-Poyau et al. 2008).  
 
Developmental function of MEX-3: cell fate specification 
 
In anuran amphipians, nematodes, ascidians, and ecdysozoa, maternally provided 
MEX-3/PEM-3 (Posterior End Mark, the ascidian orthologue; Satou 1999) contributes to 
embryonic patterning. MEX-3 prevents expression of the posterior determinant 
Caudal/PAL-1 in the anterior of the embryo (Draper, Mello et al. 1996; Hunter and 
Kenyon 1996; Satou 1999; Schoppmeier, Fischer et al. 2009). Lack of Caudal in the 
posterior or inappropriate expression in the anterior part of the embryo results in cell 
fate transformations, such as ectopic muscle in the case of C.elegans mex-3 embryos 
(Draper, Mello et al. 1996). Interestingly, the paradigm organism for embryonic 
patterning, Drosophila, uses Bicoid instead of MEX-3 to regulate caudal (Dubnau and 
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Figure 4. Several residues of C.elegans MEX-3 are predicted to be phosphorylated.
C.elegans MEX-3 protein sequence and, below, phosphorylateable residues therein (Serine, S; Threonine, T; 
Tyrosine, Y). The likelyhood that an individual residue is phosphorylated as determined by the NetPhos 2.0 
software (http://www.cbs.dtu.dk/services/NetPhos/) is indicated in the bottom panel by a score between 0 
(unlikely) and 1 (very likely). More than ten residues received a probability score greater than 0.9. Scores above 
the threshold of 0.500 are assigned as '*S*', '*T*', or '*Y*. 
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Figure 5. Predicted MEX-3 interacting proteins and modification sites. 
Shown are potential interactors and modifiers of C.elegans MEX-3 and their respective interaction sites as 
determined by the MotifScan software (Obenauer et al, Scansite 2.0: Proteome-wide prediction of cell signaling 
interactions using short sequence motifs, 2003). A “Score” value of 0.2 indicates that the indicated motif is 
among the 0.2% best matches in the database. 
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Struhl 1996; Rivera-Pomar, Niessing et al. 1996). Drosophila MEX-3 is only expressed 
during late embryonic development in the nervous system (Schoppmeier, Fischer et al. 
2009). GLP-1/Notch, another gene involved in patterning the C.elegans embryo, is also 
regulated by MEX-3, but globally rather than in specific cells (Pagano, Farley et al. 
2009). mex-3 mutant embryos also display lineage defects in the germline. They 
contain excess germline precursor cells (Draper, Mello et al. 1996). Possibly, these are 
induced by ectopic NOS-2, a germline-specific protein which is ectopically expressed 
in somatic cells in mex-3 mutants (Jadhav, Rana et al. 2008). 
The role of mammalian MEX-3 in development has not yet been adressed, since 
vertebrate genomes encode four MEX-3 proteins (MEX-3A-D; Buchet-Poyau, Courchet 
et al. 2007), which may function redundantly. Mammalian embryos are not 
prepatterned and do not depend on maternal factors for germ layer specification, but 
MEX-3 may still contribute to aspects of embryonic development. 
 
Adult function of MEX-3: maintenance of stem cell proliferation 
 
Adult functions of MEX-3 have so far been adressed only in C.elegans, but expression 
of mouse MEX-3 in brain and testis suggest a function for MEX-3 in adult mammals 
(Buchet-Poyau, Courchet et al. 2007). C.elegans MEX-3 is specific to the germline. 
While mex-3 RNA is expressed throughout the germline, MEX-3 protein is repressed in 
the central germline by GLD-1 and accumulates in the proximal germline in oocytes. 
Upon sperm depletion or heat stress, MEX-3 relocalises from the oocyte cytoplasm to 
granular structures (Jud, Czerwinski et al. 2008). The significance of this relocalisation, 
as well as a role for MEX-3 in the proximal germline (except for maternal contribution 
to the embryo) have not been addressed. MEX-3 is also expressed at low levels in stem 
cells in the distal gonad (Ciosk, DePalma et al. 2004 and Fig. 24). In stem cells, MEX-3 
contributes to proliferation, since mutants have slightly fewer germ cells than the wild 
type (Ariz, Mainpal et al. 2009). However, MEX-3 functions redundantly with the Puf 
protein PUF-8, since the double mutant, but not either single mutant has severe 
germline proliferation defects (Ariz, Mainpal et al. 2009). MEX-3 is also required for 
germ cell proliferation and totipotency in a compound background lacking Notch 
signaling (own unpublished observations; Fig. 13). mRNAs targeted by MEX-3 in the 
germline stem cell compartment other than rme-2 have not yet been identified. A 
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bipartite MEX-3 recognition element (MRE) has been determined in vitro (Pagano, 
Farley et al. 2009; A/G/U)(G/U)AGN(0–8)U(U/A/C)UA; N = any nucleotide). However, 
this sequence occurs too frequently in the genome to allow in silico target predictions 
– 2834 genes contain MREs in their 3’UTR. Even when assuming combinatorial 
regulation by two proteins, GLD-1 and MEX-3, on germline specific RNAs, only 2 out 
of 10 predicted targets (pal-1 and glp-1) were really regulated by MEX-3 (Pagano, Farley 
et al. 2009). RNA-co-IPs have not been successful so far (own observation). Possibly, 
MEX-3 associates with mRNAs only in a short developmental time window, in a very 
small set of cells, or available reagents were simply not suited for RIP-Chip 
experiments.  
The MEX-3 protein appears to be regulated on several levels. In the germline, 
mex-3 mRNA is targeted by GLD-1. Like other maternal proteins, MEX-3 protein in the 
embryo is destabilized by OMA-1 (Lin 2003). Considering the high-low-high germline 
expression pattern, the stability of germline-expressed MEX-3 must also be regulated. 
Ubiquitous expression of MEX-3 in par-3 mutant embryos (Bowerman, Ingram et al. 
1997) does not result in ubiquitous repression of the MEX-3 target pal-1, indicating the 
requirement for modification or cofactors in MEX-3 dependent repression (Huang, 
Mootz et al. 2002). Indeed, human MEX-3 proteins are phosphorylated (Buchet-Poyau, 
Courchet et al. 2007; Courchet, Buchet-Poyau et al. 2008), and the interaction of 
human MEX-3 with 14-3-3 proteins is phosphorylation dependent (Courchet, Buchet-
Poyau et al. 2008). In C.elegans, interacting proteins (SPN-4, MEX-5, and MEX-6; 
Huang, Mootz et al. 2002; Table 2) contribute to MEX-3 mediated regulation of pal-1 in 
the embryo, but how they do so is not clear. Localisation of human MEX-3 is also 
regulated, since it shuttles between cytoplasm and nucleus via the CRM-1 export 
machinery (Buchet-Poyau, Courchet et al. 2007). 
 
MEX-3 proteins have thus been implied in vital processes such as stem cell 
proliferation and embryonic cell fate determination. Yet, very few of their mRNA 
targets are confirmed (Table 3), and in C.elegans stem cells and in vertebrates MEX-3 is 
somewhat in search for a function. MEX-3 expression in the stem cell compartment 
and its requirement for stem cell proliferation under certain conditions (Ariz, Mainpal 
et al. 2009) and this work) make MEX-3 an stem cell maintaining mystery.  
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Table 2. Protein interaction partners of MEX-3. 
interacting protein organism publication 
Argonaute 1 and 2 H.sapiens Buchet-Poyau, Courchet et al. 2007  
14-3-3 H.sapiens Courchet, Buchet-Poyau et al. 2008  
POS-1, SPN-4, UNC-57, PABP-2, K07H8.10, 
MEX-5/6, B0250.1, F25B4.2, C43E11.9, 
F40F8.5, CPG-8, FUST-1, E02D9.1 
C.elegans Huang, Mootz et al. 2002  
 
Table 3. mRNAs targeted by MEX-3. 
interacting mRNA organism publication 
bcl-2 H.sapiens Donnini, Lapucci et al. 2004  
glp-1 C.elegans Pagano, Farley et al. 2009  
nos-2 C.elegans Jadhav, Rana et al. 2008; Pagano, Farley et al. 2009  
pal-1 C.elegans Draper, Mello et al. 1996; Hunter and Kenyon 1996  
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One aim of stem cell research is to identify universal features of “stemcellness”, to 
identify the fundamental differences between cells that have and those that have not 
yet assumed a terminal identity. The goal is, of course, to understand these processes 
to a point where they can be manipulated and exploited for therapeutic purposes. 
Stem cell maintaining pathways and molecules have been identified – Wnt or Notch 
signaling, or Pumilio proteins, to name a few. Most are highly conserved. We know that 
these molecules govern cell fate decisions, but in most cases we do not know how. 
Stem cell maintaining molecules usually affect the activity of many genes and change 
the status of a cell as a whole. What a stem cell needs to remain proliferative and 
uncommitted is unclear. 
If the general status of a cell is important for the self-renewal versus 
differentiation decision – what are the most distinguishing features between stem cells 
and committed cells? Certainly, their cell cycle profile is quite unique, since in the end, 
the self-renewal versus differentiation decision boils down to whether a cell opts to 
exit the cell cycle or to divide again (or at least remain competent to do so). This is the 
decision we really need to understand if we want to be able to manipulate stem cells 
for therapeutic purposes; all stem cell factors, as different as they may be, in the end 
affect that one decision.  
In the C.elegans germline, Notch signaling and FBF proteins were found twenty 
and ten years ago, respectively, to be essential for germline stem cell maintenance. 
Although both have since been implied in stem cell biology in many other model 
systems, including vertebrates, it is not clear to date how they affect an individual 
stem cell’s decision to continue proliferation or to differentiate meiotically. Since 
particularly Notch signaling is highly conserved and required for stem cell 
maintenance in several contexts, it is highly desireable to understand the impact of 
Notch signaling on the self-renewal versus differentiation decision.  
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When I started my work at FMI, little was known about how cell fate switches can occur 
in the C.elegans germline, and about the role of conserved stem cell factors in that 
process. However, we knew that in the compound mutant background gld-2 gld-1; glp-
1, in which germline stem cells proliferate incessantly because, due to mutations in the 
meiotic factors GLD-1 and GLD-2, they cannot enter meiosis though they lack the 
stem cell factor GLP-1/Notch, MEX-3 protein is crucial to maintain both stem cell 
divisions and stem cell identity (see scheme below; a and b). We also knew at that point 
that MEX-3 was NOT required for proliferation and stem cell identity when in the 
identical background GLP-1/Notch was constitutively active (c and d).  
 
  A. (a) gld-1 gld-2; glp-1(-)    stem cell tumor 
(b) gld-1 gld-2; glp-1(-)   - MEX-3 differentiation 
   
  B. (c) gld-1 gld-2; glp-1(++)   stem cell tumor 
(d) gld-1 gld-2; glp-1(++)  - MEX-3 stem cell tumor 
 
Stem cell proliferation in case (a) is thus MEX-3 dependent; stem cell proliferation in 
case (d) is thus GLP-1/Notch-dependent. It was therefore my aim to identify how 
Notch signaling and MEX-3, respectively, protect stem cells. The idea was to identify 
genes that are regulated on the mRNA level by Notch signaling, and to continue from 
whatever we found. Among other genes, we found that Notch signaling downregulates 
the cell cycle inhibitor CKI-2. Coincidentally, it turned out that CKI-2 was the key 
target of MEX-3 in scenario (a). This prompted us to look at CKI-2 function in the 
germline more globally, and led to the next coincidental discovery that in a wild type 
background, it is not MEX-3, but another highly conserved stem cell factor that 
regulates CKI-2 expression to maintain stem cells: the Pumilio proteins FBF. In 
addition, we found that Notch signaling primarily affects genes that are also regulated 
by the C.elegans equivalent of the Polycomb Repressive Complex 2 (PRC2), by the MES-
proteins. The MES proteins are epigenetic modifiers involved in X-chromosome 
silencing in the germline and are required in a transgenerational manner for germ line 
stem cell proliferation. How these two pathways interact in detail is however beyond 
the scope of this thesis.  
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4. Identification of Notch target genes in stem cells 
 
As previously mentioned, Notch signaling maintains C.elegans germline stem cells. 
Screens based on temperature sensitve loss and gain-of-function alleles have yielded 
genes genetically interacting with Notch signaling (Maine and Kimble 1989; Maine and 
Kimble 1993; Sundaram and Greenwald 1993; Qiao, Lissemore et al. 1995). Many of 
them were found to modulate pathway component activity and availability, such as the 
endocytic and proteolytic machinery. Others are still not characterized because they 
would not have a phenotype on their own (Lissemore, personal communication). 
However, these screens yielded no hints about events downstream of Notch signaling. 
How the information provided by Notch signaling is translated into cell behaviour 
therefore remains a black box. Since Notch signaling regulates transcription (Bray 
2006), we wanted to identify genes whose RNA levels change in response to Notch 
signaling using C.elegans tiling arrays and hoped to identify genes directly regulated 
by Notch signaling and/or of importance for stem cell maintenance.  
The phenotypes of Notch loss and gain-of-function mutations could not be more 
different. While gain-of-function mutations induce stem cell tumors, stem cells are lost 
already during juvenile stages in the loss-of-function (Fig. 6A). mRNA expression 
patterns of gain and loss of function mutants can therefore not be compared directly. 
However, meiotic differentiation in the Notch loss-of-function mutant depends on two 
pro-meiotic factors, GLD-1 and GLD-2 (Kadyk and Kimble 1998). In the absence of 
GLD-1 and GLD-2, stem cells cannot enter meiosis and continue to proliferate even 
when they do not receive a Notch signal (Fig. 6A). Accordingly, we compared the 
expression profiles of germ cells in the presence/absence of Notch signaling in a gld-1 
gld-2 mutant background. Strong Notch gain-of-function mutations are dominant and 
difficult to maintain even at low temperatures and as heterozygotes. The canonical 
null allele on the other hand is closely linked to a strong unc mutation. We therefore 
chose temperature-sensitive mutations, glp-1(ar202tsgf) and glp-1(e2141tslf). Both are 
wild type at 15°C and fully penetrant at 25°C. P0 animals of gld-1 gld-2; glp-1(lf) and 
gld-1 gld-2; glp-1(gf) animals were raised at the permissive temperature and shifted to 
the restrictive temperature at the L4-adult transition. Germlines from 50 animals of 
the F1 generation, which had been raised entirely at the restrictive temperature, were 
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Figure 6. Experimental setup to identify Notch-responsive genes in C.elegans germline stem cells.
(A) Schematic drawings of a wild type gonad (top) and the effect of loss (lf) and gain (gf) of function mutations 
in the Notch receptor on germline stem cell proliferation (below) in the presence or absence of gld-1 and gld-2. 
Removing the pro-meiotic proteins GLD-1 and GLD-2 prevents stem cell loss even in the absence of Notch 
signaling. Red labels, genotypes used for expression analysis. (B) Gonad dissection. Gonads are released by a 
cut with an injection needle behind the pharynx, dissected away from the soma and collected in sample buffer 
by mouth pipette. 50 gonads were collected for each technical replicate. (C) Samples hybridized to Affimetrix 
C.elegans tiling arrays. A, B, biological replicates. 1, 2, 3, technical replicates. e2141, loss of function allele of 
glp-1/Notch. ar202, gain of function allele of glp-1/Notch. 
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dissected in triplicate and handed over to Eric Cabuy from the Genomics facility at FMI 
for amplification, array hybridisation and scanning (Figs. 6B and 6C).  
Initial analysis performed by Dimos Gaidatzis from the Bioinformatics Facility 
at FMI revealed high correlation across all arrays (Fig. 7A). This indicates that we 
successfully reduced background noise, and that only few genes are differentially 
expressed. Expression values averaged from all arrays display a bipartite distribution 
(Fig. 7B). The left peak represents transcripts that are not expressed above background 
noise, the right peak contains expressed transcripts. To identify genes differentially 
expressed in the presence or absence of Notch, a fold-change value was calculated for 
each biological repeat seperately. Correlating and averaging changes observed in first 
and second biological repeat revealed that a small group of genes increases in 
expression in response to Notch signaling (Figs. 7C and D). 114 genes / 130 isoforms 
are upregulated more than 2 fold, 10 genes / 11 isoforms go down more than 2 fold 
(Table 4).  
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Figure 7. Quality control and identification of differentially expressed genes.
(A) Correlation plot of all arrays. Light color indicates high correlation, dark color indicates lower correlation. 
As expected, correlation is higher within than between genotypes both between technical (1,2,3) and biological 
(A,B) replicates. (B) Histogram of average gene expression. Left peak, background / noise; right peak, expressed 
genes. Average Expression Values were obtained by averaging expression across all arrays. (C) MA plot (M, 
magnitude of change; A, average expression). Green/red dots, genes up/downregulated by Notch signaling 2 
fold or more. Most upregulated genes have an average expression value (X-axis) just above background, 
indicating that they may be not just be upregulated, but switched on by Notch signaling. (D) Correlation of fold 
changes between first and second biological replicate. Green/red dots, as in (B). Upregulation correlates well 
between biological replicates. Values in B, C, and D are given in log2.
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Table 4. Notch target genes.
Genes identified as down- (A) or upregulated (B) at least 2 fold. 
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Table 4. Notch target genes.
Genes identified as down- (A) or upregulated (B) at least 2 fold. 
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4.1 Notch signaling crosstalks to the C.elegans Polycomb proteins 
 
Using the online gene-ontology analysis tool DAVID, components of the core 
proteasome or genes linked to mitochondrial metabolism appeared mildly enriched 
among Notch regulated genes (data not shown). We were however struck by another 
property of coregulated genes: Among 114 genes upregulated 2fold, 52 reside on the 
X-chromosome, which is almost 4 fold more than expected (Fig. 8A). This enrichment 
is significant (Fig. 8B). The X-chromosome is largely silent in the C.elegans germline. 
We confirmed that this is also true in the germline tumors used for analysis (Fig. 8C 
and 8D).  
The machinery responsible for X-chromosome silencing in the germline 
consists of a group of four proteins: MES-2, MES-3, MES-4 and MES-6 (Pirrotta 2002). 
The MES proteins were discovered in screens for Maternal Effect Sterile mutations 
(hence the name; Paulsen, Capowski et al. 1995). Homozygous F1 animals develop 
normally. However, germ cells arrest proliferation and degenerate during larval stages 
iin the F2 generation (Paulsen, Capowski et al. 1995; Holdeman, Nehrt et al. 1998). MES 
proteins were found to belong to two distinct complexes with different chromatin 
modifying activities (Xu, Fong et al. 2001). MES-2, MES-3 and MES-6 are considered the 
C.elegans equivalent of Polycomb repressive complex 2 (PRC2). MES-2 is orthologous 
to Enhancer of Zeste, MES-6 to Extra Sex Combs, while MES-3 is a novel protein. MES-
2, MES-3 and MES-6 methylate H3K27 via the SET domain of the EZH protein MES-2 
(Bender, Cao et al. 2004). MES-4 is not part of the complex and deposits H3K36 
methylation marks (Bender, Suh et al. 2006). The two complexes localize to and modify 
histones on autosomes (MES-4) and heterosomes (MES-2, MES-3, MES-6), respectively, 
and prevent association of the other with their territory (Fong, Bender et al. 2002; Fig. 
8A). Deletion of MES-4 causes relocalisation of MES-2,3,6/PRC2 from the X-
chromosome to autosomes. In the following, H3K27 methylation levels and repression 
cannot be maintained on the X-chromosome in mes-4 mutants, similar to the situation 
in mes-2/3/6 mutants. 
Genes deregulated in the F1 generation of MES-4 mutants have been identified 
by microarray analysis (Bender, Cao et al. 2004). Many of these genes are X-linked. 
Since we found a bias towards X-linkage among Notch target genes, we wondered 
whether Notch signaling and the MES proteins would co-regulate genes. Indeed we 
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Figure 8. Notch-responsive genes are disproportionally X-linked. 
(A) 52 of 114 upregulated (>2 fold) genes reside on the X chromsome (dark blue; 45.6%). This is almost four 
fold more than the expected fraction (13.6%). (B) Among 100 independent random samplings of 114 genes, the 
maximum number of X-linked genes obtained was 25. Therefore, the probability to obsere 52 X-linked genes 
among 114 genes is less than 1% (p < 0.01). (C) Density plot of average expression values. Red line, distribution 
of average expression of X-linked genes. Black line, distribution of average expression of autosomal genes. 
Most X-linked genes are not or only lowly expressed. (D) MA-plot similar to Figure 7B, but separated by 
chromosomal location. Few X-linked genes are expressed above background; most upregulated genes are X-
linked. 
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found that Notch target genes overlapped with 71 genes described as significantly 
deregulated in MES-4 F1 mutants (data not shown and Bender, Suh et al. 2006). Susan 
Strome (University of California) in the following kindly shared her unpublished data 
on gene regulaiton in mes-2, mes-3, mes-4, and mes-6 mutants obtained from two 
different microarray platforms, “oligo” and “amplicon”. Fascinatingly, genes 
deregulated in these mutants overlap very well with genes that respond to Notch 
signaling (Fig. 9B). While according on the “oligo” data, the correlation is true for mes-4 
but not mes-2 or mes-3, the “amplicon” data suggests that genes deregulated in all mes 
mutants correlate with Notch target genes. Interestingly, the correlation is restricted to 
the X-chromosome (Fig. 9B). We figured that correlation may be coincidental if both 
Notch signaling and MES-2,3,6/PRC2 were involved in X-silencing in the germline. 
However, correlation dissappeared when MES-4 dependent fold changes of X-linked 
genes were randomly attributed to X-linked genes, demonstrating that Notch signaling 
and the MES-2,3,6/PRC2 converge on a specific subset of genes (Fig. 9C).  
Assuming that MES-2,3,6/PRC2 and Notch signaling regulate common targets, 
one would expect them to interact genetically. To this end, a weak gain-of-function 
allele of Notch, glp-1(ar202)gf, was crossed with mes-2 and mes-4 null mutants. 
Strikingly, 100% of glp-1(gf) mes-4 double mutant germlines (n=42) displayed germline 
tumors already at the permissive temperature of 15°C, while all glp-1(ar202) single 
mutant germlines (n=31) have wild type morphology at this temperature (Fig. 10A). In 
line with our observation that Notch-responsive genes correlate better with genes 
deregulated in mes-4 than in mes-2, mes-3, or mes-6 mutant animals, glp-1(gf) and mes-
2 did interact genetically, but the phenotype was less penetrant than the glp-1(gf) mes-
4 phenotype (Figs. 10B and 10C). 
Based on these results, we postulate that Notch signaling in C.elegans germ 
cells and the MES-proteins, particularly MES-4, antagonistically regulate a subset of 
genes residing on the X-chromosome. Also, based on the genetic interaction 
phenotype, coregulated genes are involved in the mitosis-meiosis decision of germ 
cells in C.elegans. Since germ cells of glp-1(gf) mes-4 double mutants are able to 
differentiate into sperm (Fig. 10A, proximal gonad end), female and male germ cells 
are inherently different in their response to Notch signaling or in their requirement for 
MES proteins. Future analysis of the interaction of Notch signaling with the Polycomb 
system will be carried out by Balazs Hargitai, a Post Doc in the lab.  
Results – Notch signaling crosstalks to Polycomb 
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Figure 9. Notch signaling and MES/Polycomb proteins regulate the same genes.
(A) Schematic drawing of chromatin-modifying activity and mutual regulation of MES proteins as described in 
the text. (B) Correlation of fold change in response to Notch signaling (X-axis) with fold change in the indicated 
mes mutant obtained with amplicon oligo microarray platforms (Y-axis). X-linked genes and autosomal genes 
are shown separately. Correlation is restricted to X-linked genes. (C) Randomly assorting X-linked genes with 
their respective fold changes in mes-4 mutants (panels #2-4) disrupts correlation (panel #1), indicating that 
Notch signaling and MES proteins co-regulate specific genes rather than X-linked genes in general. 
Results - Notch signaling crosstalks to Polycomb
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Figure 10. Genetic interaction of mes-4 and mes-2 with glp-1(gf)
(A) DAPI staining of dissected glp-1(ar202gf) and glp-1(ar202gf) mes-4(bn85) gonads (outlined). Animals were 
raised at the temperature permissive for the glp-1(gf) mutation, 15°C. Nonetheless, the glp-1(gf) mes-4 double 
mutant forms a germline tumor. (B) DAPI staining of glp-1(gf) gonads heterozygous (top) or homozygous 
(bottom) for mes-2(bn11). The double mutant displays a compound tumorous phenotype at the semipermis-
sive temperature of 20°C. (C) Quantification of the glp-1(gf) mes-2 compound phenotype as observed in (B). n, 
total number of gonads. In (A) and (B), an asterisk marks the distal gonad. 
Results - Notch signaling crosstalks to Polycomb
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4.2 CKI-2 repression promotes self-renewal of C.elegans germline stem cells 
 
4.2.1 Cip/Kip CKI-2 mRNA levels are affected by Notch signaling  
 
Several lines of evidence suggest that the decision of stem cells to self-renew or 
differentiate is closely connected to the cell cycle status. Terminal differentiation and 
cell cycle exit usually go hand in hand, but also partial restriction of progenitor 
potential is accompagnied with cell cycle changes. While pluripotent cells typically 
display rapid G1-to-S phase transitions, differentiation correlates with slower 
divisions, longer gap phases, and the introduction of cell cycle checkpoints (Richard-
Parpaillon, Cosgrove et al. 2004; Lange, Huttner et al. 2009). This has prompted the 
idea that cell cycle changes may not only be a consequence of differentiation, but 
substantially contribute to the decision of a cell to differentiate and, in some cases, 
may be sufficient to direct the fate decision. Forced expression of factors promoting 
cell divisions, such as Cyclin D1 and Cdk4, impede differentiation (Skapek, Rhee et al. 
1995; Lange, Huttner et al. 2009). Inversely, the cell cycle inhibitor p21 acts as a barrier 
to reprogramming (Hong, Takahashi et al. 2009). 
 Despite ample evidence for the importance of cell cycle regulation in self-
renewal and differentiation, the connection between the cell cycle and critical stem cell 
factors is not well understood. We therefore analysed whether any cell-cycle related 
genes would respond to Notch signaling based on our expression data. The expression 
of most cell cycle components was not affected. This is expected, since both tissues 
are composed of proliferating cells with stem-cell like morphology. One cell cycle 
mRNA, however, is less abundant in the presence of Notch signaling: the mRNA 
encoding the Cip/Kip family cell cycle inhibitor CKI-2 (Fig. 11A and B). This was 
confirmed by quantitative PCR on dissected gonads (Fig. 11C). 
CKI-2 is a member of the Cip/Kip family of cell cycle inhibitors. These small 
proteins bind to Cyclin E/CDK2 complexes and prevent their activation. Active Cyclin 
E/CDK2 promotes transition through the restriction point preceeding S phase. 
Transition beyond this point of the cell cycle is irreversible. Thus, Cip/Kip cell cycle 
inhibitors act as the last possible break when all components are assembled and ready 
for another cell cycle. Given previous work on the significance of G1-S regulation in 
the stem cell self-renewal versus differentiation decision in other systems (Lange and 
Results – Notch signaling affects a cell cycle inhibitor 
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Figure 11. Notch signaling downregulates cki-2 mRNA levels.
(A) Correlation plot as in Figure 8C. Coloured dots, cell cycle genes of indicated category. cki-2 is downregu-
lated in both biological repeats, A and B. (B) MA plot as in Figure 8B. Most cell cycle genes are expressed above 
background. cki-2 is downregulated by Notch signaling. (C) Verification of (A) and (B) by qPCR. Relative expres-
sion of cki-2, tbb-2 (tubulin) and act-1 (actin) mRNAs in gld-2 gld-1; glp-1(lf) (Notch OFF) and gld-2 gld-1; glp-
1(gf) (Notch ON) as determined by quantitative RT-PCR on dissected gonads. cki-2 mRNA levels are three fold 
higher in the absence of Notch signaling.   
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Calegari 2010) and our own findings on the importance of CYE-1/CDK-2 regulation by 
GLD-1 during meiotic progression (Biedermann, Wright et al. 2009), we decided to 
have a closer look at the role of CKI-2 in the germline.  
 
4.2.2 The Cip/Kip protein CKI-2 is repressed in the germline stem cells 
 
The C. elegans genome encodes two members of the Cip/Kip family: CKI-1 and CKI-2 
(Fig. 12A). They are separated by less than five kilobases and therefore likely arose 
from a gene duplication event. However, CKI-1 and CKI-2 have diverged substantially 
since both in sequence and function. CKI-1 is required in somatic blast cells for the 
proper timing of cell cycle withdrawal in the embryo as well as in juvenile seam cell 
lineages (Hong, Roy et al. 1998; Fukuyama, Gendreau et al. 2003). CKI-2 on the other 
hand is not essential and plays a minor role during vulval development (Buck, Chiu et 
al. 2009). By semi-quantitative RT-PCR and immunofluorescent detection, we found 
that CKI-1 and CKI-2 differ, in accordance with their mutant phenotypes, in their 
expression patterns. CKI-1 is expressed in specific cells in the embryo, but not in the 
germline (Fig. 12B). CKI-2 on the other hand is the predominant CKI in the adult germ 
line (Fig. 12C and 12E).  
 During 3’RACE experiments to determine the length of the cki-2 3’UTR (3’UTRs 
are usually badly annotated in C.elegans), we found that the cki-2 gene encodes two 
mRNAs (cki-2 L and cki-2 S, 1316 and 951nt long, encoding a 259 and 175 amino acid-
long protein, respectively; Fig. 12D). The larger form was cloned at a much higher 
frequency. Northern blots not only confirmed that the long isoform was far more 
abundant, but also showed that cki-2 is a germline specific transcript (Fig. 12E). 
According to in situ hybridisations, cki-2 mRNA is less abundant in the stem cell 
region, which has been observed previously (Kim and Roy 2006; Fig. 12F). This 
confirms our initial observation that Notch signaling negatively affects cki-2 mRNA 
levels.   
 The protein expression pattern suggests a role for CKI-2 in entry or 
progression through meiosis. However, the cki-2 null mutant is viable and fertile (Buck, 
Chiu et al. 2009), and CKI-2 is not essential for either process. However, the absence of 
Cip/Kip proteins is a hallmark of pluripotent cells (Ramalho-Santos, Yoon et al. 2002; 
Results – The Cip/Kip protein CKI-2 is absent from stem cells 
53
Results - The Cip/Kip protein CKI-2 is expressed in meiosis
Figure 12. The Cip/Kip protein CKI-2 is expressed in meiotic germ cells. 
(A) Phylogenetic tree of Cip/Kip proteins obtained with ClustalW (default settings). Protein sequences were 
retrieved from Uniprot. (B) Semi-quantitative RT-PCR of indicated mRNAs on indicated RNA samples (left); 
immuno-staining for CKI-1 protein on dissected gonad and embryos (outlined; right). Both cki-1 mRNA and 
CKI-1 protein are exclusively detected in embryos. rme-2, germline-specific transcript. pal-1, germline and 
embryonic transcript. act-1, actin. glp-4, germlineless animals. (C) Immunodetection of CKI-2 in a dissected 
gonad (outlined). CKI-2 is expressed upon meiotic entry but absent from the distal-most stem cell compart-
ment. (D) cki-2 gene structure. By 3’RACE analysis, cki-2 encodes two alternatively spliced mRNA isoforms, 
cki-2 L and S. (E) Northern blot of cki-2 mRNA isolated from non-gravid wild type, glp-4 and cki-2(ok2105) 
mutants using a probe against both isoforms. cki-2 L (black arrowhead, 1316nt plus poly-A tail) predominates, 
while cki-2 S (951nt + poly-A tail, empty arrowhead) is hardly detectable. cki-2 mRNA is absent from germline-
less glp-4 animals. (F) In situ hybridisation for cki-2 on dissected gonads (outlined; distal region) of the 
indicated genotypes. cki-2 mRNA is absent from the stem cell compartment. Scale bars: 50µm. .  
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Ginis, Luo et al. 2004; Barta, Vinarsky et al. 2010), which made us wonder whether 
repression of CKI-2 in GSCs is important for their maintenance. 
  
4.2.3 MEX-3 regulates expression of CKI-2 in certain genetic backgrounds 
 
Although cki-2 mRNA is present in Notch ON as well as in Notch OFF tumors (Fig. 11), 
we could not observe CKI-2 protein by immunofluorescence in either case (data not 
shown). Thus, an additional regulatory mechanism preventing CKI-2 protein 
expression must exist. Posttranscriptional regulation is common in germ cells and is 
often mediated by the 3’UTR of mRNAs (Merritt, Rasoloson et al. 2008). A prime 
candidate for regulation of CKI-2 expression in Notch OFF tumors, where cki-2 mRNA, 
but not the protein, is expressed, is the KH domain RNA binding protein MEX-3. 
Previous experiments by Björn Biedermann, a former PhD student in the lab, had 
demonstrated that MEX-3 was required for proliferation and the maintenance of stem 
cell identity in Notch OFF, but not Notch ON tumors (Fig. 13A). If MEX-3 would 
promote proliferation through repression of cki-2, this may explain why Notch OFF 
tumors, which express cki-2 mRNA, but not Notch ON tumors, where the mRNA is less 
abundant, depend on MEX-3. Indeed, CKI-2 protein is upregulated in mex-3, gld-1, gld-
2; glp-1(lf) (Notch OFF mex-3(-)) germ cells, indicating that MEX-3 prevents CKI-2 
expression in Notch OFF tumors (Fig. 13B).  
 We therefore tested a direct association of MEX-3 with the cki-2 mRNA. To this 
end, we expressed a GFP-tagged MEX-3 in Notch OFF mex-3(-) animals. The transgene 
was originally created in the laboratory of Jennifer Schisa (Jud, Razelun et al. 2007) 
and curiously, although it does not rescue the embryonic lethality of mex-3 mutants, 
rescues the proliferation defect of Notch OFF mex-3(-) germ cells. cki-2 mRNA can 
indeed by co-immunoprecipitated with MEX-3:GFP to the same extent as the 
established targets rme-2 and pal-1 (Fig. 13C). 
 Next, we tested whether CKI-2 expression in Notch OFF mex-3(-) germ cells was 
causal to germ cell proliferation arrest and differention. To this end, we constructed 
mex-3 gld-1 gld-2; cki-2; glp-1 (Notch OFF mex-3(-) cki-2(-)) mutant animals. To our 
satisfaction, germcells in Notch OFF mex-3(-) cki-2(-) animals proliferated just like in 
Notch OFF animals (Table 5). Since removal of CKI-2 suppresses the proliferation 
defect caused by the mex-3 mutation, we assume that CKI-2 is sufficient to arrest 
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Figure 13. MEX-3 maintains stem cell identity by repressing CKI-2
(A) Proximal region of dissected gonads (outlined) of the indicated genotype stained for DAPI and HLH-1. In 
the absence of Notch signaling, germ cells initiate somatic differentiation (eg, express the muscle-specific 
transcription factor HLH-1) upon depletion of MEX-3, indicating that MEX-3 in this background prevents 
differentiation of germ cells. (B) CKI-2 staining on dissected gonads (outlined) of the indicated genotypes. 
MEX-3 prevents accumulation of CKI-2 and promotes proliferation of germ cells (compare gonad size). (C) 
HIM-3 staining on dissected gonads (outlined) of the indicated genotypes. Removal of CKI-2 not only rescues 
the proliferation defect (compare gonad size), but also prevents accumulation of the meiotic marker HIM-3, 
an early step in germ cell differentiation. (D) cki-2 mRNA co-immunoprecipitates with MEX-3. Fold enrichment 
over input of the indicated mRNAs in a MEX-3:GFP RNA-co-IP. rme-2, pal-1, known targets of MEX-3. act-1, 
actin; tbb-2, tubulin; ama-1, RNA Pol II. 
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germ cell proliferation, to induce differentiation, and that it can associate with and be 
regulated by MEX-3. 
 
Table 5. Contributions of MEX-3 and Notch signaling to CKI-2 regulation and stem cell 
maintenance. 
genotype   phenotype 
cki-2 
mRNA 
CKI-2 
protein 
gld-1 gld-2; glp-1(-)   stem cell tumor high - 
gld-1 gld-2; glp-1(-) - MEX-3  differentiation n.d + 
gld-1 gld-2; glp-1(-) - MEX-3 - CKI-2 stem cell tumor   
gld-1 gld-2; glp-1(++)   stem cell tumor low - 
gld-1 gld-2; glp-1(++) - MEX-3  stem cell tumor n.d - 
 
 The fact that the proliferation defect of Notch OFF mex-3(-) germ cells could be 
rescued by depleting cki-2 allowed us to test potential differential requirements of cki-
2 S and cki-2 L. An RNAi clone targeting exons 4 and 5, which are present in cki-2 L but 
not cki-2 S, rescued the proliferation defect of Notch OFF mex-3(-) germ cells as 
efficiently as an RNAi clone directed against the entire cki-2 coding sequence (data not 
shown). At least in the Notch OFF background, cki-2 S therefore does not contribute to 
cell cycle regulation.  
 Immunostainings for meiotic markers in the germline stem cell tumors Notch 
OFF and Notch OFF mex-3(-) cki-2(-) indicated that, although germ cells proliferate in 
both cases to a similar extent, they may be inherently different in their meiotic 
disposition. HIM-3 and HTP-3, components of the synaptonemal complex, are absent 
from stem cells and are deposited on chromosomes in early meiosis. Both are however 
expressed in mitotically proliferating Notch OFF mex-3(-) cki-2(-) germ cells and, at 
lower levels, in Notch OFF germ cells (Fig. 14). Thus, proliferating germ cells in those 
tumors may represent some kind of transit amplifying stem cell population, which in 
the wild type is short lived and therefore has not yet been described. 
 However, although MEX-3 regulates CKI-2 protein expression and associates 
with the cki-2 mRNA in sensitized genetic backgrounds, CKI-2 is not overexpressed in 
the stem cell compartment of the mex-3 single mutant (Fig. 15). This left us with the 
task to identify additional regulators of CKI-2 expression. 
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Figure 15. MEX-3 is not required for CKI-2 repression in the wild type stem cell compartment.
Distal end of dissected mex-3 mutant gonads (outlined) stained for DAPI (top) and CKI-2 (bottom). CKI-2 is 
not expressed in stem cells in the absence of MEX-3. 
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Figure 14. Germ cell tumors may represent a transit amplifying population.
Meiotic entry region of dissected gonads (outlined) of indicated genotype stained for the meiotic markers 
HTP-3 and HIM-3. Arrowhead, meiotic entry zone as indicated by the appearance of half-moon shaped nuclei. 
HIM-3 or HTP-3 are not expressed in the wild type distal stem cell compartment. Levels increase prior to and 
during meiotic entry (top gonad). In terms of HIM-3/HTP-3 expression, gld-2 gld-1; glp-1 germ cell tumors 
resemble wild type germ cells prior to transition zone, while mex-3 gld-2 gld-1; cki-2; glp-1 germ cell tumors 
resemble germ cells after meiotic entry (boxes/arrows). 
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4.2.4 The cki-2 3’UTR mediates repression of a reporter in germline stem cells 
 
To test if CKI-2 expression may be regulated via its 3’UTR, we produced transgenic 
lines expressing a reporter gene (Histone 2B coupled to GFP) from a defined locus on 
chromosome two (Frokjaer-Jensen, Davis et al. 2008; Merritt, Rasoloson et al. 2008). 
The expression pattern of this reporter is entirely controlled by the 3’UTR and 
regulatory elements therein (Merritt, Rasoloson et al. 2008). All germ cells expressed 
H2B-GFP when it was fused to the 3’UTR of the housekeeping gene tbb-2 (tubulin). 
When coupled to cki-2 3’UTR, the reporter was repressed in the stem cell compartment, 
just like endogenous CKI-2 (Fig. 16A). The cki-2 3’UTR is therefore sufficient to 
reproduce the expression pattern of endogenous CKI-2, and accordingly must recruit 
regulators that prevent translation of the reporter in stem cells. 
 
4.2.5 The cki-2 3’UTR recruits two conserved stem cell factors: MEX-3 and FBF 
 
Regulation conferred by the cki-2 3’UTR may depend on miRNAs. According to 
available online prediction tools MirWip, PicTar, MirZ, and TargetScan (Lall, Grun et al. 
2006; Ruby, Jan et al. 2006; Hammell, Long et al. 2008; Hausser, Berninger et al. 2009), 
cki-2 is however likely not a miRNA target – in contrast to its sibling gene cki-1, which 
harbours several conserved miRNA binding sites in its 3’UTR. We figured – based on 
our observation that CKI-2 overexpression in compound backgrounds drives stem 
cells into meiosis – that proteins required to maintain stem cells in the C.elegans 
germline may be candidates to regulate cki-2. RNA binding stem cell factors in 
C.elegans include FBF-1 and FBF-2 (collectively referred to as FBF), two very similar 
and largely redundant proteins of the Pumilio family, as well as the Pumilio family 
member PUF-8 and the conserved KH-domain protein MEX-3, which function 
redundantly to maintain stem cell proliferation. mex-3 puf-8 double mutants germ cells 
arrest proliferation during juvenile stages (Ariz, Mainpal et al. 2009). fbf-1 fbf-2 double 
mutants set up a germline during juvenile stages, but after the initiation of 
spermatogenesis in late L4, stem cells are lost by differentiation into sperm 
(Crittenden, Bernstein et al. 2002). 
 Sequences required for association of MEX-3 and Pumilio proteins with their 
targets have been identified in vitro and in vivo (Table 1 and Pagano, Farley et al. 2009). 
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Figure 16. The cki-2 3’UTR confers repression in stem cells and contains conserved elements.
(A) Gonads (outlined) from live worms expressing reporters (depicted schematically; black triangles: recombi-
nation sites) under the control of the indicated 3’UTR. The distal gonad is marked by an asterisk. The cki-2 
3’UTR prevents expression in stem cells. Scale bar, 50µm. (B) Alignment of the C.elegans cki-2 3’UTR and 
equivalent sequences from C.briggsae, C.brenneri, and C.remanei. Several regions are conserved, indicating 
functionality. MRE1, MRE2, FBE1-4 and ∆FBE1-4 are indicated by colours. Pale region, exon 4 of cki-2 S (see 
Figure 12).
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In both cases, recognition sites are fairly redundant and therefore likely to occur by 
chance every few hundred base pairs. Relevant sites in sequences such as UTRs, which  
have to fit functional constraints locally and are otherwise free to evolve, can be 
identified based on conservation. For example, miRNA target prediction algorythms 
use conservation to determine the probability of a site being true. Hans Rudolf Hotz 
from the Bioinformatics facility at FMI therefore extracted the putative cki-2 3’UTR 
sequences from C.briggsae, C.brenneri, and C.remanei. In alignments using ClustalW 
and VectorNTI, several regions were conserved, indicating functionality (Fig. 16B). To 
our satisfaction, one conserved block contained the MEX-3 binding motif DKAG(N0-
8)UHUA (MRE; D = A, G, or T; K = G or T; H = A, C, or T; Pagano, Farley et al. 2009). 
Other conserved clusters contained variations of the UGU – AU motif, hallmark of Puf 
protein binding sites (Wickens, Bernstein et al. 2002) Table 1, and Fig. 16B).  
 The assay normally used in the lab to test protein-RNA interactions includes 
cell-free in vitro translation of the protein and coprecipitation with a biotin-labelled 
RNA. This assay has been used successfully to confirm GLD-1 binding to its targets 
(Lee and Schedl 2001; Biedermann, Wright et al. 2009; Wright, Gaidatzis et al. 2010). 
However, the same experiment with FBFs, PUF-8 and MEX-3 proved technically 
challenging. While MEX-3 would require the addition of crude worm extract to 
associate with its putative cognate sequence – rendering our attempts to show direct 
association pointless - Pumilio proteins would not associate with the positive control 
gld-1 mRNA (Crittenden, Bernstein et al. 2002) at all. We therefore initiated a 
collaboration with the lab of Sean Ryder at Massachusettes Medical School, who have 
expertise in determining RNA-protein interactions with fluorescence electrophoretic 
mobility shift (F-EMSA) and fluorescence polarization (FP) assays and have previously 
worked with Pumilio and MEX-3 (Pagano, Farley et al. 2009; Pagano, Clingman et al. 
2011). The putative MEX-3 recognition element occurs twice in the cki-2 3’UTR. The 5’ 
MRE (MRE2; ATAGacatTCTA) caught our attention because of its conservation. The 3’ 
MRE (MRE1; AGAGaauuUCUC) was identified only by targeted search because is not 
conserved. MRE1 cannot be tested by in vitro methods because it folds into a stable 
hairpin, and is not expected to associate with MEX-3 in vivo. In contrast, the 5’ MRE 
(MRE2; AUAGacauUCUA) is highly conserved and associated with MEX-3 tightly (K
d, app 
= 
9 ± 1 nM F-EMSA, 15 ± 1 nM FP). Mutant variants that disrupt MRE2 bound MEX-3 with 
reduced affinity, confirming the specificity of the interaction (Fig. 17A; Table 6). 
Results – The cki-2 3’UTR mediates regulation 
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 Interestingly, the MEX-3 motif was originally reported to consist of two half 
sites (A and B) separated by maximally eight bases. However, in the case of the cki-2 
3’UTR, two B sites seem to contribute to binding, with more than eight bases 
intervening between the A site and the second B site (Table 6). 
 
Table 6. Affinities of MEX-3 and FBF-2 for predicted binding sites in the cki-2 3’UTR. 
Identifier Sequence 
Kd,app 
(GS) 
Kd,app 
(FP) 
cki-2 MRE2 WT ACUCAAAUCAUAGACAUUCUAGUUAUAAAU 9 ± 1 nM  15 ± 1 nM 
cki-2 MRE2 mut1 ACUCAAAUCCCCCACAUCCCCGUUAUAAAU 80 ± 20 nM 76 ± 4 nM 
cki-2 MRE2 mut2 ACUCAAAUCCCCCACAUCCCCGUCCCCAAU > 500 nM > 500 nM 
gld-1 FBEa AUAGAAUCAUGUGCCAUACAUCAUGUUG 32 ± 1 nM 11 ± 2 nM 
cki-2 FBE1 WT UUUAUCUGUGAAUUUGAAAU 26 ± 12 nM 5 ± 1 nM 
cki-2 FBE1 mut UUUAUCACAGAAUUUGAAAU > 500 nM > 500 nM 
cki-2 FBE2 WT CAUACCCUGUCCAUUUCUGU > 500 nM > 500 nM 
cki-2 FBE2 mut CAUACCCACACCAUUUCUGU > 500 nM > 500 nM 
cki-2 FBE3 WT CAUUUCUGUGUUCUACUCCU 240 ± 8 nM 114 ± 2 nM 
cki-2 FBE3 mut CAUUUCACAGUUCUACUCCU NB > 500 nM 
cki-2 FBE4 WT CUACUCCUGUAAAAAAAGUC 300 ± 40 nM 95 ± 3 nM 
cki-2 FBE4 mut CUACUCCACAAAAAAAAGUC NB >> 2 M 
reported values are the average of three replicates ± one standard deviation 
  
Results obtained in the meantime with reporters in vivo suggested that PUF-8 may not 
be crucial for regulation via the cki-2 3’UTR, while FBF proteins were definitely involved 
in regulating the reporter (see next section). Within a highly conserved region required 
for reporter regulation in vivo (next section), we observed five UGU motifs in the 
context of four possible FBF binding elements, FBE1 through 4 (Fig. 16B). FBE1 and 
FBE4 are conserved, while FBE2 and FBE3 are not. FBF-1 and FBF-2 act redundantly to 
promote stem cell divisions (Bernstein, Hook et al. 2005) and bind identical sequences 
in vitro (Wang, Opperman et al. 2009). Because FBF-2 is easier to handle biochemically, 
it was used for interaction assays. FBF-2 was found to bind with high affinity to FBE1 
(K
d, app 
= 26 ± 12 nM, F-EMSA, 5 ± 1 nM, FP), which is comparable to the previously 
described FBF affinity to a site in the gld-1 3’UTR (K
d, app 
= 32 ± 1 nM, F-EMSA, 11 ± 2 
nM, FP;  (Merritt and Seydoux 2010). We also found that FBF-2 bound with modest 
affinity to FBE3 and FBE4 elements (FBE3:  K
d, app 
= 240 ± 8 nM F-EMSA, 114 ± 2 nM FP; 
FBE4:  K
d, app 
= 300 ± 40 nM F-EMSA, 95 ± 3 nM FP), and weakly to FBE2, which is less 
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Figure 17. Affinities of MEX-3 and FBF-2 for binding elements in the cki-2 3’UTR.
(A) Representative F-EMSA gel pictures demonstrating association of MEX-3 with wild type and mutated 
elements (top). Quantification of F-EMSA gel pictures (center). Quantification of affinity as determined by 
fluorescence polarization assays (bottom). Fraction of bound RNA (center) and polarization (bottom) were 
plotted as a function of protein concentration and fit to the Hill equation to determine the apparent equilib-
rium dissociation constant (Kd,app). (B) Association of FBF-2 to cognate elements in the cki-2 and gld-1 3’UTRs 
as in (B). See Experimental Procedures or Table 6 for oligonucleotide sequences used.
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well conserved (K
d, app 
> 500 nM). Mutating the UGU sequence to ACA eliminated FBF 
binding to all elements (Fig. 17B; Table 6).  
 These experiments demonstrate that both MEX-3 and FBF-2 tightly associate 
with specific conserved elements in the cki-2 3’UTR and may therefore not only be 
relevant for regulation in vivo, but actually promote stem cell identity and 
proliferation through the repression of the cell cycle inhibitor and differentiation-
promoting factor CKI-2. 
 
4.2.6 A region associating with FBF-2 in vitro is required for regulation in vivo  
 
In parallel to above in vitro experiments, we took a more unbiased approach to identify 
regulatory regions in the cki-2 3’UTR. We generated reporter lines with overlapping 
deletions in the cki-2 3’UTR (Fig. 18A). Deletion of the putative MEX-3 binding site, 
MRE2, did not affect distal repression of the reporter (∆M2). Among five deletions 
removing both MRE2 and a substantial portion of the 3’UTR (∆1∆M2, ∆2∆M2, 
∆3∆M2, ∆4, ∆M2∆5), only ∆3∆M2 caused distal expression of the reporter (Fig. 18A). 
Intriguingly, the ∆3∆M2 deletion covers several partially conserved putative 
Pumilio/FBF binding elements. Removing only those elements (∆FBE1-4) caused distal 
de-repression to the same extent as ∆3∆M2 (Fig. 18A). In contrast, removing only the 
high-affinity site ∆FBE1 did not cause substantial derepression, although extremely 
faint GFP-H2B expression could be observed, as if the ∆FBE1 reporter was just barely 
repressed (data not shown). We therefore conclude that FBE1, although the highest 
affinity site as determined in vitro, needs to cooperate with other sites in the ∆FBE1-4 
region to achieve repression.  
 
4.2.7 Removing CKI-2 rescues the stem cell loss of FBF mutants 
 
To test whether FBF proteins not only associate with FBE1-4 in vitro, but really mediate 
reporter regulation in vivo, we introduced the wild-type cki-2 3’UTR into the fbf-1 fbf-2 
mutant. Since fbf-1 fbf-2 adults do not maintain a stem cell compartment, we assayed 
L4 larvae, in which stem cells do not yet depend on FBF and look superficially normal 
(Merritt and Seydoux 2010). Indeed, the reporter was derepressed in the distal 
germline in fbf-1 fbf-2 animals (Fig. 18B). However, expression was still comparably 
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Figure 18. FBE1-4 and FBF-1/2 are required for cki-2 3’UTR repression.
(A) FBE1-4 are required for distal reporter repression mediated by the cki-2 3’UTR. Schematic representation 
of deletions introduced into the cki-2 3’UTR reporter transgene (top). Images of the stem cell compartment of 
live worms (outlined) expressing the indicated reporter transgenes. A region containing FBE1-4 is required for 
repression. (B) cki-2 3’UTR reporter expression in wild type (top) or fbf-1 fbf-2 mutant (bottom) gonads 
(outlined). Boxed regions are displayed magnified and contrast-enhanced on the left. Scale bars, 50µm. 
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weak. To test which sequences are required for this residual repression, we also 
recombined the ∆FBE1-4∆MRE2 and ∆FBE1-4 reporters with fbf-1 fbf-2. 
Unfortunately, the only fbf-1 fbf-2 ∆FBE1-4 reporter line obtained from 700 singled 
balanced worms would not stably express the reporter even after repeated outcrossing 
(see Experimental Procedures). Since both a weakly expressing fbf-1 fbf-2 ∆FBE1-4 and 
the stably expressing fbf-1 fbf-2 ∆FBE1-4∆MRE2 animals express GFP-H2B uniformly 
along the germline, we think that FBE1-4 recruits other repressors in fbf-1 fbf-2 
mutants. RNAi mediated depletion of candidate proteins - MEX-3, PUF-8, and all other 
Puf proteins of C.elegans for which RNAi clones were available in the lab (PUF-3, PUF-
11, PUF-7, PUF-5, PUF-6) - did not enhance distal expression of the cki-2 3’UTR 
reporter in fbf-1 fbf-2 mutants.  
 Our results demonstrate that FBF represses cki-2 in germline stem cells, and 
suggests that an additional factor we could not identify contributes to repression of 
cki-2 during larval development, when FBF is not critical. However, the effect is 
mediated through the region encompassing FBE1-FBE4, because this region is required 
for the residual repression observed in fbf-1 fbf-2 mutant animals.  
 To test whether deregulation of CKI-2 was involved in the stem cell loss of fbf-
1 fbf-2 animals, we constructed fbf-1 fbf-1 cki-2 triple mutants. As expected, most fbf-1 
fbf-2 mutant animals lost GSCs by day one of adulthood (Figs. 19A and B). In contrast, 
90% of the fbf-1 fbf-2 cki-2 adult animals retained GSCs (Fig. 19B). The reduced 
proliferation phenotype seen in puf-8 (RNAi) (Fig. 20A) or puf-8 (RNAi); mex-3 animals 
(Ariz, Mainpal et al. 2009) could not be suppressed by removing CKI-2 (Fig. 20B), and 
the cki-2 3’UTR reporter was not derepressed by puf-8(RNAi). Together, these results 
demonstrate that CKI-2 is repressed in GSCs by FBF proteins, but not by PUF-8, and 
suggest that this repression is critical for the maintenance of GSCs. 
 
4.2.8 Induced overexpression of CKI-2 in stem cells 
 
Previously described experiments in sensitized genetic backgrounds demonstrated 
that ectopic expression of CKI-2 is sufficient to induce proliferation arrest and 
differentiation. For full proof of concept, we wanted to test a potential effect of CKI-2 
overexpression on stem cell proliferation or stem cell identity. However, there are 
currently no tools available for inducible expression in the C.elegans germline. 
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Figure 19. CKI-2 contributes to stem cell loss in fbf-1 fbf-2 mutants.
(A) Dissected DAPI-stained gonads (outlined) from 1 day old fbf-1 fbf-2 animals. Stem cells in fbf-1 fbf-2 
mutants are lost by differentiation via pachytene and spermatocyte stages into mature sperm. Representative 
images for four stages of progressive stem cell loss are shown. Boxed regions are magnified to the left. (B) 
Quantification of stages described above in fbf-1 fbf-2 and fbf-1 fbf-2 cki-2 mutant animals on day one of 
adulthood. While stem cells have been mostly lost from fbf-1 fbf-2 double mutant gonads, they are retained in 
90% of fbf-1 fbf-2 cki-2 triple mutant gonads.
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Figure 20. PUF-8 does not regulate CKI-2.
(A) DAPI stainings of gonads (outlined) dissected from puf-8(RNAi)-treated worms of the indicated genotypes. 
puf-8(RNAi) induces a “dwarf” gonad in wild type and cki-2 mutants alike, indicating that the puf-8(RNAi) 
phenotype is not caused by CKI-2 expression (B) DIC images of gonads (outlined) from puf-8(RNAi)-treated 
worms of the indicated genotypes. Depletion of PUF-8 in a mex-3 mutant background prevents germ cell 
proliferation irrespective of a cki-2 mutation, indicating that the germ cell proliferation defect of puf-8(RNAi) 
mex-3 animals is not caused by CKI-2 expression. (C) Live gonads (outlined) expressing the cki-2 3’UTR 
reporter treated with control (top) or puf-8 (bottom) RNAi. The reporter is not derepressed in the stem cell 
compartment upon depletion of PUF-8. 
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Heatshock promotors work, if at all, only from the bend region onwards. We therefore 
decided to use a constitutive promotor to express a CKI-2 transgene in stem cells, and 
to confer inducible derepression using the rme-2 3’UTR. The mRNA encoding the yolk 
receptor rme-2 is translationally repressed in stem cells by MEX-3 (Ciosk, DePalma et 
al. 2004). Depleting MEX-3 from the germline derepresses rme-2, but does not have 
any adverse effects on stem cells. By thethering the cki-2 coding sequence to the rme-2 
3’UTR, we hoped to induce CKI-2 expression in the distal stem cell compartment upon 
depletion of MEX-3. Since tagging CKI-2 with GFP may interfere with its function, we 
used the operon technique (Merritt, Rasoloson et al. 2008) to monitor expression of the 
transgene. With this tool, two genes separated by intergenic sequence from the 
endogenous gpd-2/gpd-3 operon are expressed from the same promotor, but are 
individually controlled posttranscriptionally by their repective 3’UTRs (Fig. 21A). As 3’ 
gene in the operon, we cloned GFP-H2B under the control of the tbb-2 3’UTR. GFP-H2B 
expression would therefore confirm that the mRNA encoding both genes was 
expressed throughout the germline. The CKI-2 coding sequence under the control of 
the rme-2 3’UTR was cloned as 5’ gene in the operon (Fig. 21A). Transgenic lines were 
crossed into the mex-3(or20) mutant – and, surprisingly, developed normally. Antibody 
stainings for CKI-2 confirmed that we could not properly overexpress CKI-2 in the 
stem cell compartment with this approach. Although we observed overexpression of 
CKI-2 from transition zone onwards, distal levels remained low (Fig. 21B). Either the 
rme-2 3’UTR does not permit substantial distal expression, or CKI-2 protein is 
produced but subsequently degraded. An experiment demonstrating sufficiency of 
CKI-2 in promoting differentiation/meiotic entry therefore still needs to be performed. 
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Figure 21. CKI-2 cannot be overexpressed in the stem cell compartment. 
(A) Schematic drawing of a transgene designed for inducible overexpression of CKI-2 in the stem cell 
compartment. The operon concept from Merritt et al, 3' UTRs are the primary regulators of gene expression in 
the C. elegans germline, 2008, was adapted to allow expression of untagged CKI-2 and GFP-H2B from the 
same promotor. CKI-2 was placed under the control of the rme-2 3’UTR, which is repressed in stem cells by 
MEX-3 (Ciosk et al, ATX-2, the C. elegans ortholog of ataxin 2, functions in translational regulation in the germ-
line, 2004), while GFP-H2B under the control of the tbb-2 3’UTR is ubiquitously expressed (see Figure 16A). (B) 
Distal region of dissected mex-3 mutant gonads (outlined) carrying the transgene described in (A), stained for 
CKI-2 and GFP, respectively. Top, sibling strain that did not inherit the transgene. Bottom, sibling strain carry-
ing the transgene. CKI-2 is not overexpressed in the distal germline, and accordingly, stem cells are not 
affected. 
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5. Notch target genes and stem cell identity 
 
We did our best to design the microarray experiment in a way that would exclude most 
unwanted disturbing effects. Still, several features of the worm strains used may 
impact the result in an unwanted way. To be able to assay mRNA expression in the 
absence of Notch signaling, we had to use a genetic background devoid of the 
differentiation-promoting RNA regulators GLD-1 and GLD-2. These proteins are not 
expressed in germline stem cells (Jones, Francis et al. 1996; Wang, Eckmann et al. 
2002), but since both GLD-1 (as a repressor of translation) and GLD-2 (as a 
poly(A)polymerase) may affect the abundance of mRNAs, we cannot exclude unwanted 
effects caused by both background mutations. It would be necessary to compare 
expression profiles of Notch gain-of-function tumors in the presence and absence of 
GLD-1 and GLD-2 to determine the influence of those background mutations. Also, 
the two Notch receptor mutations – ar202tsgf and e2141tslf – are temperature 
sensitive, which may affect our results. The e2141tslf allele was chosen because the 
null allele usually used in the lab, q175, is linked to a marker mutation (unc-32(e189)), 
which cannot easily be introduced into the Notch gain-of-function strain. Firstly, it is 
highly desirable in expression studies to keep the inherent genetic variations to a 
minimum; secondly, unc-32(e189) animals are severely uncoordinated and have 
difficulties feeding, which may indirectly affect germline proliferation. The 
temperature-sensitive nature of both alleles implies that we cannot exclude residual 
Notch signaling in e2141tslf, nor partial or inhomogenous activation of Notch signaling 
in ar202tsgf. Finally, parental animals were raised at the permissive temperature and 
then moved to the restrictive temperture for egglay. Slight variations in the onset of 
the temperature sensitive phenotype may have cause heterogeneity in the samples. 
Also, temperature shifts present a stressor for worms, which also may induce off-
effects.   
 Nonetheless, we have reason to believe that the observed mRNA fold changes in 
response to Notch signaling reflect the actual relative abundance of transcripts and are 
not affected by gld-1 and gld-2 or glp-1 alleles. Quantitative RT-PCR experiments by 
Balazs Hargitai confirmed the regulation and the fold change range for several putative 
targets, both using temperature sensitive and null alleles. Also, a strong Notch gain-of-
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function mutant in which GLD-1 and GLD-2 were intact compared well to the 
temperature sensitive Notch mutant in the gld-1 gld-2 background.  
 Whether putative Notch target genes as determined by our approach are bona 
fide Notch targets in the distal stem cell compartment remains to be determined. 
Unlike wild type germline stem cells, cells in tumorous germ lines are in close contact 
with sheath cells that outline the proximal gonad. Proximal sheat cells communicate to 
germ cells, possibly also via Notch signaling (McCarter, Bartlett et al. 1997; Hall, 
Winfrey et al. 1999; Killian and Hubbard 2005; McGovern, Voutev et al. 2009). Genes 
that we identified as Notch targets may have responded to a signal from proximal 
sheath cells and may not react to Notch signaling distally. Also, we dissected gonads 
from adult animals that had been exposed to constitutive Notch signaling for their 
entire life span. We therefore observed a steady state after prolonged signaling, 
including secondary effects, not the initial transcriptional reaction of germ cells to 
Notch signaling. Unequivocal determination of Notch signaling targets would require 
chromatin immunoprecipitation of either NICD or LAG-3 followed by microarray 
detection or deep sequencing from wild type animals. When designing these 
experiments, it is important to bear in mind that Notch signaling can also bypass the 
nuclear component LAG-3/CSL. CSL-independent activation of target gene 
transcription has been suggested (Sanalkumar, Dhanesh et al. 2010). In addition, Notch 
signaling has been reported to directly affect protein stability without the need for 
transcription (Sriuranpong, Borges et al. 2002) and to crosstalk to other signaling 
pathways (Wnt (Hing, Sun et al. 1994; Couso, Knust et al. 1995; Diaz-Benjumea and 
Cohen 1995; Rulifson and Blair 1995; Axelrod, Matsuno et al. 1996; Blair 1996; 
Neumann and Cohen 1996; Brennan, Tateson et al. 1997; Brennan, Klein et al. 1999; 
Wesley 1999; Lawrence, Klein et al. 2000; Strutt, Johnson et al. 2002; Hayward, Brennan 
et al. 2005; Sanalkumar, Dhanesh et al. 2010), GSK3beta (Foltz, Santiago et al. 2002; 
Saint Just Ribeiro, Hansson et al. 2009), BMP (Dahlqvist, Blokzijl et al. 2003; Takizawa, 
Ochiai et al. 2003), TGF-beta (Blokzijl, Dahlqvist et al. 2003; Rao and Kadesch 2003), 
EGFR (Tsuda, Nagaraj et al. 2002), MAP-kinase (Ordentlich, Lin et al. 1998; Zecchini, 
Brennan et al. 1999; Shaye and Greenwald 2002; Weijzen, Rizzo et al. 2002), NFkappaB 
(Nickoloff, Qin et al. 2002; Osipo, Golde et al. 2008), PKB/Akt (Rangarajan, Syal et al. 
2001)) and thus may regulate target genes indirectly. 
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 Whether or not genes that respond to Notch signaling in the tumorous settings 
used in our experiments are really expressed in stem cells, are really involved in their 
maintenance, and really react to Notch signaling therefore remains to be determined.  
 
5.1 Crosstalk to MES-2/3/6 proteins/PRC2 
 
 The bias towards X-linked genes among genes upregulated in response to 
Notch signaling is striking, as well as their correlation with genes deregulated in 
Polycomb mutants mes-2, mes-3, mes-4, and mes-6. However, only a subset of X-linked 
genes and a handful of autosomal genes are affected, if we assume that both platforms 
grasp the full extent of regulation and report few false negatives. Correlation is lost 
upon randomization, which demostrates that X-linkage alone is not sufficient for 
correlation. Also, immunofluorescence experiments performed by Balazs Hargitai show 
that, despite the upregulation of a number of X-linked genes, the X-chromosome is 
still globally painted with repressive H3K27me3 marks in the Notch gain-of-function 
germline tumor.  
 Notch gain-of-function mutants and mes mutants interact genetically. If MES-
2,3,6/PRC2 usually repress genes that are upregulated by Notch signaling, removing 
MES-2,3,6/PRC2 from mild Notch gain-of-function mutants should aggravate the 
phenotype, which is indeed the case. This confirms that the observed correlation is not 
an artefact, and indirectly supports the idea that we really identified Notch responsive 
genes, and that those genes we identified really contribute to germ cell proliferation 
(and possibly, stem cell identity). We are therefore confident that Notch signaling and 
C.elegans Polycomb regulatoin converge on a common set of genes. How they 
mechanistically do so remains to be determined. Notch target gene regulation requires 
chromatin remodeling (see also introduction). In the absence of Notch signaling, target 
genes are thought to be constitutively repressed by a transcription-hostile chromatin 
environment. Many remodelers and modifying complexes have been shown to affect 
the constitutive repression of target genes, the degree of transcriptional activation, and 
the shutdown of transcription; the precise composition and requirements of repressive 
and activating complexes however seemingly is strongly contextdependent. Based on 
our results, the MES proteins may be involved in repression of target genes before 
Notch signaling or in their shutdown after Notch signaling.  
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 Polycomb was first discovered in Drosophila as a repressor of homeotic gene 
expression and body patterning. In vertebrates, repressive H3K27 methylation 
deposited by PRC2 in stem cells is commonly associated with genes encoding 
developmental regulators. PRC2 is supposed to mediate cellular memory of 
developmental cues (Margueron and Reinberg 2011). Similarly, MES-4, by association 
with germline expressed genes, has been suggested to memorize “germ cell identity” 
over generations (Rechtsteiner, Ercan et al. 2010). A possible scenario would be that 
Notch signaling as the key cue maintaining C.elegans germline stem cells provides 
information on germ cell identity that is remembered by the MES proteins, and thus 
passed on in the absence of Notch signaling  to the next generation. 
 A link between Notch signaling and Polycomb has been previously suggested in 
Drosophila. Mutations in the fly protein Tantalus, which interacts with the Polycomb 
protein ASX (additional sex combs), elicits phenotypes reminiscent of Notch mutations 
and interacts with Notch genetically (Dietrich, Yang et al. 2005). Deregulation of the 
Polycomb proteins Pipsqueak and Lola cooperate with Delta overexpression in the 
formation of tumors in Drosophila (Ferres-Marco, Gutierrez-Garcia et al. 2006). 
However, Polycomb has been suggested to affect the availablity of core pathway 
components in flies and thus to act upstream of Notch signaling (Martinez, 
Schuettengruber et al. 2009; Herz, Madden et al. 2010). To our knowledge, we therefore 
show for the first time that Polycomb regulation and Notch signaling converge on a 
defined set of genes, which should also enable us to dissect the specifics of the 
coregulatory events. Do NICD and MES-2,3,6/PRC2 actually physically associate with 
the genes that are deregulated in their absence/hyperactivity? Do they co-occupy the 
same promotors? Does NICD (or other components of the signaling cascade) guide 
MES-2,3,6/PRC2 proteins to target genes, or inversely? Do the MES proteins affect 
repression, activation, maintenance, or shutdown of transcription of Notch targets? Do 
the two pathways also target genes independently of each other? Does the MES system 
somehow affect Notch signaling upstream of target gene activation, for example by 
modulating availability of core pathway components, as has been observed for the 
CoREST complex and Notch signaling pathway components in C.elegans vulval 
development (Bender, Kirienko et al. 2007)? All these experiments require the 
establishment of tissue-specific chromatin-IP procedures and reagents, which are not 
yet available for the worm. During the design of such experiments, it is important to 
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keep in mind that the strongest correlation as well as genetic interaction of Notch 
signaling was actually observed for MES-4. Although mutations in MES-4 cause 
identical defects as mutation of the C.elegans PRC2 complex components MES-2, MES-
3, and MES-6, MES-4 is not actually part of the complex and deposits a different mark, 
H3K36me. Therefore, Notch may actually crosstalk to H3K36 methylation rather than 
to the MES-2,3,6/PRC2 mark H3K27me, and the weak interaction with MES-2, MES-3, 
and MES-6 may be a secondary effect. In contrast to H3K27me, H3K36me correlates 
with high transcription levels and is thought to be deposited during transcription in 
the gene body (Buratowski and Kim 2011). Interestingly, H3K36 methylation has also 
been associated with post-transcriptional deacetylation and re-silencing of genes (Lee 
and Shilatifard 2007) and is thought to be mutually exclusive with the H3K27 
methylation mark deposited by PRC2 (Yuan, Xu et al. 2011). The hypothesis that Notch 
target genes cannot not be properly silenced in mes mutants might explain why genes 
that react to Notch signaling and genes that are upregulated in mes mutants overlap. 
However, the F1 mes mutant phenotype does not suggest hyperactive Notch signaling, 
since these germlines are – if anything - underproliferated, while Notch gain-of-
function germlines are tumorous.  
 
5.2 CKI-2 
 
5.2.1 Role and regulation of CKI-2 in the C.elegans germline 
 
In genomewide expression analyses, we found that mRNA encoding the Cip/Kip cell 
cycle inhibitor CKI-2 was less abundant in the presence of Notch signaling. The effect 
of Notch signaling on cki-2 mRNA levels was verified by quantitative PCR. Nonetheless, 
the observed regulation could very well be indirect. We find that cki-2 is targeted by 
FBF proteins, which have a record of destabilizing their targets (Goldstrohm, Hook et 
al. 2006; Goldstrohm, Seay et al. 2007). FBF proteins may just be more abundant or 
more active in Notch ON germ cells than in Notch OFF germ cells (although fbf-1 and 
fbf-2 mRNA levels are not affected by Notch signaling, Fig. 22). Promotor studies and 
chromatin-IP experiments would be required to determine if Notch signaling also 
regulates cki-2 transcription directly. The putative cki-2 promotor, 4.5kb of intergenic 
sequence separating cki-1 and cki-2, was not able to drive expression of a GFP reporter 
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Figure 22. fbf transcription does not depend on Notch signaling.
MA-plot (X-axis, average expression; Y-axis, fold change) of transcript levels in response to Notch signaling. 
fbf-1 and fbf-2 mRNAs (red and green dot, respectively) are expressed above background and do not change in 
abundance in response to Notch signaling, indicating that Notch signaling is not required for fbf-1 / fbf-2 
transcription. Values are given in log2.
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in the germline upon microparticle bombardment. However, since microparticle 
bombardment notoriously produces multicopy arrays prone to heterochromatisation 
in the germline, we cannot exclude that the used promotor fragment would have been 
competent to drive expression of a single-copy integrated transgene. Alternatively, the 
cki-2 promotor may extend beyond the 5’ intergenic sequence of cki-2. Indeed, regions 
upstream of cki-1 are required for cki-2 expression (Buck, Chiu et al. 2009). Fosmid 
engineering (Dolphin and Hope 2006; Sarov, Schneider et al. 2006; Zhang, Nash et al. 
2008; Tursun, Cochella et al. 2009) would be the method of choice to determine 
whether cki-2 expression is regulated transcriptionally, through which elements, and 
whether Notch signaling is involved.    
 Based on our immunofluorescence and semi-quantitative PCR assays, CKI-2 is 
expressed in the germline and also in the somatic gonad (data not shown), while CKI-1 
is specific to embryos. This conflicts with earlier evidence of CKI-1 expression in the 
germline and regulation by E3 ubiquitin ligase CUL-2 (Feng, Zhong et al. 1999). We 
confirmed that CKI-2, but not CKI-1 staining disappears in cki-2 mutants. Since both 
antibodies do not perform very well, different staining protocols may provide an 
explanation why Feng et al. could not notice CKI-2 expression in the germline.  
 We observe a division of labor between CKI-1 and CKI-2, CKI-1 acting in the 
soma, and CKI-2 in the germline. CKI-1 and CKI-2 likely arose from a gene duplication 
event, since they are separated by only 4.5 kilobases. Since CKI-1 in contrast to CKI-2 
is essential, CKI-1 most likely retained the function of the ancestral gene to mediate 
withdrawal of cells from the cell cycle during development. Somatic expression of CKI-
2, which we and others have observed with transgenes containing genomic cki-2 
sequence (Fukuyama, Gendreau et al. 2003), is likely due to incomplete inclusion of 
regulatory sequences in those transgenes, since we cannot detect cki-2 in the soma by 
Northern blot or by immunofluorescence. Interestingly, according to new annotations, 
the intergenic region between cki-1 and cki-2 as well as sequences upstream of cki-1 
are rich in non-coding RNA loci, which may contribute to regulation of the locus.    
 Generally, we think that cki-2 is expressed at low levels. Immunofluorescent 
stainings are of low intensity, in situ hybridisation requires a long (eg, label-rich) 
probe and, just like Northern blots, extended development times. In particular, the 
alternative isoform cki-2 S was hardly detectable by Northern blot. The exclusion of 
exons 4 and 5 in cki-2 S generates alternative C-termini, but does not affect the CKI 
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domain. We therefore assume that both cki-2 S and cki-2 L retain inhibitory activity 
towards CyclinE/CDK2 complexes. They may however differ in cell cycle independent 
functions, as has been proposed for vertebrate Cip/Kip proteins. Regions outside the 
inhibitory domain of vertebrate p27 and p57 have been reported to promote 
differentiation independently of the proteins’ effect on cell cycle progression 
(Ohnuma, Philpott et al. 1999; Gui, Li et al. 2007). cki-2 S and l may also be 
differentially expressed between germline and somatic gonad, where CKI-2 staining 
has also been observed (data not shown). 
 Our experiments indicate that repression of CKI-2 in stem cells is important to 
promote stem cell proliferation and stem cell identity. But why would CKI-2 be 
expressed in more proximal gonad regions? CKI-2 is upregulated in the transition 
zone concomitantly with meiotic entry, but the protein is not essential for entry or 
progression through meiosis, since cki-2 null mutants set up a wild type germline and 
are fertile. One clue may lie in the observation that most germline events in C.elegans 
are regulated redundantly. For example, MEX-3 and PUF-8 are required redundantly 
for mitotic proliferation, and GLD proteins together promote meiotic entry and 
progression. Similarly, CKI-2 may act redundantly with promeiotic proteins. CKI-2 has 
been proposed to be required for centrosome elimination, a finding which we and 
others could not confirm (Kim and Roy 2006; Buck, Chiu et al. 2009). However, CKI-2 
may be required for other cell cycle related processes during meiotic progression, such 
as distinguishing pre-meiotic S-phase from mitotic S-phases, recombination, 
apoptosis, DNA damage repair, or oocyte maturation. The Drosophila Cip/Kip protein 
Dacapo is specifically required for genome stability during pre-meiotic S-phase 
(Narbonne-Reveau and Lilly 2009). In C.elegans, RAD-51, a marker of double strand 
breaks induced during meiosis, displays a wild type localization pattern in cki-2 
mutants, and the cki-2 mutant strain does not diplay abnormally high mutation rates 
(as indicated by the spontaneous occurrence of locomotion mutants in the population) 
or defects in meiotic segregation (as indicated by high spontaneous incidence of males 
in the population; data not shown). We did however notice that the meiotic marker 
phospho-SUN-1, a linker protein anchored in the nuclear envelope (Penkner, Fridkin et 
al. 2009), labels a slightly expanded zone in cki-2 mutants although it is eventually 
downregulated in late pachytene. A more detailed characterization of meiotic 
processes and their timing in the cki-2 mutant, or an RNAi screen for genes affecting 
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cki-2 mutants but not wild type worms, may help to determine a role of CKI-2 in the 
germline.  
 Despite the fact that CKI-2 is still in search of a function in the wild type 
germline, it is expressed in a regulated pattern. The 3’UTR of cki-2 is sufficient to 
confer this expression pattern to a reporter, indicating that the cki-2 3’UTR may be the 
prime source of expression regulation also for endogenous CKI-2. However, the 
expression pattern of the reporter and the expression pattern of endogenous CKI-2 as 
observed by immunofluorescence are not entirely identical. While the reporter gets 
upregulated gradually and uniformly in all nuclei in early transition zone, endogenous 
CKI-2 is specifically expressed in crescent-shaped transition-zone nuclei but not in 
neighbouring cells if they have not yet adopted the typical transition zone 
morphology. Additional mechanism such as protein degradation are therefore likely 
regulating CKI-2 prior to meiotic entry. 
 To identify regions involved in 3’UTR directed regulation, we looked for 
sequences conserved between the nematode species C.elegans, C.briggsae, C.brenneri, 
and C.remanei. This approach was partly successful – FBE1, which associates tightly 
with FBF-2 in vitro, and FBE4, which associates weakly, are indeed conserved, and FBF-
1/FBF-2 regulate a reporter in vivo. However, one of the nonconserved elements (FBE3) 
also associates with FBF-2 in vitro. Inversely, the conserved MRE2 element associates 
tightly with MEX-3 in vitro, but in wild type adults, MEX-3 does not appear to regulate 
CKI-2 expression. MEX-3 restricts CKI-2 expression only in the compound mutant 
background gld-1 gld-2; glp-1. Although considering conservation was thereful helpful 
in our approach, the unbiased approach using reporter deletions was definitely crucial. 
Also, recently evolved regulatory elements would have escaped our attention with the 
conservatory approach. For example, miRNA binding sites are not necessary conserved. 
Most miRNA prediction programs do not consider the cki-2 3’UTR as a miRNA target; 
however, the TargetScan software identified the seed region of miRNAs 44, 45, 247, 
and 61, CUAGUCA, in the cki-2 3’UTR. The ∆1 deletion removes this site, but does not 
affect distal repression, indicating that these miRNAs do not contribute to CKI-2 
regulation in the germline. 
 One potential MEX-3 binding element, MRE1, supposedly forms a stable stem 
loop structure and therefore is not predicted to associate with MEX-3. However, a 
recent report suggests that protein binding to the 3’UTR can unfold secondary 
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structures occluding regulatory sites (Kedde, van Kouwenhove et al. 2010). We cannot 
exclude a similar mechanism for MRE1, although we would expect some sequence 
conservation in that case. MRE2, the second, conserved MEX-3 binding element, tightly 
associates with MEX-3. Mutation experiments revealed that each halfsite of MRE2 is 
sufficient to direct association, at least in vitro. Also, they identified a second halfsite 
that does not conform to the in vitro defined criteria for MREs (Pagano, Farley et al. 
2009) because it is separated by more than eight nucleotides from the first halfsite. 
This kind of binding element structure would likely not have been determined by 
oligonucleotide selection experiments in vitro, and it will be interesting to see whether 
other MEX-3 targets contain similar arrangements. The second halfsite may increase 
the affinity of MEX-3 for the region, enhancing its chances to recognize its bona fide 
binding site. Alternatively, an intermediate association/dissociation step involving the 
second halfsite may render MEX-3 binding and dissociation energetically more 
favourable or regulatable. It is also possible that the second half site is not relevant in 
vivo, and is an artefact provoqued by the use of short oligos in the interaction assays 
that lack the context of the entire 3’UTR.  
 Based on our observations that the region containing FBE1-4 is required for 
reporter regulation, that FBFs are required to fully repress a wild type reporter, and 
that the FBF mutant phenotype, but not the puf-8(RNAi) phenotype can be rescued by 
depletion of cki-2, we focused our in vitro association studies on FBF. FBF-1 and FBF-2 
redundantly remain germline stem cells, implying that both associate with key targets. 
Therefore, only affinity to FBF-2 was determined. However, FBF-1 and FBF-2 do differ 
in a few amino acids in the first Pumilio repeat and may therefore also differ in their 
affinities towards targets. Comparing affinity and association dynamics of FBF-1 and 
FBF-2 with various cognate sequences would therefore be an interesting experiment. 
PUF-8 was not tested in vitro because mutating cki-2 does not rescue the phenotype of 
puf-8(RNAi) animals, nor is the reporter derepressed distally upon depletion of PUF-8. 
However, both experiments rely on RNAi, because cki-2 as well as the reporter 
integration site are too close to puf-8 to attempt recombination. Also, for unknown 
reasons, the cki-2 3’UTR reporter expresses very poorly in PUF-8 depleted animals, 
hampering attempts to detect - possibly faint – reporter derepression in the distal 
stem cell compartment. Since additional factors that require the region between FBE1 
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and FBE4 are obviously required for reporter regulation, PUF-8 remains a candidate 
regulator of CKI-2 expression.  
The sequences of FBE1-4 and their consensus correspond to the FBF-1 binding 
element determined by yeast-3-hybrid based selection and mutagenesis of short 
sequences (Table 8; Bernstein, Hook et al. 2005). The high-affinity element FBE1 and 
the non-binding element FBE2 both conform to the UGU(N2-4)AU consensus and are 
flanked by similar nucleotides. However, the FBE1 spacer contains a Purine following 
the UGU trinucleotide (which is according to the consensus strongly favoured but not 
obligatory in this position). FBE3 and FBE4 lack the 3’ AU dinucleotide, but do contain 
AU rich 3’ sequences. Interestingly, FBFs were thought to require three nucleotides 
between UGU trinucleotide and AU element (as opposed to two nucleotides required by 
PUF-8; Opperman, Hook et al. 2005). We find that FBE1, which has a two-nucleotide 
spacer, associates with FBF tightly. 
 
Table 8. FBE1-4 correspond to the FBF consensus motif.  
element sequence in vitro affinity for FBF-2 
FBE1        UUUAUCUGUGAAUUUGAAAU ++++ 
FBE2      CAUACCCUGUCCAUUUCUGU - 
FBE3    CAUUUCUGUGUUCUACUCCU + 
FBE4      CUACUCCUGUAAAAAAAGUC + 
consensus       YWYWYCUGURWWHWW  
FBF-1 binding site  NVNDNNHNUKHDHNDDN  
R = A,G; K = G,U; Y = C,U; W = A,U; V = A,C,G; D = A,G,U ; H = A,C,U ; N = any base 
 
 Curiously, the cki-2 3’UTR of cki-2 L (not of cki-2 S) contains, similar to its 
mammalian counterparts, an intron of 1.5kb only 54 bases downstream of the stop 
codon. The presence of exon junction complexes downstream of the stop codon 
usually triggers nonsense mediated decay (NMD; Chang, Imam et al. 2007). Possibly, 
NMD contributes to degradation of cki-2 mRNA in proliferating cells both in worms 
and vertebrates. NMD components have also been implied in translational regulation 
(Isken, Kim et al. 2008). Since cki-2 S does not contain an intron, alternative splicing in 
this case may determine whether cki-2 is subject to NMD regulation or not. 
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Interestingly, the 3’UTR of vertebrate p27 and p57 is also spliced. Certainly, the 
conservation of Cip/Kip 3’UTR splicing indicates the presence of a conserved 
regulatory mechanism acting on those mRNAs which is yet to be discovered.  
 
5.2.2 The role of MEX-3 in stem cell regulation 
 
MEX-3, as indicated in the introduction, is a curious protein. We find that MEX-3 
tightly associates with the MRE2 site in the cki-2 3’UTR, which is also extraordinarily 
conserved – yet, in the wild type, neither MRE2 nor MEX-3 are required for reporter 
regulation. Additionally, in a genetic background where we know MEX-3 is essential for 
germ cell proliferation (gld-2 gld-1; glp-1), deleting the element from a reporter does 
not cause the expected effect (derepression), but the opposite (mild repression; data 
not shown), an observation we cannot explain to date. The requirement of crude worm 
extracts for association of MEX-3 with the cki-2 mRNA in biotin assays implies the 
need of cofactors or protein modifications for association. During monoclonal 
antibody testing, we observed two closely spaced bands on western blots (data not 
shown), as if part of the protein pool carried a modification. Human MEX-3 proteins 
are phosphorylated (Buchet-Poyau, Courchet et al. 2007); phosphorylation is also 
predicted for C.elegans MEX-3. Also, C.elegans MEX-3 has been shown to associate 
with several proteins and, since it is the only MEX-3 family member without a C-
terminal RING finger domain, may require protein partners that contain a RING finger. 
Our observation that an ectopic MRE site implanted into the tbb-2 3’UTR cannot confer 
regulation to a reporter agrees with the idea that MEX-3 may be unable to recognize its 
targets unless modified or bound by a cofactor. Sensitized backgrounds where MEX-3 
is required for proliferation, puf-8 or gld-1 gld-2; glp-1(lf), may be useful to screen for 
cofactors required for MEX-3 function in stem cells. 
 In the C.elegans germline, MEX-3 is required during early development, since 
germ cells never proliferate in puf-8 mex-3 double mutant larvae. The early 
requirement for MEX-3 may indicate a role for MEX-3 in the proliferation arrest of L1 
germ cells upon starvation. In our hands, mex-3 mutant animals were able to enter and 
exit the dauer stage as assayed by body morphology. They were also able to enter and 
exit adult reproductive diapause, but neither entry or exit rates, nor the number of 
germ cells over time and their ability to reconstitute a germline after prolonged 
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starvation were quantified, experiments that might finally reveal a role for MEX-3 in 
germline stem cells.  
 
5.2.3 FBF/Pumilio proteins and stem cell maintenance 
 
FBF/Pumilio proteins notoriously pop up in germ cell and stem cell contexts (Wickens, 
Bernstein et al. 2002), an observation substantiated by the expression of DjPum in 
planarian stem cells, which have extraordinary regenerative capabilities (Salvetti, Rossi 
et al. 2005). RNA-coIP expermiments have suggested that FBF/Pumilio proteins govern 
entire pathways and functional units of the transcriptome. Indeed, C.elegans FBF 
associates with many factors of the meiotic entry program, such as the structural 
components of meiotic chromosomes HIM-3, HTP-1 and -2, SYP-1 and SYP-2. All 
these proteins are ectopically expressed in fbf-1 fbf-2 mutants, but their depletion does 
not restore stem cells in fbf-1 fbf-2 mutants (Merritt and Seydoux 2010). This suggests 
that among the many targets of FBF/Pumilio proteins, few may be actually relevant, 
and also indicates that the cki-2 mRNA is a key target of FBF in germline stem cell 
maintenance in C.elegans. 
 Cip/Kip mRNAs have previously been co-immunoprecipitated with FBF/Pumilio 
proteins in vertebrates and C.elegans (Morris, Mukherjee et al. 2008; Kershner and 
Kimble 2010). Human Pum1 has recently been shown to modulate the accessibility of 
the p27 3’UTR for miRNAs, and thus to regulate the decision of cultured cells to 
remain quiescent or divide (Kedde, van Kouwenhove et al. 2010). Sterical hindrance of 
miRNA mediated regulation by RNA binding proteins has been previously 
demonstrated for DND in zebrafish germ cells (Kedde, Strasser et al. 2007) and may be 
of yet unrecognized importance in miRNA mediated regulation. Indeed, FBF/Pumilio 
targets contain disproportionally many miRNA binding sites (Galgano, Forrer et al. 
2008; Leibovich, Mandel-Gutfreund et al. 2010), but cki-2 is a weak candidate for 
miRNA-mediated regulation based on the available prediction tools MirWip, 
TargetScan, PicTar, MirZ (our observation; Lall, Grun et al. 2006; Ruby, Jan et al. 2006; 
Hammell, Long et al. 2008; Hausser, Berninger et al. 2009). 
 While cki-2 is likely not co-targeted by miRNAs and FBF/Pumilio proteins, it 
may be destabilized by FBF-2. In yeast, Puf proteins have been shown to recruit the 
CCR4-NOT-POP deadenylase complex, resulting in deadenylation and de-stabilization 
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of mRNA (summarized in (Chritton and Wickens 2010). At least the gld-1 mRNA 
appears to be repressed by C.elegans FBF in a similar manner (Suh, Crittenden et al. 
2009), suggesting a possible mechanism for cki-2 regulation. Consistently with this 
possibility, the cki-2 message is less abundant in germline stem cells (Fig. 12F and Kim 
and Roy 2006). However, since mRNAs associating with FBF proteins can be recovered 
(Kershner and Kimble 2010), FBF likely does not induce immediate degradation of all 
associated mRNAs. 
 During our experiments, we observed that another FBF/Pumilio protein 
redundantly required for germline stem cell proliferation in C.elegans, PUF-8, was 
required more generally to maintain reporter expression (Fig. 20C). Also, puf-8 
germlines are generally smaller than wild type, but mostly correctly patterned, 
suggesting that PUF-8 may be globally required to maintain mRNA expression levels in 
the germline, a working model that may be worth following up. 
FBF/Pumilio proteins are also essential for neuronal functions (reviewed by 
Baines 2005; Weston and Baines 2007). Interestingly, neuronal fate has been postulated 
as “default” differentiation pathway of ESCs (Tropepe, Hitoshi et al. 2001; Smukler, 
Runciman et al. 2006), and C.elegans germ cells can be transformed into neurons by 
the removal of just one histone chaperone (Tursun, Patel et al. 2011). RNA regulators 
originally described in germ cells, Nanos and Brat, regulate core neuronal processes 
such as excitability and synapse growth (Muraro, Weston et al. 2008; Menon, Andrews 
et al. 2009). In this context, it is worth mentioning that Drosophila neurons express 
MEX-3, though a neuronal function of MEX-3 remains to be determined. Among the 
few messages enriched in previous MEX-3 RNA co-IP experiments in the lab 
(unpublished data) were vacuolar ATPases, proteins that set up proton gradients 
across membranes. Also, Notch responsive genes are enriched for messages involved 
in mitochondrial function. Mitochondria, which control the availability of protons in a 
cell, have been implied in stem cell maintenance previously (Rehman 2010). The 
electrochemical properties of C.elegans germline stem cells and stem cells more 
generally may therefore impact their decision to self-renew and differentiate.  
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5.2.4 Regulation of the cell cycle in stem cell self-renewal and differentiation 
 
Though cki-2 deletion has no obvious consequences for germ cell development, our 
findings suggest that CKI-2 repression is critical for stem cell maintenance. This agrees 
with observations that cell cycle inhibitors, including Cip/Kip family members, are 
usually depleted from stem cells (Stead, White et al. 2002; Ginis, Luo et al. 2004; Barta, 
Vinarsky et al. 2010), and that differentiation correlates with upregulation of Cip/Kip 
cell cycle inhibitors in cell culture and in vivo (Lee, Reynisdottir et al. 1995; Matsuoka, 
Edwards et al. 1995; Parker, Eichele et al. 1995). Phenotypes of p27 and p57 knockout 
mice suggest that Cip/Kip cell cycle inhibitors are required for timely cell cycle exit 
and differentiation of developmental progenitor cells in many tissues, for example in 
the lens (Fero, Rivkin et al. 1996; Kiyokawa, Kineman et al. 1996; Nakayama, Ishida et 
al. 1996; Yan, Frisen et al. 1997; Zhang, Liegeois et al. 1997; Zhang, Wong et al. 1998; 
Zhang, Wong et al. 1999). p21 knockout mice are superficially wild type, but display 
impressive regenerative abilities and have therefore been termed “healer strains” 
(Bedelbaeva, Snyder et al. 2010). p21 has also been shown in vitro to act as a barrier to 
reprogramming (Hong, Takahashi et al. 2009), suggesting that pluripotency and p21 
expression are not compatible. However, reports on the sufficiency of Cip/Kip cell 
cycle inhibitors in the induction of differentiation are controversial. While 
overexpression of p27 in oligodendrocyte precursors arrests proliferation but does not 
induce expression of terminal differentiation markers (Tikoo, Osterhout et al. 1998), 
p27 and p21 seem both necessary and sufficient for terminal marker expression in 
human intestinal epithelial cells (Quaroni, Tian et al. 2000; Deschenes, Vezina et al. 
2001). 
 Our results suggest that ectopic expression of CKI-2 contributes to stem cell 
differentiation in fbf-1 fbf-2 mutants, and is sufficient to drive germ cells into 
differentiation in gld-2 gld-1; glp-1(lf) mutants. Cip/Kip proteins are well-established 
inhibitors of Cyclin E/Cdk2 activity, which promotes G1-S progression in the cell cycle. 
We therefore think that CKI-2 promotes differentiation via inhibition of Cyclin 
E/CDK2. C.elegans germline stem cells require CyclinE, since they fail to proliferate in 
cye-1 mutants or upon depletion of CYE-1 (Seydoux, Savage et al. 1993; Fay and Han 
2000; Jeong, Verheyden et al. 2011), and regulation of Cyclin E by GLD-1 is essential 
for meiotic progression (Biedermann, Wright et al. 2009). We therefore propose that a 
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high-low gradient of CYE-1/CDK-2 in the germ line, produced and controlled by 
conserved stem cell factors and pro-meiotic proteins, mediates the self-renewal 
versus differentiation decision (Fig. 23). Nonetheless, we cannot exclude cell cycle 
independent functions of CKI-2 during differentiation. Regions outside the CDK-
inhibiting domain of vertebrate p27 and p57 have been reported to promote 
differentiation independently of the proteins’ effect on cell cycle progression 
(Ohnuma, Philpott et al. 1999; Gui, Li et al. 2007), for example by stabilizing 
neurogenin (Vernon, Devine et al. 2003). Stem cell loss in fbf-1 fbf-2 mutants is not 
completely prevented by depleting CKI-2; however, Cyclin E/CDK2 may not be 
sufficiently present or active in this mutant in the first place to sustain stem cell 
proliferation throughout adulthood. 
 Cyclin E and CDK2 have critical functions also in the mouse germ line (Geng, Yu 
et al. 2003; Ortega, Prieto et al. 2003), and mitotic arrest and differentiation of germ 
cells in the fetal testes correlates with suppression of Cyclin E and activation of several 
CKIs, including p27Kip1 (Western, Miles et al. 2008). Accumulation of p27, achieved by 
protection of p27 mRNA from miRNA-mediated repression through the RBP DND1 
(Kedde, Strasser et al. 2007), is thought to facilitate cell cycle arrest and differentiation 
of spermatogenic cells (Cook, Munger et al. 2011). Thus, Cyclin E/Cdk2 emerges as a 
conserved player in germ cell development. This stands to reason, since the decision to 
embark on the meiotic program is thought to preceed S-phase (Forsburg and Hodson 
2000; Watanabe, Yokobayashi et al. 2001), and thus happens when the cell cycle is 
controlled by Cyclin E/CDK2.  
 Although a direct role of Cyclin E/Cdk2 in the self-renewal versus 
differentiation decision in the germ line remains to be tested, it is intriguing that a 
similar role for Cdk2 has been reported in embryonic stem cells (Neganova, Zhang et 
al. 2009). This might reflect an intimate connection between Cyclin E/Cdk2 and self-
renewal in general, or a shared mechanism operating in germ cells and early embryonic 
cells (from which ES cells are derived). 
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Figure 23. 
Master regulators of the self-renewal versus differentiation decision converge on Cyclin E/CDK2.
This work together with Biedermann et al, Translational repression of cyclin E prevents precocious mitosis and 
embryonic gene activation during C. elegans meiosis, 2008 suggests that many, if not all, regulators of the 
self-renewal versus differentiation decision in the C.elegans germline converge on CYE-1/CDK-2, by regulat-
ing the activity (FBF and MEX-3 via the CYE-1/CDK-2 inhibitor CKI-2) or availability (GLD-1) of the complex. 
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 How do insights gained during this work integrate with previous findings? In 
what respect have we contributed to the fields of C.elegans stem cell biology, Notch 
signaling, and stem cell biology in general?  
 Several of the described results should contribute substantially to each area. 
For example, we are not aware of any previous successful attempts to identify Notch 
target genes in C.elegans stem cells, or in pure stem cell populations in a genetically 
controlled way in any other organism. In addition, we describe for the first time 
convergence of Notch signaling and Polycomb-mediated regulation on the same genes. 
This is exciting, since both pathways are of paramount importance during 
developmental processes and cell fate decisions. Notch signaling presents short and 
pulsed cues during development; Polycomb proteins mediate cellular memory by 
maintaining the expression states of genes. In C.elegans, MES proteins mediate 
transgenerational memory of germline stem cell identity – possibly “remembering” the 
information provided by Notch signaling in the previous generation. 
 In addition to the link between Polycomb and Notch signaling, we newly 
characterized the role of a previously unknown player in the selfrenewal-versus-
differentiation decision of C.elegans germline stem cells, CKI-2. CKI-2 was previously 
not known to be expressed in the germline. We also find that the cki-2 mRNA is 
targeted by two conserved stem cell factors, the RNA binding proteins MEX-3 and 
FBF/Pumilio. Both had been previously implicated in stem cell maintenance in 
C.elegans and, in the case of FBF/Pumilio, other organisms as well, but it was not clear 
how they would control stem cell fate. We can now for the first time link both proteins 
directly to the machinery executing the decision between stem cell selfrenewal and 
differentiation, the cell cycle. In the case of FBF/Pumilio, this link has been described; 
however, we show for the first time that it is actually relevant for stem cell populations 
in vivo. MEX-3 in vertebrates has not yet been implicated in stem cell biology; it is 
however highly expressed in proliferating cell lines, and it will be very interesting to 
follow research on MEX-3 in vertebrates. In addition, our findings strengthen the cell 
cycle hypothesis. This concept has been around for many years and states that cell 
cycle and cell fate decisions are not only tightly linked, but that cell cycle regulation, 
particularly of the G1-S phase transition, may actually be upstream of cell fate choice 
in some cases. The fact that stem cells are maintained longer when the cell cycle 
inhibitor CKI-2 is absent supports that view.  
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Nematode culture, mutants, constructs, and transgenic lines 
Standard procedures were used to maintain animals and perform RNAi by feeding. 
Worms were grown at 25°C unless stated otherwise. Alleles used are mex-3(or20), gld-
2(q492), gld-1(q485), glp-4(bn2) (I); fbf-1(ok91), fbf-2(q704), cki-2(ok2105), mes-2(bn11) 
(II), glp-1(ar202), glp-1(e2141) (III), mes-4(bn85) (V).  
Previously described strains used are JA1522 (unc-119(ed3) III; weSi6(mex-5 
promotor::GFP-H2B::tbb-2 3’UTR), courtesy of Eva Zeiser, laboratory of Julie Ahringer) 
and pie-1::GFP::mex-3 from (Jud, Czerwinski et al. 2008), courtesy of Jen Schisa. 
Transgenic lines expressing reporter constructs were generated using the Gateway 
Reporter Cloning System (Merritt, Rasoloson et al. 2008) and the MosSCI direct 
insertion protocol (Frokjaer-Jensen, Davis et al. 2008).  
We observed that GFP-containing reporters got silenced in trans to the GFP-marked 
mIn1[mIs14] balancer. The balancer contains pharyngeal GFP integrated as multicopy 
transgene; these are usually silenced in the germline and are known to elicit small-
RNA dependent silencing of similar sequences. Derepression required outcrossing to 
wild type for several generations and the use of the unmarked mIn1 balancer.  
RNAi was performed by feeding with RNAi clones from the Ahringer and Vidal RNAi 
libraries, except for cki-2 L RNAi generated in this study and mex-3 available from the 
lab stocks. 
 
Primers / cloning: 
The RNAi clone specifically targeting cki-2 L was generated with primers IK252 and 
IK253, and cloned into pMD3. Small deletions were introduced into the cki-2 3’UTR 
entry clone (generated by Mathias Senften) by site directed mutagenesis using primers 
IK298 and IK299 for M1, IK300 and IK301 for FBE2, IK302 and IK303 for M2, IK314 
and IK315 for M2exp, and IK312 and IK313 for FBE1-4. The cki-2 coding sequence for 
the overexpression construct was cloned into pDONR221 using primers IK278 and 
IK279 on cDNA. The operon entry vector was generated using primers IK280 and 
IK281 to amplify the gpd-2,3 intergenic region; IK282 and IK283 to amplify GFP-H2B; 
IK284 and IK285 to amplify the tbb-2 3’UTR. Fragments were then joined by fusion 
PCR and cloned into pDONRP2R-P3. The ectopic M2 site was inserted into the tbb-2 
3’UTR by site directed mutagenesis on the entry vector containing tbb-2 3’UTR using 
the primers IK323 and IK324. 
Experimental Procedures 
92
   
 W
o
rm
 s
tr
a
in
s
 u
s
e
d
/
g
e
n
e
ra
te
d
 
N
o
tc
h
 p
ro
je
c
t 
1
1
8
 
g
lp
-
1
(a
r2
0
2
);
  
5
2
2
 
g
lp
-
1
(a
r2
0
2
);
 +
 /
 D
n
T
IG
 
8
5
3
 
u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(1
7
5
) 
/
 h
T
2
[q
Is
4
8
] 
3
9
7
 
u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(o
z
1
1
2
) 
/
 u
n
c
-
3
6
(e
2
5
1
) 
g
lp
-
1
(q
1
7
5
) 
 
3
1
8
, 
3
1
9
 
g
ld
-
2
(q
4
9
2
) 
g
ld
-
1
(q
4
8
5
);
 g
lp
-
1
(e
2
1
4
1
) 
/
 h
T
2
[q
Is
4
8
] 
9
0
, 
3
2
4
, 
3
4
4
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 g
lp
-
1
(a
r2
0
2
) 
/
 h
T
2
[q
Is
4
8
] 
9
3
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 g
lp
-
1
(a
r2
0
2
) 
/
 h
T
2
[q
Is
4
8
] 
m
u
s
c
le
-
Y
F
P
 
9
1
, 
9
5
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 g
lp
-
1
(a
r2
0
2
) 
/
 h
T
2
[q
Is
4
8
] 
8
8
, 
9
2
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 g
lp
-
1
(a
r2
0
2
) 
/
 h
T
2
[q
Is
4
8
];
 m
u
s
c
le
-
Y
F
P
 
2
1
3
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
),
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(q
1
7
5
) 
/
 h
T
2
 [
q
Is
4
8
] 
[u
n
c
-
1
1
9
::
G
F
P
, 
ro
l-
6
 (
s
u
1
0
0
6
)]
 
2
1
0
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(q
1
7
5
) 
/
 h
T
2
 [
q
Is
4
8
];
 m
u
s
c
le
-
Y
F
P
  
5
2
0
 
m
e
s
-
4
(b
n
8
5
) 
/
 D
n
T
IG
 
5
2
1
 
g
lp
-
1
(a
r2
0
2
);
 m
e
s
-
4
(b
n
8
5
) 
/
 D
n
T
IG
 
4
3
3
 
m
e
s
-
2
(b
n
1
1
) 
u
n
c
-
4
(e
1
2
0
)/
m
n
C
1
 d
p
y
-
1
0
e
1
2
8
()
 u
n
c
-
5
2
(e
4
4
4
) 
5
2
6
 
m
e
s
-
2
(b
n
1
1
) 
u
n
c
-
4
(e
1
2
0
) 
/
 m
n
C
1
 d
p
y
-
1
0
(e
1
2
8
) 
u
n
c
-
5
2
(e
4
4
4
);
 g
lp
-
1
(a
r2
0
2
) 
C
K
I-
2
 p
ro
je
c
t 
d
iv
e
rs
e
 s
tr
a
in
s
 
 
3
5
7
 
c
k
i-
2
(o
K
2
1
0
5
) 
3
7
1
, 
3
5
8
 
c
k
i-
1
(g
k
1
3
2
) 
/
 m
In
1
[d
p
y
-
1
0
(e
1
2
8
) 
m
Is
1
4
] 
1
0
7
 
M
R
2
5
8
 (
N
2
; 
rr
E
x
2
5
8
 [
fe
m
-
1
::
c
k
i-
2
C
; 
e
lt
-
2
::
G
F
P
])
 
5
2
7
 
fb
f-
1
(o
k
9
1
) 
5
7
4
 
fb
f-
2
(q
7
3
8
) 
8
4
2
, 
8
4
8
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
 
8
5
8
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 +
 ;
 m
e
x
-
3
 /
 h
T
2
[q
Is
4
8
] 
3
5
9
, 
3
7
0
 
p
u
f-
8
(q
7
2
5
) 
3
6
7
 
p
u
f-
8
(o
k
3
0
2
) 
8
6
0
 
m
In
1
[d
p
y
-
1
0
(e
1
2
8
)]
 /
 u
n
c
-
4
(e
1
2
0
) 
3
7
2
 
c
u
l-
2
(e
k
1
) 
/
 u
n
c
-
6
4
(e
2
4
6
) 
 
4
0
7
 
a
x
Is
1
4
7
1
[p
ie
-
1
 p
ro
m
:G
F
P
:F
B
F
-
1
 O
R
F
:f
b
f-
1
 3
’U
T
R
, 
u
n
c
-
1
1
9
 (
+
)]
 
4
1
0
 
a
x
Is
1
7
0
2
[p
ie
-
1
 p
ro
m
:G
F
P
:F
B
F
-
2
 O
R
F
:f
b
f-
2
 3
’U
T
R
, 
u
n
c
-
1
1
9
 (
+
)]
 
93
   
 
6
4
 
n
m
y
-
2
::
P
G
L
-
1
::
G
F
P
 
s
tr
a
in
s
 c
a
rr
y
in
g
 c
k
i-
2
(o
k
2
1
0
5
) 
 
4
1
2
, 
4
1
3
 
c
k
i-
2
(o
k
2
1
0
5
);
 c
u
l-
2
(e
k
1
) 
/
 u
n
c
-
6
4
(e
2
4
6
) 
3
9
8
 
c
k
i-
2
(o
k
2
1
0
5
);
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(1
7
5
) 
/
 h
T
2
[q
Is
4
8
] 
7
4
4
 
c
y
e
-
1
(e
h
1
0
) 
/
 d
p
y
-
1
4
(e
1
8
8
) 
I;
 c
k
i-
2
(o
K
2
1
0
5
) 
8
4
1
, 
8
4
5
, 
8
5
6
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
c
k
i-
2
(o
k
2
1
0
5
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
 
4
0
0
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
) 
/
 h
T
2
[q
Is
4
8
];
 c
k
i-
2
(o
k
2
1
0
5
) 
3
9
9
 
m
e
x
-
3
(o
r2
0
) 
/
 h
T
2
[q
Is
4
8
];
 c
k
i-
2
(o
k
2
1
0
5
) 
4
0
1
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
) 
/
 h
T
2
[q
Is
4
8
];
 c
k
i-
2
(o
k
2
1
0
5
) 
3
9
6
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 c
k
i-
2
(o
k
2
1
0
5
);
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(1
7
5
) 
/
 h
T
2
[q
Is
4
8
] 
to
 b
e
 f
ro
z
e
n
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
c
k
i-
2
(o
k
2
1
0
5
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
fe
m
-
1
(h
c
1
7
) 
to
 b
e
 f
ro
z
e
n
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
 /
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
fe
m
-
1
(h
c
1
7
) 
to
 b
e
 f
ro
z
e
n
 
c
k
i-
2
(o
k
2
1
0
5
);
 n
m
y
-
2
::
P
G
L
-
1
::
G
F
P
 
to
 b
e
 f
ro
z
e
n
 
g
ld
-
1
(q
4
8
5
) 
/
 h
T
2
[q
Is
4
8
];
 c
k
i-
2
(o
k
2
1
0
5
) 
to
 b
e
 f
ro
z
e
n
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
1
(q
4
8
5
) 
/
 h
T
2
[q
Is
4
8
];
 c
k
i-
2
(o
k
2
1
0
5
) 
M
E
X
-3
 c
o
IP
 
 
3
4
3
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
);
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(q
1
7
5
) 
/
 h
T
2
 [
q
Is
4
8
];
 G
F
P
::
M
E
X
-
3
 
re
p
o
rt
e
r 
tr
a
n
s
g
e
n
e
s
 
 
4
6
7
 
a
x
ls
[c
k
i-
2
 p
ro
m
o
te
r(
5
k
b
):
:G
F
P
-
H
2
B
::
tb
b
-
2
 3
’U
T
R
] 
4
6
1
, 
4
6
2
 
a
x
ls
[m
e
x
-
5
::
C
K
I-
2
(s
ta
rt
 t
o
 e
n
d
 o
f 
3
’U
T
R
):
:g
p
d
-
2
-
3
 G
F
P
-
H
2
B
 t
b
b
-
2
 3
’U
T
R
] 
4
8
2
, 
4
7
0
, 
4
7
6
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
tb
b
-
2
 3
’U
T
R
] 
4
1
8
 
a
x
ls
[p
ie
-
1
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 (
s
h
o
rt
 i
s
o
fo
rm
)]
 
4
2
0
, 
4
2
1
, 
4
3
6
 
a
x
ls
[p
ie
-
1
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
] 
5
2
8
, 
5
3
0
, 
5
3
9
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 w
t]
 
4
7
4
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
M
2
] 
5
3
1
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
M
2
e
x
p
] 
5
3
3
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
M
2
e
x
p
] 
5
3
4
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
M
2
e
x
p
] 
4
7
1
, 
4
7
2
, 
4
7
3
, 
4
7
7
, 
4
7
8
, 
4
8
3
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
M
1
 ∆
M
2
] 
4
6
6
, 
4
6
8
, 
4
6
9
, 
4
7
5
, 
4
8
0
, 
4
8
1
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
2
] 
4
8
4
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
2
 ∆
M
2
] 
5
3
2
, 
5
3
5
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
:c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
] 
5
2
9
, 
5
3
6
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
:c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
 ∆
M
2
e
x
p
] 
94
   
 
5
3
8
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
:c
k
i-
2
 3
’U
T
R
 ∆
3
 ∆
M
2
] 
5
3
7
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
:c
k
i-
2
 3
’U
T
R
 ∆
5
 ∆
M
2
] 
5
2
4
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
:t
b
b
-
2
 3
’U
T
R
 +
 M
E
X
-
3
 s
it
e
] 
5
2
5
 
a
x
ls
[m
e
x
-
5
::
G
F
P
-
H
2
B
:t
b
b
-
2
 3
’U
T
R
 +
 M
E
X
-
3
 s
it
e
] 
5
4
8
 
rr
rS
i9
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 w
t]
 
5
5
0
 
rr
rS
i1
1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 w
t]
 
5
5
5
 
rr
rS
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
M
2
] 
5
5
8
 
rr
rS
i1
3
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
] 
5
5
9
 
rr
rS
i1
4
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
] 
5
6
0
 
rr
rS
i1
5
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
] 
7
2
7
 
rr
rS
i1
5
3
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
'U
T
R
 ∆
F
B
E
2
] 
7
2
8
 
rr
rS
i1
5
4
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
2
 ∆
M
2
] 
7
3
1
 
rr
rS
i1
5
6
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
2
 ∆
M
2
] 
7
3
2
 
rr
rS
i1
5
7
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
1
 ∆
M
2
] 
7
3
3
 
rr
rS
i1
5
8
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
1
 ∆
M
2
] 
8
5
7
 
rr
rS
i1
9
6
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
] 
8
5
9
 
rr
rS
i1
9
5
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
 ∆
M
2
] 
5
5
1
 
rr
rS
i1
6
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
1
 ∆
M
2
] 
5
6
1
 
rr
rS
i1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
2
 ∆
M
2
] 
5
5
7
 
rr
rS
i1
7
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
2
 ∆
M
2
] 
5
6
2
 
rr
rS
i1
9
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
2
 ∆
M
2
] 
7
3
7
 
rr
rS
i1
6
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
'U
T
R
 ∆
3
 ∆
M
2
] 
5
5
6
 
rr
rS
i2
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
3
 ∆
M
2
] 
5
6
3
 
rr
rS
i2
1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
4
] 
5
6
4
 
rr
rS
i2
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
5
 ∆
M
2
] 
re
p
o
rt
e
rs
 i
n
 d
iv
.b
a
c
k
g
ro
u
n
d
s
 
 
7
4
6
, 
7
4
7
, 
7
4
8
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i9
, 
rr
rS
i1
0
 o
r 
rr
rS
i1
1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
8
5
4
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i1
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
7
4
9
, 
7
5
0
, 
7
5
1
, 
7
5
2
, 
7
5
4
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 ∆
M
2
 3
’U
T
R
] 
8
4
7
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i1
9
5
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
ck
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
 ∆
M
2
] 
to
 b
e
 f
ro
z
e
n
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i1
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
to
 b
e
 f
ro
z
e
n
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 ∆
M
2
 3
’U
T
R
] 
to
 b
e
 f
ro
z
e
n
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[d
p
y
-
1
0
(e
1
2
8
)]
; 
rr
rS
i1
9
5
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
 ∆
M
2
] 
95
   
 
8
7
2
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(q
4
8
5
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
7
4
2
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(4
8
5
);
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(q
1
7
5
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
'U
T
R
 ∆
M
2
] 
to
 b
e
 f
ro
z
e
n
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(4
8
5
);
 u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(q
1
7
5
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 w
t]
 
to
 b
e
 f
ro
z
e
n
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(4
8
5
);
 g
lp
-
1
(a
r2
0
2
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
'U
T
R
 ∆
M
2
] 
to
 b
e
 f
ro
z
e
n
 
g
ld
-
2
(q
4
9
7
) 
g
ld
-
1
(4
8
5
);
 g
lp
-
1
(a
r2
0
2
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
'U
T
R
 w
t]
 
7
0
3
 
g
lp
-
1
(a
r2
0
2
);
 r
rr
S
i9
, 
rr
rS
i1
0
 o
r 
rr
rS
i1
1
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
8
5
5
 
g
lp
-
1
(a
r2
0
2
);
 r
rr
S
i1
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
to
 b
e
 f
ro
z
e
n
 
u
n
c
-
3
2
(e
1
8
9
) 
g
lp
-
1
(q
1
7
5
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
7
4
3
 
g
lp
-
1
(a
r2
0
2
);
 r
rr
S
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 ∆
M
2
 3
’U
T
R
] 
8
5
1
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
1
(q
4
8
5
) 
g
ld
-
2
(q
4
9
7
);
 u
n
c
-
3
2
(e
1
8
9
),
 g
lp
-
1
(1
7
5
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
2
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 ∆
M
2
 
3
’U
T
R
] 
to
 b
e
 f
ro
z
e
n
 
fb
f-
1
(o
k
9
1
) 
fb
f-
2
(q
7
0
4
) 
/
 m
In
1
[m
Is
1
4
 d
p
y
-
1
0
(e
1
2
8
)]
; 
a
x
Is
1
7
0
2
[p
ie
-
1
 p
ro
m
:G
F
P
:F
B
F
-
2
 O
R
F
:f
b
f-
2
 3
’U
T
R
, 
u
n
c
-
1
1
9
 (
+
)]
 
to
 b
e
 f
ro
z
e
n
 
a
x
Is
1
7
0
2
[p
ie
-
1
 p
ro
m
:G
F
P
:F
B
F
-
2
 O
R
F
:f
b
f-
2
 3
’U
T
R
, 
u
n
c
-
1
1
9
 (
+
)]
; 
rr
rS
i1
0
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 w
t 
3
’U
T
R
] 
to
 b
e
 f
ro
z
e
n
 
a
x
Is
1
7
0
2
[p
ie
-
1
 p
ro
m
:G
F
P
:F
B
F
-
2
 O
R
F
:f
b
f-
2
 3
’U
T
R
, 
u
n
c
-
1
1
9
 (
+
)]
; 
rr
rS
i1
9
6
[m
e
x
-
5
::
G
F
P
-
H
2
B
::
c
k
i-
2
 3
’U
T
R
 ∆
F
B
E
1
-
4
] 
C
K
I-
2
 o
v
e
re
x
p
re
s
s
io
n
 
 
4
5
3
 
rr
rS
i1
5
9
[m
e
x
-
5
::
C
K
I-
2
(s
ta
rt
 t
o
 e
n
d
 o
f 
3
’U
T
R
):
:g
p
d
-
2
-
3
_G
F
P
-
H
2
B
_
tb
b
-
2
 3
’U
T
R
] 
8
5
2
 
c
y
e
-
1
(e
h
1
0
) 
/
 d
p
y
-
1
4
(e
1
8
8
);
 r
rr
S
i1
5
9
[m
e
x
-
5
::
C
K
I-
2
(s
ta
rt
 t
o
 e
n
d
 o
f 
3
’U
T
R
):
:g
p
d
-
2
-
3
 G
F
P
-
H
2
B
 t
b
b
-
2
 3
’U
T
R
] 
7
4
5
 
m
e
x
-
3
(o
r2
0
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
5
9
[m
e
x
-
5
::
C
K
I-
2
(s
ta
rt
 t
o
 e
n
d
 o
f 
3
’U
T
R
):
:g
p
d
-
2
-
3
 G
F
P
-
H
2
B
 t
b
b
-
2
 3
’U
T
R
] 
7
3
5
 
m
e
x
-
3
(o
r2
0
) 
g
ld
-
1
(q
4
8
5
) 
/
 h
T
2
[q
Is
4
8
];
 r
rr
S
i1
5
9
[m
e
x
-
5
::
C
K
I-
2
(s
ta
rt
 t
o
 e
n
d
 o
f 
3
’U
T
R
):
:g
p
d
-
2
-
3
 G
F
P
-
H
2
B
 t
b
b
-
2
 3
’U
T
R
] 
 
96
 
 
 
______________________________________________________________________ 
 
Gonad dissection for C.elegans tiling array analysis 
Parental animals were raised at 15°C and shifted to 25°C for egglay. 50 gonads per 
sample were dissected from the F1 generation in M9 containing Levamisole, 
transferred to PicoPure sample buffer obtained from Eric Cabuy, Genomics Facility, FMI 
by mouth pipette, and frozen at -80° for further processing by the Genomics Facility. 
First biological replicate (A):  
e2141_A_1, e2141_A_2, e2141_A_3 (technical replicates of gld-2(q497) gld-1(485); glp-
1(e2141tslf)), ar202_A_1, ar202_A_2, ar202_A_3 (technical replicates of gld-2(q497) gld-
1(485);  glp-1(ar202tsgf)) 
Second biological replicate (B): 
e2141_B_1, e2141_B_2, e2141_B_3 (technical replicates of gld-2(q497) gld-1(485); glp-
1(e2141tslf)), ar202_B_1, ar202_B_2, ar202_B_3 (technical replicates of gld-2(q497) gld-
1(485);  glp-1(ar202tsgf)) 
 
Microarray  
200 ng total RNA were amplified using the Affymetrix GeneChip WT Amplified Double 
Stranded cDNA Synthesis Kit according to the manufacturer‘s instructions. The 
Affymetrix GeneChip WT Double-Stranded cDNA Terminal Labeling Kit was used for 
fragmentation and labeling of 7.5 ug cDNA. The labeled material was loaded on 
Affymetrix GeneChip C. elegans Tiling 1.0R Arrays and hybridized at 65⁰ C for 16h. 
The arrays were washed in an Affymetrix Fluidics stations with the protocol 
FS450_0001 and scanned in an Affymetrix GeneChip Scanner 3000 with autoloader 
using Affymetrix GCC Scan Control v. 3.0.0.1214 software. 
Probesets were summarized and probeset-level values normalized with the justRMA() 
function from R (version 2.10.0) / Bioconductor (version 2.5) package affy using the 
CDF environment MoGene-1_0-st-v1.r3.cdf (as provided by Bioconductor) and 
annotation from Netaffx (www.netaffx.com). 
 
Data analysis 
Initial analysis of the raw data was performed by Dimos Gaidatzis of the Genomics 
Facility at the FMI. All later analysis was performed in R by IK and is documented in 
the Appendix.  
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Validation by qPCR 
qPCR validations were performed (in contrast to the array) on Notch null mutants. gld-
2(q497) gld-1(485); unc-32(e189) glp-1(q175)/hT2[qIs48] and gld-2(q497) gld-1(485); glp-
1(ar202)tsgf / ht2(qIs48) animals were grown at 20°C. Embryos were harvested by 
hypochlorite treatment, transferred to OP50 plates and incubated at 25°C until d0.5 of 
adulthood. For each genotype, 3 x 50 gonads were dissected in M9 containing 
Levamisole, transferred into 100l ice-cold Trizol by mouth pipette, and frozen in 
liquid nitrogen. Afterwards, samples were thawed and 1g mouse RNA was added to 
each sample.  
RNA was isolated by adding 20l Chloroform, incubating 10 minutes at RT, 10 minutes 
centrifugation at 13.000 rpm in a table centrifuge. The water phase was transferred, 
50l Isopropanol were added, followed by 15 minutes incubation at RT and 10 minutes 
centrifugation at 13.000 rpm. The supernatant was removed, and the pellet was 
washed with 600l 70% EtOH, followed by 10 minutes centrifugation at 13.000 rpm. 
The samples were dried at RT for 10 minutes, resuspended in 20l DEPC, and 
incubated for 10 minutes at 60°C, followed by concentration measurement by 
NanoDrop. cDNA was synthesized with oligoT primer using the ImProm II Reverse 
transcription system from Promega according to manufacturers instructions from 
400ng RNA. 1/7 of the cDNA reaction was used for qPCR using Absolute QPCR SYBR 
green ROX mix (AbGene) on an ABI PRISM 7700 system (Applied Biosystems). PCR 
reactions were performed with an initial activation step of 15 min at 95°C, then 40 
cycles of 20 s at 95°C and 60 s at 60°C. Standard curves for quantification were 
generated from a serial dilution of input cDNA for each primer pair. 
The amount of target present in each replicate was derived from the standard curve; 
an average was calculated for the triplicates and fold enrichment was normalized to 
tubulin. 
Primers used were IK259 and IK260 for cki-2, MS-act-1-p1 and MS-act-1-p2 for 
actin, and tbb-2 f 495 and tbb-2 r 696 for tubulin. 
 
Northern Blot 
RNA was extracted with Trizol from young adults prior to embryo production, from 
glp-4 animals grown at restrictive temperature, and from embryos. 40g RNA were 
loaded per lane. The probe corresponds to SL1, 5’UTR and CDS until nucleotide 462 
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(exons 1-3) and was generated using primers IK254 and IK261. The DIG Northern 
Starter Kit from Roche was used to prepare the probe and perform hybridization 
according to the manufacturer’s instruction, except that the blocking solution was 
used at 10x concentration. 
 
Biotin-RNA Pull-down 
Biotin-RNA pull-downs were performed as in (Biedermann, Wright et al. 2009). 
 
Immunofluorescence 
Dilutions were 1:15 for CKI-1 antibody and 1:20 for CKI-2 antibody (Feng, Zhong et al. 
1999). Secondary antibodies were goat anti-mouse alexa-568, anti-rabbit alexa-568, 
and anti-rabbit alexa-488 (Molecular Probes). In most experiments, gonads were 
prepared essentially as described previously (Lin, Hill et al. 1998). For HIM-3 staining, 
gonads were dissected in M9 with Levamisole, frozen on dry ice, fixed first in 100% 
methanol (-20°C) for 5 min, and then in 3.7% paraformaldehyde, PBS, 0.08 M HEPES, 
1.6 mM MgSO4, 0.8 mM EGTA (pH 6.9) at room temperature (RT) for 5 min. 
Fluorescence and DIC images were captured with a Zeiss ImagerZ1 microscope 
equipped with an AxiocamMRm (Zeiss). Images were acquired with the same exposure 
and processed in Adobe Photoshop CS2 in an identical manner.  
 
RNA-co-IP 
Worm extracts were performed as previously described (Biedermann, Wright et al. 
2009) in duplicate from N2 and from mex-3 gld-1 gld-2; glp-1(lf); MEX-3::GFP animals 
(previously separated from balanced animals with a COPASTM Biosort from Union 
Biometrica), diluted to 2g/l and preincubated with 10l Protein A Sepharose Cl-4B 
beads per 700g total protein at 4°C for 30 minutes. 20l Protein A Sepharose beads 
that had been incubated with mouse anti-GFP antibody from Roche (11814460001) 
overnight at 4°C were added to 700g total protein in a volume of 350l and incubated 
for 5h at 4°C. IPs were then washed three times with extraction buffer. RNA was 
isolated with Trizol and processed as described before for real-time quantitative PCR. 
All incubations were done on the rotating wheel.  
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Primers used were IK259 and IK260 for cki-2, MS-act-1-p1 and MS-act-1-p2 for 
actin, tbb-2 f 495 and tbb-2 r 696 for tubulin, MS-rme2-p1 and MS-rme2-p2 for rme-
2, Jane’s ama-1 primers for ama-1, and MS-pal-1-p1 and MS-pal-1-p2 for pal-1. 
 
RNA In situ hybridisation 
RNA hybridizations were performed as described by Broitman-Maduro and Maduro 
(http://www.faculty.ucr.edu/_mmaduro/resources.htm). The probe was generated 
using primers AM015 and IK249. A Zeiss AxioImager Z1 microscope equipped with 
AxioncamMRm REV 2 CCD camera was used to capture images. All images were 
processed with Adobe Photoshop 7.0 or CS2 in an identical manner. 
 
3’RACE 
The cki-2 cDNA was determined by 3’RACE (Scotto-Lavino, Du et al. 2006). cDNA was 
generated with IK001, 3’ and 5’ ends were determined using IK2 with internal forward 
primers, and IK91 with internal reverse primers and was cloned with the TOPO® TA 
Cloning® Kit from Invitrogen.    
 
Protein purification for in vitro interaction assays 
The PUF domain (amino acids 121-632) of FBF-2 was cloned into pGEX-6P-1 (GE 
Healthcare) and transformed into BL21(DE3) codon plus cells. Cultures were grown at 
37 ºC to an OD
600
 of 0.4, shifted to 4 ºC for 15 minutes, induced with 0.1 mM IPTG, 
then incubated at 16 ºC overnight. Cell pellets were resuspended in lysis buffer (50 mM 
Tris pH 7.5, 500 mM KCl,  and 2 mM DTT, supplemented with one Complete Mini 
EDTA-free protease tablet (Roche) per 50 mL of buffer) and disrupted using a 
microfluidizer. Following clarification, the protein was purified by affinity 
chromatography using a glutiathione sepharose 4B (GE Healthcare) column. To remove 
co-purifying nucleic acids, the column was washed with lysis buffer supplemented 
with 1 M KCl then exchanged into 50 mM Tris pH 7.5, 150 mM KCl, 1 mM EDTA, 2 mM 
DTT. The protein was eluted by incubation with Precission protease (GE Healthcare) at 
4 ºC overnight which cleaves in between FBF and the N-terminal GST tag. Additional 
contaminants were removed using a HiTrap Q HP (GE Healthcare) column where 
purified FBF was recovered in the flow through. MEX-3 was purified as previously 
described (Pagano, Farley et al. 2009). 
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RNA binding assays 
RNA oligonucleotides (IDT) were labeled as described by (Pagano, Clingman et al. 
2011), and MEX-3 binding assays were performed as described in (Pagano, Farley et al. 
2009). FBF binding reactions were perfomed as described in (Koh, Wang et al. 2011) 
and (Wang, Opperman et al. 2009), with the exception that F-EMSA and FP data were 
collected as described in (Pagano, Clingman et al. 2011).  
 
Oligonucleotide sequences used to determine affinities:  
cki-2 MRE2 WT ACUCAAAUCAUAGACAUUCUAGUUAUAAAU 
cki-2 MRE2 mut1 ACUCAAAUCCCCCACAUCCCCGUUAUAAAU 
cki-2 MRE2 mut2 ACUCAAAUCCCCCACAUCCCCGUCCCCAAU 
gld-1 FBEa AUAGAAUCAUGUGCCAUACAUCAUGUUG 
cki-2 FBE1 WT UUUAUCUGUGAAUUUGAAAU 
cki-2 FBE1 mut UUUAUCACAGAAUUUGAAAU 
cki-2 FBE2 WT CAUACCCUGUCCAUUUCUGU 
cki-2 FBE2 mut CAUACCCACACCAUUUCUGU 
cki-2 FBE3 WT CAUUUCUGUGUUCUACUCCU 
cki-2 FBE3 mut CAUUUCACAGUUCUACUCCU 
cki-2 FBE4 WT CUACUCCUGUAAAAAAAGUC 
cki-2 FBE4 mut CUACUCCACAAAAAAAAGUC 
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urodele amphibian  amphibian retaining a tail after metamorphosis, eg. 
Salamander 
anuran amphibian  amphibian losing their tail during metamorphosis, such as 
frogs 
Ctenophores marine combed jellyfish 
Diptera  order of insects characterized by one wing pair  
Epimorphis  regeneration of bodyparts by the formation of new tissue (as 
opposed to morphallaxis] 
Ecdysozoa  animals shedding their cuticle during growth  
Gonochoristic species  individuals are either male or female (as opposed to 
hermaphroditic species, where individuals are both male and 
female). 
Hydra  radial-symmetrical freshwater polyp 
Morphallaxis regeneration of bodyparts by the rearrangement of cells, not 
by proliferation. Example: Hydra. 
Teratoma Teratoma are cancerous lesions likely derived from early, 
undifferentiated germ cells. 
Tunicata, Ascidians  order of marine filter feeder 
diploblast  organisms which develop from two primary germlayers, 
endoderm and ectoderm 
monotremes  egglaying mammals 
HAT Histone acetyl transferase 
TRIM protein Tripartite Motif protein  
HDAC  Histone deacetylase 
CIR  Co-repressor interacting with RBP-J 
SAGA complex  Spt-Ada-Gcn5-Acetyltransferase complex 
SKIP  Ski-interacting protein 
TFIID, TFIIA  Transcription factors IID, IIA, components of the 
transcription initiation complex. 
NICD  Notch intracellular domain 
MAM  Mastermind 
CSL   collective name for CBF1, Su(H), and LAG-3 
GCN5  Acetyltransferase 
PCAF  P300/CBP-associated factor 
SWI/SNF  SWItch/Sucrose NonFermentable, ATPase 
H3K4, H3K27  Lysine 4 and 27, respectively, of Histone 3 
LID/KDM  Little imaginal discs/Lysine demethylase 
ASX  Additional sex combs 
Cdk  Cyclin dependent kinase 
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script_1 (data distribution - avgExpr vs fold change, density plot).r 
 
# read in contrast file obtained from Dimosthenis Gaidatzis / Bioinformatics Facility, FMI 
 contrast <- read.delim("NotchContrasts.txt") 
 head(contrast) 
 dim(contrast) # 24822 isoforms called 
 
# changing column names 
 colnames(contrast) <- c("isoform", "fcboth", "fc1", "fc2", "avgExpr") 
 summary(contrast) 
 dim(contrast) 
 # [1] 24822     5 
 
# checking distribution of average expression values with histogram 
   pdf("average expression values.pdf") 
 hist (contrast$avgExpr, breaks = 100, 
         main = c("average expression values", "n = 24822 isoforms"), 
             xlab = "average expression from all arrays" 
             ) 
   dev.off() 
   
# checking correlation of fold changes from first and second repeat 
 
   pdf("fold change correlation from rep1 and rep2.pdf") 
 plot  (contrast$fc1, contrast$fc2, 
  pch = "*", col = "black", 
  main = "repeat 1 vs repeat 2", 
  xlab = "fold change (1), log2", ylab = "fold change (2), log2" 
          ) 
   points  (contrast$fc1[contrast$fcboth>=1], contrast$fc2[contrast$fcboth>=1], 
            pch = "*", col="green") 
  points  (contrast$fc1[contrast$fcboth<=-1], contrast$fc2[contrast$fcboth<=-1], 
            pch = "*", col="red") 
   abline  (h = 0, col = "grey", lty = 2) 
 abline  (v = 0, col = "grey", lty = 2) 
 legend  ("bottomright", bty = "n", 
legend=c("2 fold upregulated (average regulation)", "2 fold downregulated 
(average regulation"), 
            col=c("green", "red"), pch = "*") 
   dev.off() 
   
# checking relation of average expression values with pooled fold changes from both repeats 
 
  pdf("MA plot.pdf") 
 plot  (contrast$avgExpr, contrast$fcboth, 
  pch = "*", col = "black", 
  main = "fold change versus average Expression", 
  xlab = "average expression", ylab = "fold change (1+2), log2" 
          ) 
   points  (contrast$avgExpr[contrast$fcboth>=1], contrast$fcboth[contrast$fcboth>=1], 
    pch = "*", col="green") 
 points  (contrast$avgExpr[contrast$fcboth<=-1], contrast$fcboth[contrast$fcboth<=-
1], pch = "*", col="red") 
     abline  (h = c(1, -1), col = "grey", lty = 2) 
 legend  ("bottomright", bty = "n", 
            legend=c("2 fold upregulated", "2 fold downregulated"), 
            col=c("green", "red"), pch = "*") 
 dev.off() 
 
 
script_2 (reading in annotation, generating workspace).r 
 
Appendix – R scripts 
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# reading in Dimos' contrast file 
 contrast <- read.delim ( "NotchContrasts.txt") 
  
# changing to workable column names 
 colnames(contrast) <- c("isoform", "fcboth", "fc1", "fc2", "avgExpr") 
 
# adding as columns: WBGeneID, Intronerator, etc 
 # fetch identifiers 
  i <- (contrast$isoform) 
  head(i) 
  length(i) 
  write.table(  
    i,  
    "isoforms_on_chip.txt",  
    col.names=F,  
    row.names=F,  
    quote=F 
    ) 
 
# retrieve annotation from wormmart, using build 190. saved as annotation.txt 
 
# read annotation into R 
 annotation <- read.delim("annotation.txt") 
 dim(annotation)  # all 24822 returned 
 
# merge contrast values with annotation, test, save 
 cont.ann <- merge(contrast, annotation, by.x=1, by.y=5) 
 dim(cont.ann) 
 head(cont.ann) 
 cont.ann[cont.ann$isoform =="C55C3.7",] 
 contrast[contrast$isoform =="C55C3.7",] 
 annotation[annotation$Sequence.Name..Transcript. =="C55C3.7",] 
 colnames(cont.ann) <- c("isoform", "fc_bothrepeats", "fc_repeat1", "fc_repeat2", 
"avgExpr", "WBid", "public_name", "gene_name", 
"chromosome") 
 write.table (cont.ann, 
   "NotchContrasts_annotated.txt",  
   row.names = F, quote = F 
   ) 
 
 # Workspaced used from now: notchcontrast_ann.RData 
   
 
script_3 (extracting regulated genes, chromosome bias).r 
 
# open Workspace notchcontrast_ann.RData 
   
# extract differentially regulated genes (unique list) 
 
   up <- as.factor(as.character(unique(cont.ann$gene_name[cont.ann$fc_bothrepeats >= 
1]))) 
   down <- as.factor(as.character(unique(cont.ann$gene_name[cont.ann$fc_bothrepeats 
<= -1]))) 
   length(up)   # 114 genes 
   length(down) # 10 genes 
   
   write.table  (unique(cont.ann[cont.ann$fc_bothrepeats >= 1,c(2:9)]), 
                quote = FALSE, row.names = FALSE, sep = "\t", 
                "upregulated genes.txt") 
 write.table  (unique(cont.ann[cont.ann$fc_bothrepeats <= -1,c(2:9)]), 
                quote = FALSE, row.names = FALSE, sep = "\t", 
                "downregulated genes.txt") 
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   dim(unique(cont.ann[cont.ann$fc_bothrepeats >= 1,c(2:9)])) 
   dim(unique(cont.ann[cont.ann$fc_bothrepeats <= -1,c(2:9)])) 
 
# compare chromosome distribution 
 
 up <-   unique(cont.ann[cont.ann$fc_bothrepeats >= 1,c(6:9)]) 
 down <-  unique(cont.ann[cont.ann$fc_bothrepeats <= -1,c(6:9)]) 
 alle <-   unique(cont.ann[,c(6:9)]) 
 dim(up)     # 114 genes go up 
 summary (up$chromosome) 
 dim(alle)   # 18050 genes 
 summary (alle$chromosome) 
 dim(up[up$chromosome == "X",])  # 52 of up genes are on X 
 
# generate 100 random lists of 114 genes, count genes on X, save results.  
 test1 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test2 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test3 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test4 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test5 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test6 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test7 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test8 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test9 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 test10 <- as.factor(as.character(sample(alle$gene_name, 114))) 
 
  
 t1 <- alle[alle$gene_name %in% test1,] 
 length(t1$chromosome[t1$chromosome == "X"]) 
 t2 <- alle[alle$gene_name %in% test2,] 
 length(t1$chromosome[t2$chromosome == "X"]) 
 t3 <- alle[alle$gene_name %in% test3,] 
 length(t1$chromosome[t3$chromosome == "X"]) 
 t4 <- alle[alle$gene_name %in% test4,] 
 length(t1$chromosome[t4$chromosome == "X"]) 
 t5 <- alle[alle$gene_name %in% test5,] 
 length(t1$chromosome[t5$chromosome == "X"]) 
 t6 <- alle[alle$gene_name %in% test6,] 
 length(t1$chromosome[t6$chromosome == "X"]) 
 t7 <- alle[alle$gene_name %in% test7,] 
 length(t1$chromosome[t7$chromosome == "X"]) 
 t8 <- alle[alle$gene_name %in% test8,] 
 length(t1$chromosome[t8$chromosome == "X"]) 
 t9 <- alle[alle$gene_name %in% test9,] 
 length(t1$chromosome[t9$chromosome == "X"]) 
 t10 <- alle[alle$gene_name %in% test10,] 
 length(t1$chromosome[t10$chromosome == "X"]) 
 
# results saved in .txt 
 
 pdf("random 114 genes - X linkage.pdf") 
 randoms <- read.table("random_samples.txt") 
 hist (randoms[,1], breaks = 20, main = c("X linked fraction among 114 randomly 
sampled genes", "n = 100"), ylab = "frequency", xlab = "X-linked genes among 
114 random genes") 
 dev.off() 
 
 pdf("chromsome bias.pdf") 
 cols <- rainbow(10) 
 par(mfrow = c(3,2)) 
 pie (summary(up$chromosome), main = c("upregulated genes", "n=114"), col=cols, 
radius = 1) 
 pie     (summary(alle$chromosome), main = c("all genes on array", "n=18050"),  
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            col=cols, radius = 1) 
 dev.off() 
 
# compare expression of x and autosomes 
 
 x <- unique(cont.ann[cont.ann$chromosome == "X",c(2:9)]) 
 auto <- unique(cont.ann[cont.ann$chromosome != "X",c(2:9)]) 
 pdf("silent X-chromsome.pdf") 
 plot (density(x$avgExpr), col = "red", lwd = 2, 
                         main = "X-linked genes are mostly silent in germ cell tumors", 
                         ylab = "frequency", xlab = "average expression level") 
 lines (density(auto$avgExpr), col = "black", lwd = 2) 
 legend ("topright", lty = 1, lwd = 2, col = c("red", "black"), legend = c("expression of X-
linked genes", "expression of autosomal genes"), bty = "n") 
 dev.off() 
 
# MA plot by auto/heterosomes, respectively. 
 
 auto <- cont.ann[cont.ann$chromosome != "X",] 
 hetero <- cont.ann[cont.ann$chromosome =="X",] 
 dim(auto) # 21349 
 dim(hetero) # 3473 
 
 pdf("MA plot, auto-hetero.pdf", width = 14) 
 par(mfrow=c(1,2)) 
   plot  (auto$avgExpr, auto$fc_bothrepeats, 
  pch = "*", col = "black", 
  main = c("autosomes", "n(isoforms)=21349"), xlim=c(2,13), ylim=c(-2,4), 
  xlab = "average expression", ylab = "fold change (1+2), log2" 
          ) 
    abline  (h = c(1, -1), col = "grey", lty = 2) 
  plot  (hetero$avgExpr, hetero$fc_bothrepeats, 
  pch = "*", col = "black", 
  main = c("X-chromosome","n(isoforms)=3473"), xlim=c(2,13), ylim=c(-2,4), 
  xlab = "average expression", ylab = "fold change (1+2), log2" 
          ) 
     abline  (h = c(1, -1), col = "grey", lty = 2) 
  dev.off() 
 
 
script_4 (correlating notch and mes data).r 
 
# open Workspace containing Notch data 
 
 mes <- read.delim("gene.sets_mes.expr.table_2009.11.13.txt") 
 colnames(mes) 
 dim(mes) 
 summary(mes) 
  
# two platforms: oligo and amplicon. 
# oligo: mes2, mes3, mes4 - value of mutant over wildtype 
# amplicon: mes3, mes3, mes4, mes6 - value of mutant over wildtype 
 
# How does the data distribute in terms of fold changes and expression values? 
 
 hist   (mes$A.mes.2.amplicon,  # exchange colname for other categories 
        breaks = 100, ylim=c(0,500), xlim=c(4,16)) 
 
# The mes data contains some less genes or isoforms: 
 
   dim(mes)        # 22227 rows 
   dim(cont.ann)   # 24822 rows 
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# merge the two tables by Wormbase ID 
 
   colnames(mes) 
   colnames(cont.ann) 
   m <- merge(mes, cont.ann, by.x=3, by.y=6) 
   dim(m)          # 24571 rows 
 
# save as new workspace: notch_and_mes.RData 
# separate into X-linked and autosomal genes, test 
# correlate notch with each platform, separated by autosome and heterosome. 
 
 auto <- c("I", "II", "III", "IV", "V") 
 x <- m[m$chromosome == "X",] 
 a <- m[m$chromosome %in% auto,] 
 x[c(1:50), c(1,4,69)] 
 a[c(1:50), c(1,4,69)] 
 
 xl <- c(-1.2, 3) 
 yl.a <- c(-0.8, 1.5) 
 yl.o <- c(-2, 3.5) 
 pdf ("notch-mes-correlationplot_amplicon.pdf", height = 8, width = 14) 
 par (mfrow=c(2,4), pch= "*") 
 plot (a$fc_bothrepeats, a$M.mes.4.amplicon, xlim = xl, ylim = yl.a) 
  abline  (v=0, h=0) 
plot (a$fc_bothrepeats, a$M.mes.2.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (a$fc_bothrepeats, a$M.mes.3.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (a$fc_bothrepeats, a$M.mes.6.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.4.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.2.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.3.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.6.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
dev.off () 
 
 pdf ("notch-mes-correlationplot_oligo.pdf", height = 8, width = 14*3/4) 
 par (mfrow=c(2,3), pch= "*") 
plot (a$fc_bothrepeats, a$M.mes.4.oligo, xlim = xl, ylim = yl.o) 
 abline  (v=0, h=0) 
plot (a$fc_bothrepeats, a$M.mes.2.oligo, xlim = xl, ylim = yl.o) 
 abline  (v=0, h=0) 
plot (a$fc_bothrepeats, a$M.mes.3.oligo, xlim = xl, ylim = yl.o) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.4.oligo, xlim = xl, ylim = yl.o) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.2.oligo, xlim = xl, ylim = yl.o) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, x$M.mes.3.oligo, xlim = xl, ylim = yl.o) 
 abline  (v=0, h=0) 
dev.off () 
 
# is this specific for certain genes or just a general effect because both act on the X? 
# correlate Notch-dependent foldchanges with randomized mes-4 fold changes 
 
 a <- x$M.mes.4.amplicon 
 a1 <- sample(a, length(a)) 
 a2 <- sample(a, length(a)) 
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 a3 <- sample(a, length(a)) 
 
 yl.a <- c(-0.5, 1.5) 
 pdf ("randomized correlation.pdf", height = 4, width = 14) 
par (mfrow=c(1,4), pch= "*") 
plot (x$fc_bothrepeats, x$M.mes.4.amplicon, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, a2, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, a3, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
plot (x$fc_bothrepeats, a4, xlim = xl, ylim = yl.a) 
 abline  (v=0, h=0) 
dev.off () 
 
 
script_5 (cell cycle genes).r 
 
# open Workspace containing Notch data 
# read in a list of cell cycle genes 
 
cc <- read.delim("cellcycle.txt") 
 
# extract interesting categories for the plot 
 
 CDK   <- as.factor(as.character(cc$Gene.WB.ID[cc$category == "CDK"])) 
 cyclin   <- as.factor(as.character(cc$Gene.WB.ID[cc$category == "cyclin"])) 
 inhibitor  <- as.factor(as.character(cc$Gene.WB.ID[cc$category == "inhibitor"])) 
phosphatase  <- as.factor(as.character(cc$Gene.WB.ID[cc$category == 
"phosphatase"])) 
 
# mark in correlation plot and MA plot 
 
cols <- c("orange", "green", "blue", "red") 
 
pdf("cell cycle - fc correlation.pdf") 
plot (cont.ann$fc_repeat1, cont.ann$fc_repeat2, 
  pch = "*", xlim = c(-2,4), ylim = c(-2,4), 
  main = c("regulation of cell cycle genes by Notch"), 
        xlab = "first repeat, fold change (log2)",  
ylab = "second repeat, fold change (log2)") 
 abline (h = 0, v = 0)) 
 points (cont.ann$fc_repeat1[cont.ann$WBid %in% CDK], 
  cont.ann$fc_repeat2[cont.ann$WBid %in% CDK], pch = 19, col = cols[1]) 
     points (cont.ann$fc_repeat1[cont.ann$WBid %in% cyclin], 
  cont.ann$fc_repeat2[cont.ann$WBid %in% cyclin],  pch = 19, col = 
cols[2]) 
 points (cont.ann$fc_repeat1[cont.ann$WBid %in% phosphatase], 
  cont.ann$fc_repeat2[cont.ann$WBid %in% phosphatase],  
pch = 19, col = cols[3]) 
 points (cont.ann$fc_repeat1[cont.ann$WBid %in% inhibitor], 
  cont.ann$fc_repeat2[cont.ann$WBid %in% inhibitor], pch = 19, col = cols[4]) 
     legend ("bottomright", legend = c("CDK", "cyclin", "phosphatase", "inhibitor"), 
              col = cols, pch = 19, bty = "n") 
dev.off() 
 
pdf("cell cycle - MA plot.pdf") 
 plot (cont.ann$avgExpr, cont.ann$fc_both, 
  pch = "*", xlim = c(2,14), ylim = c(-2,4), 
  main = c("regulation of cell cycle genes by Notch"), 
       xlab = "average expression", ylab = "fold change (from both repeats)") 
 points (cont.ann$avgExpr[cont.ann$WBid %in% CDK], 
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  cont.ann$fc_both[cont.ann$WBid %in% CDK], 
  pch = 19, col = cols[1]) 
points (cont.ann$avgExpr[cont.ann$WBid %in% cyclin], 
  cont.ann$fc_both[cont.ann$WBid %in% cyclin], 
  pch = 19, col = cols[2]) 
 points (cont.ann$avgExpr[cont.ann$WBid %in% phosphatase], 
  cont.ann$fc_both[cont.ann$WBid %in% phosphatase], 
  pch = 19, col = cols[3]) 
 points (cont.ann$avgExpr[cont.ann$WBid %in% inhibitor], 
  cont.ann$fc_both[cont.ann$WBid %in% inhibitor], 
  pch = 19, col = cols[4]) 
   legend ("topright", legend = c("CDK", "cyclin", "phosphatase", "inhibitor"), 
              col = cols, pch = 19, bty = "n") 
  dev.off()   
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Generation of a mouse monoclonal MEX-3 antibody 
 
Clearly, the precise role of MEX-3 in the stem cell compartment remains to be 
determined. Since RNAi of cki-2 does not rescue puf-8 mex-3 double mutants (Fig. 20B), 
MEX-3 likely regulates other mRNAs apart from cki-2 in stem cells. However, RNA-co-
IPs and microarray analysis using available MEX-3 antibodies yielded unexpectedly few 
targets at low enrichement rates (observation of Björn Biedermann). The MEX-3 
transgene available in the lab (see Methods) does not rescue the embryonic lethal 
phenotype of embryos born from mex-3 mutant mothers, although it can replace MEX-
3 in mex-3 gld-1 gld-2; glp-1 mutants. Since the basis of this discrepant behaviour is 
not clear, this transgene is not a perfect tool to isolate bona fide MEX-3 targets. We 
thus decided to raise a monoclonal antibody against MEX-3. Considerations for 
peptide design were presence of the sequence in all C.elegans MEX-3 isoforms, 
location outside the KH domains, lack of conservation in mouse, low Methionine, 
Tryptophane or Cystein content to facilitate peptide production, low chance of 
posttranslational modification by prediction algorithms, and high charge as a predictor 
for surface exposure. Based on these criteria, three peptides (4068610, 
FYRRAFGNSNPFNQKE + C; 4068611, DPEDIAQFLNYRTSIGVQ + C; and 4068612, 
CDHNDHTLVPING) were injected by the FMI monoclonal antibody facility (Fig. 24A). All 
antibody clones that specifically recognized MEX-3 in immunofluorescence assays and 
Western blot analysis (Fig. 24B and 24C; Table 7) were directed against peptide 
4068611, DPEDIAQFLNYRTSIGVQ. It will be curious to see whether cki-2 mRNA can be 
co-immunoprecipitated with MEX-3 from gld-1 gld-2; glp-1 animals using this 
antibody, and which additional MEX-3 targets mRNA-co-IPs and genome wide analysis 
of targets will yield.   
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Figure 24. Generation of a monoclonal mouse antibody against MEX-3.
(A) MEX-3 protein sequence with domains and possible modifications indicated. Peptides 610, 611 and 612 
were chosen to be unmodified, unconserved, and surface exposed. (B) Dissected gonad and embryos (outlined) 
stained with supernatant from clone 72G (embryos) and 78L (germline). Pictures shown are representative for 
all clones that performed well in immunofluorescence (see Table 7). In the germline, MEX-3 is expressed in 
stem cells (asterisk) and oocytes. In embryos, MEX-3 localizes to P-granules and to the AB lineage. a,b,c,d: 1, 
2, 4, and ~10 cell stage embryo. (C) Western blot using indicated clones on lysate from N2 (left band) and 
mex-3(RNAi) treated (right band) animals. Clones 78L, 5E, 78A, and 47N detect a single band that disappears 
upon mex-3(RNAi) and perform well in immunofluorescence (see Table 7).
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Table 7. Performance of individual MEX-3 antibody clones. 
clone pept. immunofluorescence Western (N2 vs mex-3(RNAi)) 
5 E 611 mex-3, no background recognizes MEX-3, no background 
76 G 611 mex-3, no background recognizes MEX-3, no background 
78 L 611 mex-3, no background recognizes MEX-3, no background 
47 N 611 mex-3, no background recognizes MEX-3, no background 
46 V 610 mex-3, no background recognizes MEX-3 but also sth else 
12 B 611 mex-3, no background recognizes MEX-3 but also sth else 
55 G 611 mex-3, no background recognizes MEX-3 but also sth else 
85 E 611 mex-3, no background no signal 
22 C 611 mex-3, no background not tested 
47 H 611 mex-3, no background not tested 
78 A 611 mex-3, somatic gonad recognizes MEX-3, no background 
26 B 611 mex-3, somatic gonad recognizes MEX-3, no background 
69 T 611 mex-3, sth. else in mid pachytene recognizes MEX-3, no background 
68 M 611 
mex-3, somatic gonad, funny epitope in 
late pachytene nuclei 
recognizes MEX-3 but also sth else 
62 H 611 
mex-3, nuclei, particularly around the 
bend 
recognizes right size weakly, but not 
much depleted in RNAi 
62 D 612 
mex-3, high cytoplasmic background in 
germline, gut 
not tested 
21 F 610 
mex-3, nuclear epitope that is also 
cytoplasmic distally, gets off nuclei when 
dividing, in TZ 
not tested 
72 G 611 mex-3, somatic gonad membranes not tested 
30 L 611 mex-3, sth else as well not tested 
70 N 612 
mex-3, high cytoplasmic background 
(smallish points) in central gonad 
not tested 
73 A 610 not tested not tested 
44 O 612 
nuclei in gonad, gut, punctae, somatic 
gonad sheeth 
not tested 
8 D 612 
punktae in oocytes (few), distal, 
pachytene (many). Very likely 
centrosomes. 
not tested 
36 D 612 
somatic gonad membrane, punctae in 
cytoplasm, nuclear epitope in embryos, p 
granules in embryos 
not tested 
88 H 612 
somatic gonad, nuclei until bend, p 
granules 
not tested 
72 H all weakly p-granules not tested 
29 D 611 
centrosomes, punctae in rachis, maybe 
sth in oocyte nuclei 
not tested 
7 P 610 
decorates entire outside of the gonad 
(but does not look like membrane 
staining) 
not tested 
13 A all 
dots in all tissues. In the germline, they 
are absent from the rachis.  
not tested 
68 F 610 
granular in germline, membranes, nuclei 
from bend on 
not tested 
17 G 612 maybe weak mex-3, sth else not tested 
94 K 611 no staining no signal 
58 C 611 no staining not tested 
82 N 611 no staining not tested 
52 W all no staining not tested 
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